Development of Phosphate Based Glass Scaffolds for the Repair of Craniofacial Bone by Al-Qaysi, Mustafa
1 
 
Development of Phosphate Based Glass Scaffolds for the 
Repair of Craniofacial Bone 
 
A thesis submitted to the University College London in 
fulfilment of the requirements for the degree doctor of 
philosophy by 
 
Mustafa Al-Qaysi BDS (Iraq), MSc(Iraq) 
University College London 
 
2018 
UCL Eastman Dental Institute 
Biomaterials and Tissue Engineering Research Division 
University College London 
  
2 
 
Declaration 
I, Mustafa Al-Qaysi confirm that the work presented in this thesis 
is my own. Where information has been derived from other 
sources, I confirm that this has been indicated in the thesis. 
 
 
Signature:                                                date: 6 th December 2017  
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
 
This thesis is dedicated to 
the memory of my father 
and my grand mother 
 
 
 
 
 
 
 
 
4 
 
 
Acknowledgements 
Firstly, I would like sincerely to thank my primary supervisor, Professor 
Jonathan Knowles, for his educational advice and guidance and for his 
immense support and encouragement throughout my PhD study.  
I would like to acknowledge my secondary supervisor, Dr Rishma Shah for 
her support.  
I would like to thank the higher Committee of education development in Iraq 
(HCED) for funding my PhD study as a part of educational scholarship 
programme.  
I would like to acknowledge Dr Graham Palmer, Dr George Georgiou, Dr 
Nicola Mordan for their training and technical assistance. I would like to thank 
Dr Farzad Fouroutan for his teaching and supervision regarding glass 
making procedure. I would like to thank Dr Nick Walters, Dr Tuula Eriksson, 
Dr Nasser Al-Qhatani for their help and advice concerning cell culture related 
studies.  
I would gratefully thank Dr Piyaphong Panpisut, Dr Alaa Aldaadaa, Mayda 
Arshad, Nazanin Owji, SongYi Baek for their support. 
Finally, I would like to hugely acknowledge my wife and my two daughters 
Sura and Sadan for their whole support and patience through my PhD 
journey. 
 
5 
 
 
 
Abstract 
Degradable phosphate-based glasses have been known to have many 
potential properties to work as biomaterials for bone repair clinical 
applications. Although several studies were performed on different 
compositions to investigate the most appropriate glass formula, no specific 
formula was found to be the most favourable for clinical application.  
The main aim of this thesis was to fabricate and biologically assess 
phosphate glass scaffold made from specific elements known for their 
potential in promoting bone growth.  
To achieve this, primary studies were done on four different compositions of 
both zinc and strontium phosphate-based glass discs. The next study was to 
further investigate the best two zinc and strontium glass compositions that 
were obtained from the primary studies using glass beads. As a result of this 
study, specific composition of both zinc and strontium phosphate glass, 
having the most favourable cellular response, was recommended to be used 
for the following experiments. Based on previous compositions, another 
study was performed to surface functionalise glass discs by coating them 
with carbon nanotubes (CNTs) and polycaprolactone polymer (PCL) to 
assess the effect of surface modification on cellular adhesion and metabolic 
activity. This was subsequently followed by manufacturing, mechanical 
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testing and structural evaluation of zinc and strontium scaffolds. Another 
experiment was carried out to identify the most suitable technique for scaffold 
cells seeding by coating scaffolds with fibronectin and collagen.  The final 
study aimed to assess different types of zinc and strontium phosphate glass 
scaffolds (non-coated, CNT-coated) in both static and dynamic conditions. 
For the assessment of these scaffolds under dynamic conditions, a perfusion 
bioreactor was custom made that worked continuously for  28 days.  
The results revealed that the most preferable glass compositions were 
identified as ZnO5% and SrO17.5%. Also, glass coating with CNTs and PCL 
has found to encourage cells adhesion and metabolic activity as it enhanced 
both surface roughness and hydrophilicity. Scaffold production by sintering 
technique was thermally optimised and scaffold cellular seeding using 
collagen coating has yielded the most efficient seeding density. The final 
results displayed that the most suitable cellular response was found in CNT 
and PCL coated scaffolds under dynamic conditions (perfusion bioreactors 
cultivated scaffolds). 
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Impact Statement  
Nowadays, many patients are suffering from bone defects. These defects 
may be due to trauma such as traffic accidents or war injuries, pathology 
such as tumours or may be due to congenital defects such as cleft palate. 
Clinical procedures for managing bone repair defects are mainly dependant 
on the severity and extent of the defect. While simple defects can be treated 
by conservative procedures where the body repairs the defect by itself, the 
huge defects may need to the surgical procedures intervention as the defect 
is beyond human body repair. These procedures may involve the application 
of graft material to be placed in the defect site to accelerate the repair 
procedure. These graft materials could be derived from humans or animals 
and could be synthetically fabricated. 
The main aim of this study is to produce scaffolds from phosphate-based 
glasses for bone repair applications. This may be of valuable individual and 
industrial importance. 
Regarding its importance to individuals, the treatment of such defects 
nowadays is usually performed using autografts (grafts taken from the same 
patient) or allografts (grafts taken from other donors). It is important to 
mention that these treatments need extensive surgical procedures that are 
associated with many side effects such as discomfort, chronic postoperative 
pain, donor site morbidity, unpredictable bone resorption and high risk of 
infection at the donor site. In addition to all of these complications, other 
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complications are associated with allografts which are potential 
immunological rejection and cross infection. Therefore, the developed 
phosphate-based glasses scaffolds could be a good alternative as it is made 
of biologically acceptable material and can be applied directly without the 
need for doing further surgical procedures. 
Concerning its impact on industry, the majority of the synthesised materials 
for bone defect repair are mainly dependant on xenografts such as BioOss. 
Although these choices have shown impressive clinical results, there are 
limitations in their application as they have low mechanical properties and 
they are used particularly for repairing small bone defects in bones that are 
not under load. For example, BioOss is used in dental applications for 
alveolar ridge augmentation or for managing periodontal defects. There is 
another disadvantage which is linked to the material of these xenografts. 
These materials are basically animal bones (cows or pig’s bones) that are 
treated by special methods to remove the bone proteins leaving the inorganic 
core materials of these bones to be used clinically. This procedure may be 
costly and also there are some obligations to be observeded for some 
patients who refuse the application of such materials for ethical and religious 
reasons. The produced phosphate-based glasses scaffolds have been 
shown to have mechanical properties slightly better than BioOss and also are 
cost effective because they are made basically of element oxides that are 
available in the market within a reasonable price. Moreover, their production 
is not as complicated as that for xenografts. 
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As a result of the previous aspects, if more research is done on these 
materials in future, these materials may be valuable in helping many people 
around the world who are presenting with severe bone injuries and may 
therfore improve their personal lives. 
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Chapter 1 Introduction and review of the literature 
1.1 Bone  
Bone is an important and dynamic living human tissue that has the ability to 
continuously repair and remodel during human life (Widmaier et al., 
2006).There are also various functions that bone does such as storage of 
minerals and production of blood cells within its marrow spaces (Seeley, 
2000). Its primary function is to maintain a physiological support and 
mechanical protection to the human body which play an essential role in 
providing a body framework (Taichman, 2005). 
1.1.1 Classification of bone  
Bone can be classified according to their morphology into three types; long 
bones, short bones or flat bones. Long bone usually has length that is 
greater than its width and it is formed by cartilaginous precursors via 
endochondral ossification. An example of such bone is limbs’‎bones‎such‎as‎
tibia, femur and radius. Short bone, in turn, is bone that is formed with the 
same precursor as long bone though its width is as similar as its length. An 
example of it are the carpals and the tarsals of the hands and feet. Flat 
bones, furthermore, do not have cartilaginous precursors and they are made 
usually via intramembranous ossification. They have usually flat and/or a 
curved appearance and commonly form the skull bone, the ribs, the sternum 
and the scapulae (Lieberman, 2009). 
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1.1.1.1 Long Bones 
These are made of three distinctive segments which are epiphysis, 
metaphysis and diaphysis (Clarke, 2008). The epiphysis is the polar most 
outer layer of the bone that covers the area of the joints. It is mainly formed 
by compact bone providing it with mechanical properties (Einhorn et al., 
2007). The metaphysis is the area of transformation between epiphysis and 
diaphysis. It is formed from thin compact bone and thick trabecular bone 
beneath it. This part has significant role in skeletal growth because it involves 
the epiphyseal plate (growth plates) and its nourishing blood vessels (Lewis, 
1956). Conversely, the diaphysis is mainly composed from thick compact 
bone and thin trabecular bone surrounding the central intramedullary canal 
that is also called the marrow cavity (Clarke, 2008).  
1.1.1.2 Short, flat and irregular bones  
 They share similar structural patterns involving thin bony plates of both 
compact bone; covered by periosteum on the outside, and cancellous bone; 
covered by endosteum in the middle. These bones lack the cylindrical shape, 
and they are usually flat  (Currey, 2002a). 
1.1.2 Bone microscopic anatomy 
At a microscopic view, two types of bone can be identified according to bone 
architecture; cortical (compact) and cancellous bone (spongy bone) (Hing, 
2004). Cortical bone forms the external part of a bone. It is characterised by 
its solid and dense structure so as to withstand the external forces. It is 
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composed of well organised structural units called osteons or the Haversian 
system (Currey, 2002b). This system has a cylindrical shape and is made of 
appropriately arranged bone matrix (bone lamella). The bone matrix arranges 
itself in multiple circles around the central Haversian canals. These canals 
serve as the main channel for supplying the bone with blood vessels and 
nerves (Widmaier et al., 2006). Moreover, there are other various small 
channels, perpendicularly intersecting the parallel arranged bone lamella, 
called‎ Volkmann’s‎ canals.‎ Volkmann’s‎ canals‎ main‎ role‎ is‎ to‎ connect‎ the‎
blood vessels and nerves all the way in the whole compact bone ( Figure 1.1) 
(Guyton and Hall, 2006). There are multiple well-arranged spaces distributed 
in the bone lamella called lacunae that are occupied by osteocytes. 
Osteocytes are spider shaped cells that are mature bone cells (Figure 
1.1)(Currey, 2002b). 
 
Figure ‎1-1 Cortical and cancellous bone. Reprinted from  Regenerative Medicine and Tissue 
Engineering, chapter 24, (Chao Le Meng Bao and K.Y., 2013), Advances in Bone Tissue 
Engineering, Regenerative Medicine and Tissue Engineering, copyright (2013), with permission 
from In Tech 
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Spongy bone is not as organised as compact bone. It locates at the inner 
part of bone and is formed from poorly arranged bone. It consists of irregular 
interconnected bone rods and plates called trabeculae (Figure 1.1). These 
trabeculae embrace osteocytes that are interconnected with each other by 
canaliculi. The nutrient distribution through spongy bone occurs through the 
sporadically scattered canaliculi (Currey, 2002b). 
1.1.3 Bone chemical compositions  
Bone is composed of inorganic and organic components.  The organic part 
constitutes around 30-35% of bone mass whereas the inorganic part 
occupies around 65-70% of it (Widmaier et al., 2006). The organic element 
constitutes both the cellular component and the osteoid which is part of the 
bony matrix that includes ground substance (proteoglycan and glycoproteins) 
and collagen fibres. There are three types of bones cells: osteoblasts, 
osteocytes   and osteoclast (Guyton and Hall, 2006, Philippart et al., 2015). 
Osteoblasts are originally multi-potential mesenchymal stem cells derivatives 
(Maher et al., 2015). Stem cells have the potential to differentiate into 
different cell types. If these cells were stimulated in vitro via specific markers 
such as dexamethasone,  they may give rise to mono-potential progenitor 
cells called osteoprogenitors, which have an extensive proliferation capability 
(Pittenger et al., 1999). This differentiation can lead to pre-osteoblast 
development, as a preliminary step preceding osteoblast formation, and may 
yield in confined intercellular substance production (Aubin and Triffitt, 2002). 
The final differentiated osteoblasts are responsible for the deposition of 
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extracellular matrix (osteoid). Osteoid has many roles such as  providing the 
bone with the needed mechanical requirement ,promotion of intercellular 
adhesion and also cellular signalling (Florencio-Silva et al., 2015).  
Once engulfed by the mineralised bony matrix, fully differentiated osteoblasts 
become osteocytes that are interconnected among themselves by fluid filled 
small canals (Currey, 2002b). Osteocytes have two main functions; the first 
one is mechanotransduction as they transform the stress induced signals of 
bone bending or stretching through the canalicular fluid flow. The second 
function is the secretion of some matrix proteins such as osteocalcin and 
hyalouranate that play an important role in cellular adhesion (Bonewald, 
1999). 
Osteoclasts are multinucleated huge cells containing 4 to 40 nuclei. They 
have the capability of bone removal and resorption. Osteoclasts are 
generally derived from marrow monocyte-macrophage lineage (Boyle et al., 
2003). During bone resorption processes, osteoclasts tend to secrete both 
hydrogen ions and cathepsin K enzyme. H+ ions will decrease the pH and 
enhance the required acidic environment for the resorption processes of 
inorganic compound , whereas cathepsin K enzymes play a significant role in 
the destruction of the highly saturated type I collagen intercellular matrix 
(Parfitt, 1994, Boyle et al., 2003). 
1.1.3.1 Organic matrix components 
The extracellular matrix of bone is defined as a substance that surrounds the 
cellular component of bone and is composed from mineral and an organic 
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component which is produced by osteoblasts (Currey, 2002b). The organic 
compound constitutes about 35% of bone mass. Bone matrix is composed of 
many proteins; collagenous and non-collagenous. The collagenous proteins 
represent about 85 to 90% in which type I collagen is the most predominant. 
The rest (10-15%) is non-collagenous proteins such as osteocalcin, 
osteonectin, bone sialoproteins, proteoglycans and osteopontin (Brodsky and 
Persikov, 2005). 
1.1.3.1.1 Collagen  
Collagen is the major organic protein of the bony extracellular matrix. It 
constitutes about 70-90% of the bony organic component. While 97% of this 
is type I collagen, the remnant is of type II, III, V and X collagen (Marks and 
Popoff, 1988). Collagen has a major role in bone health and function. Keene 
et al (1991) supposed that the different types of collagen present in bone 
may improve the attachment of different muscloskeletal related tissues such 
as tendons, ligaments and periosteum to the cortical bone (Keene et al., 
1991). Moreover, collagen especially type 1 may enhance the maturation of 
osteoblasts and encourage matrix mineralisation (Lynch et al., 1995). 
Salaszynk et al (2004) examined the effect of collagen on stem cells and 
hypothesised that collagen may have a promoting effect for osteogenic 
differentiation of stem cells (Salasznyk et al., 2004). A later study showed the 
important action of collagen in preserving bone strength and mineral content 
maintenance. This study linked the age-related collagen modifications and 
collagen diseases with the decreased bone quality and fragility of bone 
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(Viguet-Carrin et al., 2006). McNerny et al (2015) suggested that collagen 
crosslinking may play a highly important role in bone health and that cross 
linking disorders may impact negatively on bone quality and bone strength 
resulting in bone with a high susceptibility to fractures (McNerny et al., 2015). 
1.1.3.1.2 Glycoproteins 
Glycoproteins are protein matrix compounds produced by the attachment of 
carbohydrates to a protein core. They may have various active sites on their 
structure, which may react with cell wall and membrane receptors (Hughes, 
2014). There are various types of glycoproteins such as fibronectin, 
vitronectin, bone sialoprotein, osteonectin, osteocalcin and osteopontin 
(Boskey and Robey, 2013). 
Fibronectin is a bone matrix protein synthesised by connective tissue cells. 
Although‎it‎has‎many‎functions,‎ its’‎essential‎role‎ is‎to‎work‎as‎an‎adhesive‎
glycoprotein and helping in the fibrous network assembly of the extracellular 
matrix. This property enhances binding and interaction among different 
extracellular matrix components and cell surface receptors (Romberger, 
1997). Fibronectin was reported to be formed  during the first step of bone 
formation and has a central role in osteoblast regulation (Grzesik and Robey, 
1994). 
Vitronectin is serum protein, initially known as S-protein. Due to its cell-
spreading activity and attachment hyperactivity to cells, it is not found at high 
levels in bone mineralised matrix (Grzesik and Robey, 1994). Beside its cell 
attachment activity, it shows good ability to bind to plasminogen activator 
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inhibitor and affect the regulation of coagulation and complement factors 
(Schvartz et al., 1999). 
Bone sialoprotein is also a glycoprotein that is defined as sialic acid 
contained glycoprotein. Apart from bone, it can be found also in other human 
mineralised tissues such as dentine, cementum and mineralized cartilage 
(Foster et al., 2015). Generally, there is an idea that its expression is related 
to the mineralisation process. It is thought to be a late marker for osteoblastic 
differentiation and at the same time an early marker for matrix mineralisation 
(Bianco et al., 1991). Recent studies revealed that the lack of this protein 
may be related to impaired osteochondral bone development (Holm et al., 
2015). 
1.1.3.1.3 Osteonectin  
Osteonectin is the highly abundant non-collagenous organic protein; it is 
formed by both osteoblasts and fibroblasts (Rosset and Bradshaw, 2016). 
One of the chemically significant characteristics of osteonectin is that it holds 
several di-glutamate bonds that have the ability to conjugate with other ions 
and molecules that play a positive role in bone such as calcium, collagen and 
hydroxyapatite. Therefore, its suggested to be involved in cell- matrix 
interaction rather than the mineralisation process  (Hing, 2004). 
1.1.3.1.4 Osteocalcin  
Osteocalcin is an abundant non-collagenous protein like osteonectin. It is a 
Matrix Gla protein (MGP) whose synthesis is fully dependent on vitamin K 
(Hauschka et al., 1989). Osteocalcin, clearly has a high affinity to calcium 
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ions as its structure contains a special alignment of Gla proteins which 
assists in the absorption of hydroxyapatite. Moreover, its structure terminated 
with -COOH may help as a site for cellular interaction (Neve et al., 2013). 
Although the role of osteocalcin is not fully understood, some studies 
suggested that it plays a role in bone resorption and osteoclast cell 
differentiation. One study was performed to determine the function of 
osteocalcin. This study was done by genetically engineering free osteocalcin 
mice to examine the effect of lacking osteocalcin. The results showed that 
free osteocalcin mice were able to form more bone than the normal mice with 
lower remodelling activity because of the reduced action of osteoclasts (Ducy 
et al., 1996). Rammelt et al (2005) concluded in another study of multiple 
grafting of synthesised hydroxyapatite/collagen implants in the tibia head of 
rat. Osteocalcin was investigated also by adding it to one of the implanted 
samples while leaving the other site as control. The results of this in vivo 
experiment suggested that osteocalcin may enhance bone modelling as 
osteocalcin treated sites displayed bone remodelling activity through the 
acceleration of transformation from woven bone to lamellar bone  (Rammelt 
et al., 2005). Recently it was found that osteocalcin has a positive role in 
osteogenesis and bone metabolism (Neve et al., 2013). 
1.1.3.1.5 Osteopontin   
Osteopontin is identified as a phosphorylated glycoprotein that is present in 
many tissues and has a high affinity for hydroxyapatite (Butler, 1989). 
Studies have revealed that it is expressed and secreted in the bone matrix 
43 
 
osteoid as a part of the bone formation process via preosteoblasts, 
osteoblasts and osteocytes (Marks and Popoff, 1988). Many researchers 
have reported that osteopontin may enhance cellular attachment of 
osteoblasts and fibroblasts(Oldberg et al., 1986, Somerman et al., 1987). 
Some findings claimed that its expression may have a contribution in bone 
development and showed that its expression is significantly enhanced during 
the late mature phase of osteoblasts (Butler et al., 1996). 
1.1.3.1.6 Proteoglycans  
Proteoglycans are extracellular proteins that are made of main protein 
molecules attached to long sequences of polysaccharides and 
glycosaminoglycans GAGs. GAGs are simply a sequence of replicating 
sulphated carbohydrate units (Meisenberg and Simmons, 2016). GAGs can 
present as keratan sulphate, chondroitin sulphate or heparin sulphate (Iozzo 
and Schaefer, 2015). According to their size, proteoglycans can be divided 
into different types; two of these types are popular which are decorin and 
biglycan. Decorin and biglycan are known to inhibit bone cell attachment to 
the extracellular matrix by binding to fibronectin and preventing binding with 
cells. The presence of these proteoglycans in the osteoid makes them 
potential candidates as nucleators for hydroxyapatite precipitation (Robey, 
2002).  
1.1.3.1.7 Alkaline phosphatase 
Alkaline phosphatase (ALP) is a dimeric enzyme with two active Mg2+ and 
Zn2+ sites. This enzyme possess the ability to attack inorganic 
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pyrophosphate (ppi) groups and release free phosphate (pi) resulting in 
increasing the local inorganic concentration for mineralisation processes 
(Harmey et al., 2004). Its action during mineralisation is mostly related to its 
ability to promote hydroxyapatite crystal formation and the collagen fibril 
deposition process (Orimo, 2010). ALP is expressed in the process of stem 
cell development, so it is considered one of the stem cell development 
indicators (Stefkova et al., 2015). It is also highly expressed during stem cell 
differentiation to osteoblasts, but this high expression is only recorded in the 
early stage of differentiation. As the differentiation progresses, other markers 
are upregulated whereas alkaline phosphatase declines(Golub and Boesze-
Battaglia, 2007).   
1.1.3.2 Inorganic matrix component 
Inorganic bone matrix constitutes about 65-70% of bone mass. It is made of 
minerals which are mainly calcium and phosphate ions that bind to each 
other to form hydroxyapatite [Ca10(PO4)6(OH)2] that are usually combined 
with many other elements in the human body such as fluoride, carbonate, 
and chloride  with missing hydroxyl groups that are normally present (Currey, 
2002b, Ferraz et al., 2004). 
1.1.4  Bone development  
1.1.4.1 Intramembranous ossification 
This is the ossification process by which flat bones of the skull and mandible 
are formed. It starts by the proliferation of mesenchymal stem cells. These 
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cells have the capability to differentiate into osteoblasts. Osteoblasts secrete 
the proteoglycan proteins which are responsible for trapping calcium ions. 
This will lead eventually to osteoid formation. Within time, these cells will be 
surrounded by bone completely. At this stage, they are called as osteocytes 
instead of osteoblasts (Mitchell and Peel, 2009). 
 As the bone matrix forms, a lot of trabeculae will be formed and connect to 
each other to make cancellous bone. These trabeculae will be penetrated by 
blood vessels in which red bone marrow is present. Finally, the cancellous 
bone will be substituted by cortical bone. At the outer superficial layer of 
bone, mesenchymal cells pack and condense to form periosteum (Mitchell 
and Peel, 2009). 
1.1.4.2 Endochondral ossification 
This type of ossification involves initially the formation of the cartilage model. 
The cartilage model is formed as consequence of mesenchymal stem cells 
accumulation and proliferation in the shape of the future bone. These stem 
cells will differentiate into chondroblasts then chondrocytes. The latter is 
responsible for cartilage matrix secretion (Mitchell and Peel, 2009). 
Once the cartilage model is formed, it will be invaded by cells at various 
sites; at the centre and the periphery forming the primary and secondary 
centres of ossification. By the time, these centres of ossification slowly 
expand in all directions to end up by replacing the cartilage completely with 
bone. (except at the articular surfaces) (Figure 1.2) (Mackie et al., 2008). 
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Figure ‎1-2 Development of endochondral bone. Schematic diagram showing the events leading 
to replacement of an embryonic cartilage model by bone. (A) Cartilage model. (B) Initiation of 
formation of the primary centre of ossification in the centre of the cartilage model (C) Well 
established primary centre of ossification cartilage. (D) The formation of secondary centres of 
ossification and formation of growth plate (E) In the adult bone, the metaphyseal and 
epiphyseal bone have fused to each other. Reprinted from International Journal of Biochemistry 
and Cell Biology, volume 40,  (Mackie et al., 2008) Endochondral ossification: how cartilage is 
converted into bone in the developing skeleton, page 46-62, with permission from Elsevier. 
The endochondral ossification takes place at two different locations in the 
long bones – the primary (diaphyseal) and the secondary (epiphyseal) sites 
of ossification. Bone formation starts at the primary site, while the secondary 
(epiphyseal) sites still under autonomous control and are ossified later. As a 
result of this development, there will be a formation of layer of distinction 
between these two centers of ossification which is called a growth plate 
(epiphyseal plate) and is located between the diaphysis and the epiphysis. 
During bone growth, there will be some fusion between diaphysis and the 
epiphyseal plate forming an area called metaphysis (Morishima et al., 1995). 
At the primary central area, chondrocytes segregate into hypertrophic 
chondrocytes allowing for local calcification. This will consequently result in 
chondrocyte death because of slow diffusion and low nutrient supply 
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throughout the hardened bone (Ortega et al., 2004). There are two theories 
behind the death of hypertrophic chondrocyte. Whereas the earliest theory 
related that to apoptosis (Wilsman et al., 1981), the recent studies explain 
that this happens because of another phenomena which is morphologically 
distinct from apoptosis (Adams and Shapiro, 2002). Because of cell death, 
thin walled lacunae will be formed which will eventually be broken leaving 
small holes for microvascularisation. As a result of a highly distributed 
vascularisation, some of the cells differentiate to osteoblasts. New bone 
matrix formation happens in the central area because of deposition of both 
calcium and phosphate as hydroxyapatite with the aid of other proteins and 
alkaline phosphatase that are expressed from osteoblasts resulting in 
replacement of most of the central cartilage (Anderson et al., 2004, Kirsch, 
2006) .  
 The osteoblast plays the main role in the new bone formation. This starts at 
the beginning by producing cancellous bone on the remnant of the cartilage. 
As bone formation continues to extend to the two peripheral ends, 
osteoclasts start to remove some bone in the central area to create a hole. 
This hole will be filled with red bone marrow and called medullary trabeculae 
(Ortega et al., 2004). 
The secondary ossification develops in the same way as the primary centres 
with help from the epiphyseal artery vascularisation. Although both centres 
have the same endochondral ossification process, they slightly differ in some 
aspects. The first difference is that there is no resorption in the secondary 
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(peripheral) centres and bone remain the same in the epiphysis with no 
future resorption. The other difference is that hyaline cartilage is completely 
replaced into bone in diaphysis whereas it is not fully substituted in the 
epiphysis and there will be trace of cartilage near the end of epiphysis which 
is called epiphyseal plate that will be ossified in the early adulthood (Mackie 
et al., 2008). 
1.1.5 Osteogenic differentiation of mesenchymal stem cells  
Stem cells differentiation into osteoblast is a multi-stage procedure that 
involves many cellular changes. The first stage includes the differentiation 
into osteoprogenitors that will further differentiate into preosteoblasts which 
will lastly differentiate into osteoblasts. The identification of these stages is 
usually made by detection of specific markers which are secreted by the cells 
in specific time during the differentiation process (Figure 1.3). There are 
different types of tissue markers associated with this type of cellular 
transformation such as type I collagen, alkaline phosphatase and osteocalcin 
(Aubin et al., 1995). According to Stein et al (1990) the osteoblast 
differentiation process can be divided into three different phases. Each phase 
is regulated by specific genes which are responsible for expressing the 
phase related proteins. These phases are 1: proliferation, 2: matrix 
maturation and 3: mineralisation (Stein et al., 1990). The first phase extends 
from day 1 to day 4 after seeding, the second phase extends from day 5 to 
day 14 and the third phase from day 14 to day 28  (Aubin, 2001, Huang et 
al., 2007). 
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Regarding the proliferation phase, it was found that there is a high increase 
in cell replication with significant secretion of collagen type 1. Collagen type 1 
reached the peak of secretion on day 3 but it does not appear pronounced in 
the extracellular matrix until day 7 when collagen biosynthesis diminished 
(Quarles et al., 1992). The early secretion of collagen may play a stimulating 
role for other bone marker expression such as alkaline phosphatase and 
osteopontin which are  secreted later (Celic et al., 1998). BSP was found to 
be upregulated in this phase and preceding alkaline phosphatase expression 
(Malaval et al., 1999). The second phase is the matrix maturation in which 
there is preparation of minerals  deposition with substantial secretion of 
alkaline phosphatase (ALP) (Aubin, 2001). The mineralisation phase is 
characterised by higher expression of osteopontin, osteonectin and 
osteocalcin. Osteocalcin is not secreted until day 14 (Birmingham et al., 
2012).There is a controversy about the actual phase of osteopontin 
expression. While previous studies believed that this expression commonly 
happens during the matrix maturation stage (Stein et al., 1990), the following 
studies placed it as marker for the mineralisation phase as it is expressed 
together with osteocalcin (Stein et al., 1996). Some studies allocate its 
expression as an indicator for both phases (Owen et al., 1990). 
When looking at tissue markers, it was found that the differentiation is made 
of seven stages rather than 3 stages in which both collagen and BSP are 
secreted in the early while alkaline phosphatase is usually secreted in the 
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intermediate stages and osteocalcin is  expressed in the later mineralisation 
stage ( Figure 1.3) (Aubin and Triffitt, 2002). 
There is an indirect relationship between proliferation and differentiation. In 
other words, as osteoblasts reached the final stage of differentiation, their 
rate of proliferation will decline. This opinion was judged after measuring the 
levels of both histone (a protein associated with DNA to form chromatin) and 
mRNA which is known also as a biological indicator of proliferation. The level 
of expression of the previous two seemed to decline during the maturation 
phase (Stein et al., 1989a, Stein et al., 1989b). 
The original location of osteoblasts is also a factor that has an influence on 
the way osteoblasts differentiate and the levels of the expressed proteins. 
This influence was accounted by a study which involved studying bone taken 
from two different sites (iliac crest and mandible) of the same person to 
exclude the age factor. This study revealed that the expression of alkaline 
phosphatase and osteocalcin expression was higher for the cells from the 
iliac crest, but proliferation was higher for the mandible extracted osteoblasts 
(Kasperk et al., 1995). Another study was conducted using femoral head and 
skull bones of different patients. Although this study revealed results similar 
to the previous study in regard to alkaline phosphatase concentration, the 
proliferation results were different in that proliferation of femoral head 
extracted osteoblasts was higher than that of skull cells (McDougall, 2001). 
The in vitro osteogenic differentiation of human mesenchymal stem cells 
(hMSCs) can be controlled by the culture media condition and its 
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components. Adding dexamethasone, ascorbic acid and B-glycerol 
phosphate to the culture media can stimulate hMSCs to take the osteogenic 
lineage pathway rather than other differentiation pathways (Vater et al., 2011, 
Akahane et al., 2016). 
 
Figure ‎1-3 Postulated steps in the osteoblast lineage implying recognizable stages of 
proliferation and differentiation as detectable from in vitro and in vivo experiments. Reprinted 
from Principles of bone biology,  volume 1, chapter 4, (Aubin and Triffitt, 2002). Mesenchymal 
stem cells and osteoblasts.  
1.1.6 In Vitro osteoblast adhesion to biomaterials  
According to biomaterial definitions, adhesion is a term that involves two 
aspects: firstly the attachment aspect which happens instantly for a short 
term such as physicochemical linkages between cells and materials, and 
secondly is the adhesion aspect that happens over a longer period of time 
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and includes the intervention of extracellular proteins, cell membrane 
proteins and cytoskeleton proteins (Anselme, 2000). 
There are various organic extracellular matrix formation proteins such as 
collagen, proteoglycan, osteopontin and osteocalcin. These proteins are 
produced by osteoblasts and mostly are involved in cell adhesion. However, 
there are other molecular proteins in vitro that can aid the adhesion of 
osteoblasts such as fibronectin and vitronectin (El-Amin et al., 2003). Studies 
have shown that cells do not have high adherence ability to normal 
unconditioned materials. These materials may need to be soaked in a 
conditioning biological liquid to enhance their attachment ability (Boyan et al., 
1996) . 
To investigate cells adhesion related proteins, primary human osteoblasts 
have been seeded and cultured on different protein coated dishes. In one 
study, osteoblasts showed good adherence to fibronectin as well as to type I, 
type IV collagen and vitronectin coating, but they possessed a weak 
adherence ability to laminin and type V collagen coated dishes (Gronthos et 
al., 1997). This may be due to adhesion related proteins e.g. fibronectin, 
vitronectin and type I collagen revealing that they have a specific structure of 
Arg-Gly-Asp (RGD) peptide sequence that plays a positive role in cell 
membrane receptor fixation processes such as integrins. Other study 
confirmed the previous one in which it displayed that Arg-Gly-Asp (RGD) 
peptide coated surfaces showed better adhesion property than RGE (Arg-
Gly-glu) peptide coated surface (Rezania et al., 1997). 
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1.2 Craniofacial biomaterials  
Bone loss defects in human bodies are mainly caused by trauma, neoplasms 
and congenital abnormalities (Miloro et al., 2004). Although bone has the 
internal capacity to regenerate by itself, clinical intervention by bone 
construction (repair) procedures may be needed in some situations when 
there‎is‎a‎severe‎defect‎that‎exceeds‎the‎host‎tissue’s‎regenerative‎capacity‎
(Smith et al., 2015a). Generally, there is a misunderstanding or confusion 
regarding‎ using‎ the‎ terms‎ “bone‎ repair”‎ and‎ “bone‎ regeneration”.‎Whereas‎
the‎ term‎ “bone‎ repair”‎ defines‎ the‎ continuous‎ physiological‎ remodelling‎
process that aims to restore the optimum physiological bone structure, the 
term‎“bone‎regeneration”‎explains‎ the‎ ‎complicated‎process‎of‎ forming‎new‎
bony tissue (Donati et al., 2007). Bone regeneration procedures are mainly 
varied according to the graft materials used. These materials should have 
specific properties, (Damien and Parsons, 1991, Goldberg, 2001) such as: 
1: Mechanical requirement enabling them to support the load and maintain 
the structure. 
2: Osteoactivity requirement for enhancing the new bone formation. 
Osteoactivity involves both osteoinduction and osteoconduction.   
Osteoinduction refers to the ability to enhance the recruitment and 
osteogenic differentiation of mesenchymal cells situated near the graft 
(implant) or from revascularization. Whereas osteoconduction means that 
these materials should have spatial properties that permit the ingrowth of 
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vessels and osteoprogenitor cells from the host subject to support bone 
formation. 
3: It should not cause any pain, fracture, excessive bleeding, foreign body 
response or transmission of diseases. 
Bone engineering is a term involving both mechanical and biological (bone 
regeneration) aspects for the restoration of lost or affected tissue in order to 
provide functional bone tissue by inducing the new cells to produce bone  
(Bose et al., 2012).  
1.2.1 Autogenous bone graft (autograft): 
Autograft is still considered to be the benchmark grafting material (Farre-
Guasch et al., 2015). It can be divided into both cortical and cancellous 
grafts, or into non-vascularised and vascularised grafts (Fillingham and 
Jacobs, 2016). It is free from immunological rejection as it is a harvested 
graft originating from the same individual (Sharif et al., 2016b). They offer 
good structural support with low viral transmission possibilities. For 
maxillofacial bone repairs, it can be gained either from intraoral or extraoral 
sites. While Intraoral are the symphysis, the ramus, and the angle of the 
mandible, extraoral  sites are the iliac crest, ribs, tibia, fibula, calvaria, and 
sternum (Zimmermann and Moghaddam, 2011). However, grafts that are 
harvested from iliac crest are more optimal than other graft types and the 
mandible is the most common transplant site in dental surgery (Cypher and 
Grossman, 1996).  
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Autogenous grafts are osteoactive materials that have both the 
osteoinductive and osteoconductive properties capable of enhancing 
mesenchymal stem cell differentiation into osteoblasts and hence bone 
formation (Garcia-Gareta et al., 2015). Cortical autogenous grafts offer good 
support and mechanical properties, whereas cancellous grafts are rich with 
osteoprogenitor stem cells making them of benefit to the repair site.  
Following transplantation, the non-vascularised graft goes via a process of 
resorption and revascularisation, whereas the vascularised graft heals rapidly 
going through different remodelling stages similar to that of normal bone 
(Zimmermann and Moghaddam, 2011). The main disadvantages linked to 
this type of graft are discomfort,  chronic postoperative pain, donor site 
morbidity, unpredictable bone resorption and  high risk of infection (Sharif et 
al., 2016b). 
1.2.2 Allograft bone 
Allograft bone is one of the main types of bone graft material. They are 
usually obtained from human donors to eliminate the drawbacks of a second 
surgical site and the increased surgical time that are associated with 
autogenous graft options (Jovanovic et al., 1992). Similar to the autogenous 
graft, they are considered osteoconductive materials, though their osteogenic 
ability is lower than that of autogenous graft (Oklund et al., 1986). Allograft 
can be prepared in different sizes and be used in different augmentation 
procedures. They are applied in surgical procedures as sterilised fresh frozen 
or freeze dried materials both approved by the Food and Drug Administration 
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(FDA) (Roberts and Rosenbaum, 2012). Although many advanced 
procedures are used in their sterilisation, cross infection remains their most 
significant drawback as some incidental cases of bovine spongiform 
encephalopathy infection have been reported after allograft implantation 
(Control and Prevention, 2002). 
1.2.3 Xenograft bone 
Xenografts are bovine or pig derived skeletal tissues that have been 
deproteinated to produce inorganic bone scaffolds (Thuaksuban et al., 2010) 
. The deproteination process is performed usually by using ethylene diamine 
to extract all the organic components of bone (King et al., 2006). Commercial 
xenografts such as Bio – Oss or Pepgen-P15 are organic-free composition 
grafts that are constituted mainly from calcium phosphate, making their 
chemical and morphological properties similar to the mineral component of 
normal bone. For example; they are porous materials, and their porosity and 
spatial microstructure mimics that of human cancellous bone. This structural 
arrangement may play a positive role in angiogenesis and osteoblast 
migration (Sartori et al., 2003). Nowadays, they are used in diverse cases 
extending from small bony defect repair in clinical periodontology to 
complicated surgical cases such as maxillary sinus augmentation (Mardas et 
al., 2010, Piattelli et al., 1999). Many studies investigated the clinical use of 
xenograft alone or mixed with other bone substitutes. These clinical trials 
were performed by using different surgical procedures, and showed very 
promising clinical outcomes in regard to bone growth (Wallace et al., 2005). 
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Although xenograft materials showed good potential in the bone repair field, 
there are some ethical, personal and religious reasons that may prevent their 
medical application (Sharif et al., 2016a). 
1.2.4 Alloplastic (synthetic) graft. 
Alloplastic is a type of synthesised material used for bone tissue repair 
applications. It is mainly produced to overcome the drawbacks associated 
with the natural bone substitutes; autograft, allograft and xenograft (Hench, 
1998, Bucholz, 2002). Alloplast can be produced in different forms and with 
different physicochemical properties. They can be degradable or 
nondegradable and can be also customised in terms of their network 
structural properties such as pore size and the level of porosity (Sheikh et al., 
2015). According to their materials, they can be classified into three main 
different groups: bioceramics, polymers and  biocomposites (Sharif et al., 
2016a). These synthetic bone alternatives should fulfil the ideal requirements 
of  being biocompatible, showing no fibrotic reaction and supporting the 
newly formed bone (Giannoudis et al., 2005). Moreover, they should 
essentially be biodegradable and produced as a three-dimensional 
framework that can enhance the cellular growth (Smith et al., 2015b). 
1.2.4.1 Bioceramics: 
Tricalcium phosphate (TCP) 
TCP is porous form of calcium phosphate complex that has the formula  
Ca3(PO4)2 where the calcium to phosphate ratio is 3:2 (Damien and Parsons, 
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1991). It occurs in two‎ main‎ crystalline‎ forms‎ known‎ as‎ αTCP‎ or‎ ‎ βTCP‎
(Tamimi et al., 2012).‎ αTCP‎ showed‎ promising‎ mechanical‎ and‎ chemical‎‎
results as an injected material when it was mixed with calcium carbonate and 
other calcium phosphate precursors as a fracture site filler (Sanchez-Sotelo 
et al., 2000).‎Similarly,‎βTCP‎is‎also‎popularly‎used‎as‎a‎ filler,‎and‎showed‎
acceptable results in many clinical studies (Hashimoto-Uoshima et al., 1995). 
Nyan et al (2016)‎clarified‎ that‎both‎αTCP‎and‎ ‎βTCP‎are‎degradable,‎and‎
that‎ αTCP‎ has‎ higher‎ degradation‎ rate‎ than‎ that‎ βTCP‎ (Nyan, 2016). 
Moreover, many studies and reports presented many drawbacks associated 
with TCP application such as higher resorption rate (within 6 weeks), 
formation of fibrous tissue rather than bone during healing process (Parikh, 
2002). 
Hydroxy Apatite: 
The natural mineral phase of bone is nano-sized hydroxyapatite crystals 
having a generalised composition of Ca10(PO4)6(OH)2. In human bone, it 
presents always in combination with other ions such as F-, CO3
2-
 Na
+ or 
Mg2+and other ions. Synthetically, it can be manufactured in many techniques 
such as wet chemical deposition, biomimetic deposition, sol-gel and 
electrodeposition (Ferraz et al., 2004). Sheikh et al (2015) mentioned that the 
synthetic type can be produced in different forms: porous non-resorbable, 
solid non-resorbable, and resorbable porous. Heat is considered to play a 
major factor in synthesising the HA form and shape; using high temperature 
during manufacturing can lead to forming a non- resorbable sintered dense 
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form. Conversely, a low manufacturing temperature is responsible for the 
formation of resorbable porous HA (Sheikh et al., 2015). Many studies were 
performed to test the biological effect of both the dense and the porous types 
as an implant material in bone defect repair and revealed promising clinical 
results. One study, performed by Foster et al (2016) showed the successful 
results of using HA as cement for correcting cranial bone defects (Foster et 
al., 2016) . The main drawbacks of using hydroxyapatite is its poor 
mechanical properties as it is known for its brittleness that limits its use to 
powders, coatings, and low-loaded porous implants only (Suchanek and 
Yoshimura, 1998). As a result, many procedures were introduced to 
incorporate these materials with others, such as polymers, to enforce their 
mechanical features. 
Silicate Bioglass  
Bioglass, invented by Larry Hench, is composed mainly of silicate with other 
metal oxide additives such as phosphorous, calcium and sodium oxides 
(Vogel and Höland, 1987). It has been studied extensively due to its potential 
in bone tissue engineering as it displayed excellent bioactive properties (Kaur 
et al., 2014a). It has been suggested that these silicate glasses have the 
ability to produce a layer of calcium phosphate crystals after immersion in 
SBF (Hayakawa et al., 1999, Takadama et al., 2001, Sriranganathan et al., 
2017). Many experiments were performed on silicate based glasses alone or 
silicate glass composites and all revealed the potential of this material to be 
clinically applied in bone defect repairs as it is biodegradable, has the ability 
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to support differentiation of hMSCs and the proliferation of osteoblasts 
(Rezwan et al., 2006, Lin et al., 2009, Demirkiran et al., 2010, Thakur et al., 
2017). Despite all the advantages of the bioglass, its low degradation rate in 
comparison to phosphate glass and its brittleness are considered its weak 
points  (Knowles, 2003, Lizzi et al., 2017). 
Borate Bioglass 
Nowadays, borate based glasses are being investigated more, because of its 
chemical durability (Li et al., 2007). One study incorporated boron into silicate 
glass to encourage calcium phosphate layer deposition as it has a higher 
conversion rate than that of silicate; the outcomes were acceptable (Yao et 
al., 2007). Other studies aimed to partially or completely substitute silicates 
with borates to produce bioglass scaffolds with different structural 
compositions and different biodegradation properties. Although  results were 
promising in regards to biodegradation and hydroxyapatite deposition and 
were in agreement with the previous study, the results were less satisfactory 
in regards to mechanical strength as  boron may decrease the mechanical 
properties of glass (Fu et al., 2010b). Although in vitro studies revealed the 
ability of boron glass to promote cell proliferation at specific boron ion 
concentrations, the main identified drawback was its low mechanical 
properties that decrease with time when immersed in solutions (Fu et al., 
2009).    
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1.2.4.2 Polymers 
 Polymers can also be used in bone tissue engineering since many of these 
materials are biocompatible and biodegradable. Moreover, they are highly 
versatile because of their controlled copolymerisation that may help them to 
be produced with different biodegradation rates (Sharif et al., 2016a).  
The most commonly used polymer in cranioplasty is polymethylmethacrylate 
(PMMA). PMMA provides a protective, defect filling replacement with minimal 
postoperative inflammation (Unterhofer et al., 2017). Lara et al (1997)  
explained that the size of the bony defect may determine the type of PMMA 
used; PMMA without mesh is highly suitable for small defects (5-15cm2) 
while mesh reinforced PMMA is used for larger sized defects (16-49 cm2) 
(Lara et al., 1997). Nevertheless, the highly exothermic polymerisation 
process when it occurs in place can severely damage brain tissue. Moreover, 
being prone to infection, pulmonary embolism and lack of osseointegration 
have limited the use of such materials (Jaberi et al., 2013, Milojkovic and 
Homsi, 2014, Pikis et al., 2015). 
The poly hydroxy group polymers such as poly-lactic acid (PLA), poly-glycolic 
acid (PGA) and poly-caprolactone (PCL) have been investigated also for 
bone tissue engineering. PLA-PGA were used mainly as binders or 
conjugators to bio ceramics or allografts. The conditions associated with their 
manufacture affect the biodegradation and the mechanical properties 
negatively (Coombes and Meikle, 1994). Many studies tested its use in 
conjunction with other bioceramics (TCP or HA) to form scaffolds and 
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showed that it has good properties in terms of increasing bone growth 
(Chuenjitkuntaworn et al., 2010, Terranova et al., 2017, Bai et al., 2016). 
Another comprehensive study was conducted to examine PCL samples that 
were coated in three different bioceramics (CaP, bioglass and strontium 
added bioglass). Although all the samples exhibited good results in vitro  
regarding the cell adhesion and gene expression, the in vivo study on rats 
did not show any bone formation in any of the samples in  8 and 16 weeks 
period after implantation (Poh et al., 2016). However recent attempts have 
developed a form of  memory material that is composed from PCL and 
polydopamine for cleft palate application repairs and showed acceptable 
properties (Grunlan et al., 2016). 
1.2.4.3 Biocomposites  
Biocomposites is a term used to describe any material that is produced from 
the combination of more than one material such as ceramic–ceramic, 
ceramic–polymer or polymer–polymer for clinical use. This combination can 
result in the improvement of biological and mechanical  properties of the 
scaffold to work as an acceptable substitute for the autograft or allograft  
(Basha and Doble, 2015). There are different examples of biocomposites 
such as collagen 1 with TCP, collagen 2 with HA bioceramics, and self-
reinforced Polymers such as (PLLA, PLGA) with calcium phosphate. One 
study‎tested‎prepared‎collagen‎coated‎PCL/‎βTCP‎biocomposite‎scaffold‎and‎
found that this combination of biomaterials played a positive role in 
enhancing MG63 cell attachment and viability (Yeo and Kim, 2011).  Other in 
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vivo studies looked at the effect of carbon nanotubes (CNTs) filled polymer 
biocomposite as an implant in rabbit femoral condyles and showed that this 
biocomposite had enhanced the osteogenecity (Sitharaman et al., 2008). 
These biocomposites were designed to overcome the drawbacks of using 
bioceramics and polymer individually as they aim to combine the flexibility 
found in a polymer with the hardness of HA resulting in new material that has 
better properties than the two separate materials (Qidwai et al., 2014). 
Moreover, porosity can be introduced in these materials so that they can fulfil 
the bone tissue engineering requirements. Porosity can be produced by 
implanting many techniques such as thermally induced phase separation, 
salt leaching/freeze-drying, wet spinning, and electrospinning. 
 
 
 
 
 
 
 
 
64 
 
1.3 Phosphate glasses  
1.3.1 Introduction to phosphate glasses 
Phosphate-based glass has been investigated for more than a century. 
Although it is one of the popular oxides forming glass (along with SiO2, GeO2 
and B2O3), it lacked the popularity in research due to its reactive and 
hygroscopic nature (Knowles, 2003). Phosphate glasses have been 
examined for the last few decades as a potential biomaterial for various 
biomedical applications such as dental, maxillofacial and orthopaedic 
implants; scaffolds for bone tissue engineering, and also as a carrier for 
antimicrobial agent delivery (Knowles, 2003, Abou Neel et al., 2009b) 
Phosphate-based glasses have been studied to examine their potential for 
biomaterial applications in bone tissue engineering because they have two 
important properties. First, they have a predictable controlled degradation 
rate in aqueous media. Different glasses with different degradation rate 
ranging from 2–3 hours to 1 year or longer can simply be developed in the 
laboratory; for instance, the ternary P2O5–Na2O–CaO glasses can be 
modified by adding appropriate oxides to form quaternary or higher order 
systems with low degradation rates. Second, their main inorganic elemental 
components (e.g. Na, Ca and P) are essential elements that are naturally 
present in bone. The latter point is important especially when assessing the 
relation between phosphate glass materials and bone cells within both in 
vitro and in vivo conditions. It is even more important for bioactive implant 
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production since there should be an essential chemical bond between the 
bioactive implant interface and the surrounding tissue (Anselme, 2000). 
The basic unit of phosphate-based glass is the highly reactive and 
hygroscopic pure P2O5 molecule (Hudgens et al., 1998). The foremost 
studies on phosphate glass biomaterials concentrated on the incorporation of 
metal oxides such as Na2O and CaO to form the ternary P2O5–Na2O–CaO 
phosphate glass systems (Burnie et al., 1981, Burnie et al., 1983). It was 
found that the change in the ternary P2O5–Na2O–CaO glass composition 
may have an effect on degradation (dissolution) rate; in which increasing 
Na2O at the expense of CaO in the composition can lead to higher 
degradation rate and vice versa. Despite all the attempts that were carried 
out to find the appropriate dissolution rate of the ternary phosphate glass, it 
persisted with a relatively high degradation rate that leads to poor 
biocompatibility. This was the motivation behind performing other later 
studies to produce phosphate glass with more appropriate degradation rate 
for the application. These studies were done by adding different metal oxides 
to the glass system such as Fe2O3 (Reis et al., 2002, Kokubo et al., 2003), 
CuO (Mulligan et al., 2003, Abou Neel et al., 2005), Al2O3 (Shah et al., 
2005),TiO2 (Abou Neel E et al., 2007), ZnO (Abou Neel et al., 2008c, Salih et 
al., 2007), and SrO (Lakhkar et al., 2009). The purpose of additional metal 
oxide addition to the glass structure is two-fold: First, metal oxides serve as 
the most effective means to control the degradation rate by increasing the 
covalent nature of the bonds within the glass structure. Second, the metal 
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ions released from such glasses can have a biological function such as an 
antimicrobial effect and/or positively impact on cell proliferation and bone 
tissue regeneration (Knowles, 2003).  
According to Le Geros (2008), the use of phosphate glasses in the 
biomedical field necessitates these glasses to have specific properties to act 
as bone replacement materials (LeGeros, 2008). These properties are: 
1-Glass chemical composition that should mimic natural bone composition. 
2-Physical and chemical properties giving the glass the appropriate strength 
to withstand stress.  
3-Biological factors interaction between implanted glass and living cells that 
includes (adhesion, degradation, osteoconductivity, bioactivity).  
4- The ability to produce these glasses in different forms that may facilitate 
bone growth. 
Therefore, glass should be made or modified to cover all the required 
properties. For an example, P2O5–Na2O–CaO ternary glass may dissolve 
quickly which may affect the cellular mechanical attachments and may yield 
in significant changes in pH levels that may have an affect on cellular 
responses. To overcome this degradation, titanium oxide was added to it at a 
specific 5 mol% percentage to form the quaternary P2O5–Na2O–CaO–TiO2 
making it more resistant to degradation and with good mechanical properties 
(Lakhkar et al., 2012). 
Phosphate- polymer based biocomposites have been produced to be used 
for bone repair. An experiment was carried out by preparation of PLA 
(polylactic acid) and phosphate glass powder at different contents 
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(0%,5%,10%,20%). The results revealed that adding the glass enhanced the 
mechanical strength of the polymer and also enhanced the degradation rate. 
The biocompatibility results were satisfactory (Georgiou et al., 2007). The 
combination of phosphate glass with PCL (polycaprolactone) polymer bone 
composite was tested also, and suggested that adding the glass component 
to the polymer may lead to improvement of the composite properties (Liu et 
al., 2015).  
1.3.2 Glass composition 
Oxides are the basic component of any glass type, these oxides usually 
classified under three categories (Zachariasen, 1932) : 
1-Network forming oxides:  they are the basic oxides that can form glass by 
themselves alone without the addition of other components, they are one of 
the four Zacharasian glass forming oxides (SiO2, P2O5, B2O3, and GeO2).  
2- Network modifying oxides: they are the oxides that can modify glass 
network geometry when they bond to it, therefore the glass characteristics 
will be altered by the different percentages of these oxides, basically they are 
oxides of alkali and alkali-earth metals such as sodium oxide and calcium 
oxide. 
3- Intermediate oxides: elements such as (Al, Ga, Ti, C, V, Bi, Mo, W, S, Se 
and Te) that can replace network formers in some cases, but they lack the 
ability to form glass by themselves alone. 
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Pure phosphate glass are based on the tetrahedral phosphate anion PO4
3-
 
unit that forms a three-dimensional network (Hoppe, 1996). This network has 
resulted due to the formation of 5 free electrons in the outer orbit (3s2 3p3). 
Three of these electrons tend to form a single covalent bond with the oxygen 
atom (BO bridging oxygen), leaving the other two electrons to make double 
bond with oxygen ( Figure 1.4) (Knowles, 2003). According to this molecular 
framework, the bridging oxygens are the bonding site for modifying oxides 
such as (Na2O, CaO) (Kirkpatrick and Brow, 1995). 
 
Figure ‎1-4 Illustration of the basic phosphate tetrahydrate. Reprinted from the journal of 
materials Chemistry, Volume 13, issue 10, (Knowles, 2003). Phosphate-based glasses for 
biomedical applications.  page 2395-2401. with the permission of Elsevier. 
Furthermore, the connection between different phosphate units occurs 
through covalent bonds with their bonded oxygen atoms that are called 
bridging‎oxygens‎(BO’s).  
This bridging oxygen (BO) is a popular method to classify the type of the 
glass via the implementation of Qi terminology in which Q represents the P 
atom that is linked to several oxygen atoms to form the phosphate 
tetrahedron.‎Whereas‎‘i’‎ refers‎ to‎ the‎number‎of‎BO’s‎per‎ tetrahedron,‎as‎a‎
result of adding different metal oxides (MO) to this structure that will 
terminate the P-O-P bond in the polymer network, replace the P to form P-O-
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M non-bridging bond (NBO), decrease the number of present BO and 
whenever we add more we will end with a state of saturation where all the 
bridging oxygens are linked with metals and that will lead to PO4
-3 structures, 
following the sequence of Q3 Q2 Q1 Q0 ( Figure 1-5)(Brow, 2000, Knowles, 
2003).  
Depending on the glass composition that is based on the formula 
(M2/VO)x(P2O5)1–x where M is modifying cation oxide, v is the cation valency  
and x is the number of cation oxides molecules attached to the phosphate 
molecule, the glass can be classified into five types: ultraphosphate, 
metaphosphate, polyphosphate and  pyrophosphate and orthophosphate 
glasses (Brow, 2000).  
Ultraphosphate‎ glasses‎have‎0‎ ≤‎ x‎<‎0.5‎ and‎ their‎O/P‎ (oxide/‎phosphate)‎
ratio‎ is‎ 2.5‎ ≤‎ O/P‎ <‎ 3.‎ They‎ usually‎ have‎ Q3 and Q2 units in the glass 
structure.  Glass structure starts to resemble the vitreous P2O5 when x < 0.25 
with Q3 being the predominant structure, and for this reason they are known 
as highly reactive glasses. Metaphosphate glasses are formed when the 
cation content (x) is little higher which is equal to 0.5. As a result of that, less 
bridging oxygens are present and the oxygen to phosphate ratio (O/P) = 3. 
Metaphosphate glass structure is usually Q2 because there are less bridging 
oxygens linked to the long phosphate chain. The addition of more modifying 
oxides modifies glass structure from type Q2 to Q1 where there are more 
element oxides preventing the phosphate bridging resulting in the 
polyphosphate glass. Polyphosphate glasses have x > 0.5 and O/P > 3. 
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Further increasing of x content of cation oxide to the level of 0.67 yields in 
pyrophosphate glasses formation with O/P = 3.5, predominantly having Q1 
structure. Orthophosphate is characterized by higher x content (x = 0.75) and 
(O/P > 3.5) with mainly Q0 network structure (Figure 1.5) (Brow, 2000, 
Knowles, 2003). 
P2O5+ <1M2O                       Ultraphosphate (Q
3)     
P2O5+1 M2O                         Metaphosphate /polyphosphate (Q
2) 
P2O5+1-2 M2O                      Pyrophosphate (Q
1)             
P2O5+ 3 M2O                        Orthophosphate (Q
0) 
 
Figure ‎1-5 Effect of monovalent ion addition to P2O5 network. Reprinted from the journal of 
materials Chemistry, volume 13, issue10,  (Knowles, 2003). Phosphate-based glasses for 
biomedical applications, page 2395-2401 with the permission of Elsevier. 
With this variation in network structure, negative solubility property and 
hygroscopicity of the ultraphosphate glasses can be modified to obtain 
appropriate solubility rate by adding other metal oxides to increase the 
durability and control the degradation rate which can make the end product 
applicable in tissue engineering applications (Wazer, 1950, Brow et al., 
1990). 
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1.3.3 Glass synthesis  
1.3.3.1 Melt quenching 
 Preparation of phosphate glass by this technique firstly requires melting the 
elements oxides to the temperature exceeding the melting point temperature 
of phosphate (P2O5), the melted phosphates will eventually flux the other 
glass components and aid in their melting. This step should be followed by 
either pouring (quenching) the molten glass onto a cold surface or in graphite 
moulds. Apart from quenching glass onto a cooled surface or moulds, there 
is another method in which the glass will be quenched in water; this is called 
fritting. The fritting technique is used when the precursors are not 
hygroscopic in nature (such as phosphate glass) and when the glass may be 
needed to be produced as beads or small fragments (Kaur et al., 2016) .     
Amorphous glass production is performed by rapid cooling of the molten 
glass to a temperature below the glass transition temperature. This is done to 
pass the glass crystallisation point and ensure that the glass is crystal free. 
The glass transition temperature is the temperature of which the glass solid 
starts to behave like a viscoelastic solid. The gradual cooling of a molten 
glass to any temperature below the melting temperature (Tm) would normally 
result in crystals formation with a decrease in enthalpy. As the temperature 
declines further, more crystals will be formed and there will be a highly 
viscous mixture. While if there is a rapid decrease in glass temperature at or 
around the eutectic point temperature, temperature less than Tg (glass 
transition),  the liquid will generally be highly cooled and transformed directly 
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from a liquid state to a solid state without passing through the crystallisation 
phase ( Figure 1.6) (Shelby, 1997).  
 
Figure ‎1-6 The effect of temperature on the enthalpy (or volume) of a glass forming melt. 
Reprinted from Introduction to Glass Science and Technology  (Shelby, 1997). 
1.3.3.2 Sol-Gel 
The sol-gel technique is a method used to produce glass without using high 
temperatures that are used in the conventional melt quenching technique. 
Glass can be produced in this procedure in nanometre or micrometre sized 
particles that can be used as drug carrier for drug delivery application. 
Another property that encourages its use in drug delivery applications  is that 
its relatively low processing temperatures may allow some therapeutic 
molecules to be included during processing (Owens et al., 2016). 
Sol-gel is a multistep procedure that starts initially with the mixing of metallic 
precursors with alkoxide precursors. The next step includes the hydrolysis of 
the whole precursors using deionised water. As a result, the hydrolysis of (for 
example) silicon alkoxide, silanol groups will be formed (equation 1). This will 
be followed by silanol groups bonding with each other to form silica network 
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Si-O-Si via a process called polycondensation where the water is removed 
as a by-product resulting in sol formation (equation 2)(Kaur et al., 2016). 
Si (OR)4+ 4 H2O                                    Si(OH)4 +‎4‎R‎(OH)………….1 
Si(OH)4+ Si(OH)4                                                         Si(O)3 +H2O…………..……2 
Gelation is the next step after sol formation where there will be extra 
condensation and further networking and cross- linking between silica and 
colloid molecules. In the gelation process, there is an increase in viscosity 
and the material starts to act as an elastic solid (Brinker et al., 1985). The 
next step is aging of the gel or synergesis, and this involves a decrease of 
porosity and strengthening of gel because of continuous polycondensation. 
Hydrothermal treatment can accelerate this process. The ageing phase has a 
prominent effect on the physical properties such as porosity and mechanical 
properties of sol gel (Hench and West, 1990). 
1.3.3.3 Phosphate glass microspheres 
The use of the glass in biomedical applications necessitates production with 
specific features that can fulfil the application requirements. Many studies 
were conducted on glass microspheres to assess its potential for use in 
various biomedical applications such as drug and protein delivery, tumour 
therapy, and as bone repair materials (Kawashita et al., 2003, Kawashita, 
2005). 
The procedure by which glass microspheres are produced is called 
spheriodisation which is the production of glass particles in spherical shape 
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via the application of surface tension forces to the molten glass (Huang, 
1992, White and Day, 1994). 
Although many studies were performed to design the spheriodisation 
apparatus, the main idea behind it is the presence of a high temperature 
flame source that can be used for particle heating. Also, this procedure 
required the presence of a collector for collecting all the spheroidal shaped 
particles along their path through the flame. Various types of flame source 
can be utilised such as: gas/oxygen with acetylene, radio frequency based 
plasma flame (Gu et al., 2004, Cacaina et al., 2006, Cacaina et al., 2008, 
Sene et al., 2008). Others used other sources of heat (Methylacetylene-
propadiene propane (MAPP) cylinder) for production of titanium based 
phosphate glasses because of its high flame temperature of 2925°C in air 
(Lakhkar et al., 2012). A vertical tubular electric furnace may be used also for 
the microspheres manufacturing process, where the powder particles 
released at the top end of the furnace are altered into microspheres as they 
fall through the furnace under the effect of gravity (Martinelli et al., 2010). 
The selection of the temperature source and the type depends mainly on the 
precursor’s‎ particle‎ size;‎ high‎ temperatures‎may‎ be‎ needed‎ to‎ spheroidise‎
larger particles size.  
The particles are usually introduced to the flame bath either manually or by 
automated feeding assembly. After having been spheriodised, the 
microspheres are collected in containers. However there are also other 
procedures to produce microspheres by sol gel (Park et al., 2013a), and this 
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procedure is more suitable for silicate glasses more than phosphate glasses 
because of both the tetraethyl orthosilicate (TEOS) or the aminopropyel 
triethoxy silicate (APTES) that is used as silicate precursor to produce 
porous and hollow microspheres in the sol gel polycondensation (Wu et al., 
2010, Poorbaygi et al., 2011, Wu et al., 2011). The flame spheriodisation 
process however tends to produce mainly non-porous solid microspheres.  
1.3.4 Phosphate glass structural analysis  
1.3.4.1 X-ray Diffraction 
X-ray diffraction is a useful technique that affords valuable information about 
the atomic and molecular structure of solids. This technique works by 
investigating the interaction between X-rays and a solid substance. When a 
focused x-ray beam hits any sample at a specific wavelength, electrons 
surrounding solid atoms will start to oscillate at a wave length equal to the 
beam wavelength causing further secondary waves. These secondary waves 
usually cancel each other out especially if they were not arranged in a 
specific manner. However, if these atoms are arranged in phase or in a 
repeated manner, secondary waves will be added to each other producing 
scattered X-ray waves that may be emitted from the sample again to be 
detected by the device in the shape of well-defined peaks. The beams that 
are‎detected‎are‎called‎a‎‘diffraction‎pattern’‎and‎serve‎as‎a‎fingerprint‎of‎the‎
solid sample. This usually happens in case of a crystalline substance 
because each crystalline substance has a unique diffraction pattern (Warren, 
1969).  
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Glasses are amorphous substances which means that their compositional 
atoms are arranged in randomly. As a result, glass X-ray diffraction patterns 
do not usually show sharp peaks. They usually exhibit a broad peak pattern 
and this may be a good method to investigate the success of amorphous 
glass production (Dias et al., 2005).                                              
1.3.5 Phosphate glass degradation and Ion release 
Glass degradation is an important property of phosphate glasses enabling 
this type of glass to act as a good choice for biomaterial applications 
including bone tissue engineering. This property may permit glass to work 
primarily as a temporary device or scaffold for bone cells attachment with 
controlled release of therapeutic ions. Although many of these ions are 
proven to play a positive role in bone stasis, their release is mainly related to 
the chemistry of the glass composition. For this reason  many attempts were 
made to find the appropriate composition with the most preferred ion release 
rate (Knowles, 2003). 
Generally, mass degradation and ion release start as soon as phosphate 
glass is immersed in liquid, but this degradation is varied according to glass 
composition. Commonly, both mass degradation (weight loss) and ions 
release follow a linear trend and they have direct relation between them 
(Franks et al., 2000, Navarro et al., 2003, Brauer et al., 2006, Khor et al., 
2011). This relatively linear pattern of degradation and ion release suggests 
the benefit of phosphates glass over their silicate peers because of the 
sustainability of the release over time.  
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Gao et al (2004) suggested that degradation is a two-phase procedure; the 
first stage is an initial slow degradation while the second is called as 
subsequent uniform degradation stage. The first stage involves the initial 
diffusion of H2O molecules into the glass surface while the second phase 
involves the release of molecules from the hydrated surface which will then 
seep into the surrounding medium. The change between these two phases 
are governed by internal and external factors (Gao et al., 2004).  
Bunker et al (1984) hypothesised that the internal factors involve glass 
composition and the external ones involve solution related factors such as: 
pH, solution temperature, saturation of solution and surface area to volume 
ratio. These external factors play an important role in glass degradation, for 
example, while a higher degradation rate is more related to acidic solutions 
and higher temperatures and vice versa, lower degradation rates occur in 
highly saturated solutions or when there is a low ratio of glass surface 
exposed to the solubilising medium. Generally. There are three chemical 
reactions that are related to glass degradation: (1) acid-base reactions, 
controlled by pH at the outer surface of glass, which help in the disruption of 
the glass ionic chains; (2) hydrolysis reactions that includes the breakage of 
the P-O-P bonds, damaging and changing the glass network by breaking the 
high phosphate glass to the smaller one of PO4 3- ions and (3) hydration 
reactions that involve the incorporation of hydroxyl groups to phosphate 
molecules in a stage opposite to that of hydrolysis reactions (Bunker et al., 
1984).  
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Ions released from phosphate glasses includes the release of all its 
compositional ions including the anions and cations. Anions include the 
phosphate groups that constitute the network of the glass whereas the 
cations include all the other metal oxides that may modify the glass 
compositions.  When phosphate ions cleaved from  glass because of 
hydrolysis, they may occur in various compositions and morphology ranging 
from the commonly present simple phosphate molecules as (PO4 
3- ) ions to 
the linear phosphates such as pyrophosphate (P2O7
4–) and tripolyphosphate 
(P3O10
4–) to the cyclic species such as cyclic trimetaphosphate (P3O9
4-) and 
ending with the highly phosphate species (have more than four molecules of 
phosphate) (Ahmed et al., 2005b). Although ion chromotgraphy techniques 
are used commonly to assess   the concentration release of different 
phosphates ions in glass, higher phosphates ions (higher than P3O10
4-) were 
not assessed by this method because standard compounds were not 
available to allow calibration (Figure 1.7) (Baluyot and Hartford, 1996, 
Lakhkar et al., 2013). 
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Figure ‎1-7 Example of an anion chromatogram for phosphate species collected using a Dionex 
ICS2500 system, showing the presence of PO4
3−
, P2O7
4−
, P3O9
3−
 and P3O10
5−
 and higher 
phosphates. Reprinted from the journal of Advanced Drug Delivery Reviews, volume 65, issue 4  
(Lakhkar et al., 2013). Bone formation controlled by biologically relevant inorganic ions: Role 
and controlled delivery from phosphate-based glasses. page 405-420. With the permission of 
Elsevier. 
 
Network modifier and intermediate oxide content in ternary phosphate 
glasses also play an important role in controlling phosphate release, this role 
may be variant according to the element oxides themselves. It was found that 
increasing CaO content in glass can enhance the cross linkage among 
phosphate molecules in glass and resulting in reducing the mass loss and 
ions released too (Ahmed et al., 2005a). 
Also, adding other oxides such as gallium and titanium which have valency of 
+3 and +4 had the same effect of reducing the degradation rate and ions 
release (Abou Neel et al., 2008d, Valappil et al., 2008). Conversely, adding 
some divalents oxides to the ternary glass system may not show the same 
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pattern or trend as that for more higher +3 valency atoms.  For example, 
adding ZnO in different ratios to the tertiary P2O5–CaO–Na2O glass did not 
show significant effects on phosphates ions release or degradation rates and 
the same was seen for SrO to the same tertiary glass (Salih et al., 2007, 
Abou Neel et al., 2008b). This is due to the ZnO or SrO being added at the 
expense of CaO and so there is little change in the overall charge of the 
structure.  
Concerning other ions released from phosphate glasses such as Na+ and 
Ca2+, it was found that Na+ release is inversely related to CaO content 
especially in ternary P2O5–CaO–Na2O glasses systems having P2O5 at a 
ratio between 50-55 Mol%. This can be explained as any addition of Na2O 
content at the expense of CaO to the glass may lead to decreased glass 
connectivity and increased glass degradation(Ahmed et al., 2004a, Ahmed et 
al., 2004b, Ahmed et al., 2005a).  
Previous studies showed that there is a direct relationship between CaO and 
Ca2+ ion release in ternary P2O5–CaO–Na2O glasses containing 55 mol% of 
P2O5 (Ahmed et al., 2005a). The inclusion of 2+ charge oxides, e.g. MgO, 
SrO or ZnO with quaternary phosphate glasses as substitution to CaO or 
Na2O may affect glass ions release. As a result of this substitution, other 
factors will control the degradation which are related to the atom, such as 
ionic radius, electronegativity, bond lengths.  For example, the addition of   
2+ charge oxides such as SrO or ZnO to the titanium containing quaternary 
P2O5–CaO–Na2O-TiO2 glass may change titanium release causing an 
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enhancement in titanium ion release with the SrO or ZnO as these atoms can 
disrupt quaternary glass network making it closer to that of ternary P2O5–
CaO–Na2O  (Abou Neel et al., 2009a, Lakhkar et al., 2011). 
1.3.6 Phosphate glass biocompatibility 
Some phosphate-based glasses have been studied previously to assess 
their biocompatibility. 
Generally, there are three methods of examining phosphate-based glass  
biocompatibility: (a) in vitro including immersing the produced phosphate 
glass in artificial environment liquids, for example : citric acid or simulated 
biological fluid (SBF); (b) in vitro involving cell culture assessment by 
examining viability, proliferation, adhesion, differentiation and cytotoxicity; (c) 
in vivo including implantation of the produced glass in animal models and 
subsequent histological studies after sacrificing the animal. 
Regarding the first method, the most popular method is by immersing the 
phosphate glass in SBF. SBF is basically a mixture of Na+, K+, Mg2+, Ca2+, 
Cl–, HCO3–, HPO4
2–, and SO4 
2– ions in distilled water at specific 
concentrations nearly equivalent to those in human plasma. The bioactivity 
assessment is usually done via qualitative and quantitative estimation of 
hydroxyapatite crystal formation on the glass surface exposed to the fluid.   
Many previous studies investigated the immersion of four different 
compositions of titanium contained phosphate glass in SBF. These studies 
reported the absence of apatite layer in all the samples after incubation for 
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14 days at 37°C (Abou Neel E et al., 2007, ElBatal et al., 2009, Lucacel et 
al., 2010). Even though phosphate-based glass does not form apatite which 
would be considered as a measure of lacking bioactivity, these materials may 
attach directly to bone tissues even without hydroxyl apatite formation. 
Therefore, this attaching ability can give them the biocompatibility which is 
needed to be studied further by doing cell culture studies (Kokubo and 
Takadama, 2006, Lee et al., 2006). 
The second approach which is in vitro cell culture studies is a common 
methodology in material biocompatibility assessment. This approach involves 
seeding cells on the surface of the material, or to extracts form the 
biomaterial under test, followed by different biological tests, hence, it can 
give a significant amount of quantitative and qualitative information regarding 
the potential of the material to affect short term and long term cellular events. 
Two types of cells may be used in vitro testing according to their origin; (a) 
primary cells which are cells isolated directly from human or animal tissue 
having a limited useful life span of 10-100 days after the initial formation of 
cells, and (b) cell lines which are the cells that are tumorigenic in nature and 
have the stability to live for a long period of time for cell culture uses. Cell 
lines are the most commonly used because of their stability, long term, in 
comparison to the primary cells (Ratner, 2004).  
Many studies were done to assess the cellular effects of different phosphate 
glass compositions. Uo et al (1998) investigated the cytotoxicity of different 
compositions  of ternary P2O5–Na2O–CaO glasses on human pulp cells, and 
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the results revealed that cytotoxicity is clearly-correlated to decreasing CaO 
content (Uo et al., 1998). Salih et al (2000) also assessed tertiary 
calcium/sodium phosphate glass. This study assessed the biological reaction 
of seeded osteosarcoma MG63 cells on phosphate glass by firstly performing 
MTT metabolic assay and secondly an ELISA to assess the expression of 
BSP, ON and fibronectin (FN). The results were similar to that of Uo et al in 
which lower calcium content enhanced glass degradation and caused 
inhibition in both cellular growth and bone antigens expression (Salih et al., 
2000). However, these studies were done for short periods of times that did 
not exceed 1 week. Conversely, the work performed later by Gough et al 
(2003) assessed the long-term effects of calcium/sodium phosphate glasses 
on seeded colony forming cells CFCs. This study extended out to 28 days to 
fully understand all the stages of the osteoblast differentiation cycle on 
phosphate glass by detection of specific markers secreted during different 
stages of differentiation (Gough et al., 2003) .  
Other studies were done to test quaternary glass systems, especially zinc, 
strontium and titanium glass compositions to assess their effect on bone 
cells. Zinc phosphates glass studies showed many variations in terms of its 
effect on bone cells. In one study, human osteoblasts cells (HOB) were 
seeded on different zinc containing phosphate glass discs. This was followed 
by cell attachment and cell proliferation assessment showing that zinc 
incorporation in glass may have a positive role in both cellular attachment 
and proliferation (Salih et al., 2007). These results were confirmed later on in 
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other studies that examined the addition of different zinc oxide contents to 
silicate based glass that showed adding zinc oxide at 3.9 mol% can improve 
cellular attachment, whereas adding it at more than 7.8 mol% proportion may 
affect negatively on cellular attachment (Lusvardi et al., 2008). Other studies 
explained that adding zinc oxide to phosphate glass in higher proportions 
(more than 10 mol%) may lead to negative cytotoxic effects on MG63 cells 
(Abou Neel et al., 2008c). Later attempts aimed to evaluate the outcome of 
zinc oxide addition to bioactive silicate glass scaffolds containing Na2O, K2O, 
MgO, CaO, B2O3, TiO2, P2O5 and SiO2 on the proliferation and osteogenesis 
of human adipose stem cells (hASCs). The results revealed that zinc oxide 
addition had no significant effect on DNA content, alkaline phosphatase and 
osteopontin concentration (Haimi et al., 2009). Addition of zinc oxide to sol 
gel silicate prepared glass was evaluated also and showed that zinc addition 
can enhance alkaline phosphatase activity of rat calvarium-derived 
osteoblasts (Badr-Mohammadi et al., 2014). 
Regarding strontium phosphate-based glasses, one trial investigated the 
cellular effects of strontium oxide doping into phosphate glass on Human 
osteosarcoma cells (HOS). It was found that adding strontium oxide can 
enhance cell attachment and also change cell morphology from round to flat 
(Abou Neel et al., 2008b). Other studies done by Lakhkar and his colleagues, 
found that increasing strontium oxide content in phosphate glass may lead to 
better biological effect on MG63 in terms of cellular growth (Lakhkar et al., 
2009). Another experiment performed by Massera et al aimed to evaluate the 
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effect of adding strontium to both phosphate and silicate glass separately on 
human gingival fibroblast. This study revealed that adding strontium to any of 
these glass systems may have the potential effect of increasing cell growth 
and that cells seeded on the free strontium phosphate glass were dead at 
day 7 (Massera et al., 2015).  
Concerning titanium oxides, Navarro et al (2003) evaluated the effect of 
changing titanium oxides content on toxicity, adhesion and proliferation 
activity of human skin fibroblasts that were seeded on 44.5 P2O5–44.5CaO–
(11 – x)Na2O–TiO2 (x = 0 and 5 mol%) (Navarro et al., 2003). The toxicity 
data showed that adding titanium oxides at 5 mol% will decrease glass 
solubility resulting in enhancing cell viability. Whereas titanium dioxide free 
samples had greater solubility. Conversely, the highly soluble titanium 
dioxide free glass showed better cell adhesion ability. The explanation of 
these contrary results was unclear and may be related to glass composition 
and solubility.  
Other comprehensive results concluded that adding TiO2 to phosphate glass 
may improve the physical network of glass, hence, decreasing glass 
solubility resulting in more favourable cellular effects  (Brauer et al., 2006). 
Later studies were carried out to investigate the biocompatibility of adding 
TiO2 to the phosphate glass by using different in vitro cell biology 
methodologies. One of these studies was interested in studying glass discs  
that had the composition of 50 P2O5–(20 – x)Na2O–30CaO–xTiO2 (x = 0, 1, 3 
and 5 mol%), and using MG63 human osteosarcoma cells for seeding (Abou 
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Neel and Knowles, 2008). These cells were cultured on the glass discs for a 
7 days period which were investigated later with confocal microscopy and 
scanning electron microscopy (SEM) to evaluate cell viability and cell 
attachment. It was found that the best results in terms of both vitality and 
attachment were detected in glasses containing 3 and 5 mol% TiO2. The 
explanation was similar to that of (Brauer et al., 2006) where increasing 
biocompatibility may be due to decreased degradation rate of titanium 
dioxide containing phosphate glasses which was further confirmed by DTA 
analysis. Another study aimed to increase TiO2 content in phosphate glass to 
enhance biocompatibility. This study revealed the same results in which 
glass with TiO2 showed the most favourable results compared to TiO2-free 
glass. This study revealed that further additions of TiO2 at 10 mol% to 15 
mol% does not show any significant further changes in biological results 
(Abou Neel et al., 2008d). Another study aimed to investigate the 
biocompatibility of titanium phosphate glass beads on MG63 cells. Glass 
beads were produced in three compositions as 50 P2O5–40CaO–(10-x) –
Na2O–xTiO2, where x = 3, 5 and 7mol % to investigate the optimum 
concentration of titanium dioxide by using Alamar blue assay.  The results 
demonstrated that incorporation of 5 mol% TiO2 may lead to the most 
favourable outcomes while glass containing 7 mol% TiO2 did not exhibit any 
significant improvement compared to the glass containing 5 mol%TiO2 
(Lakhkar et al., 2012). 
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The in vivo implantation approach of glass has not been studied extensively 
because these studies face a lot of challenges and difficulties with the 
regulations and ethical approvals. These studies generally involved 
examination of implanted glass granules in bony defects of either rat or rabbit 
subjects. This step was usually followed by histological examinations after 
specified time points by using either light microscopy or polarized 
microscopy.  
Ito et al (2002) assessed the effect of adding zinc calcium phosphate glass 
ceramics into the femora of rabbit where zinc content was different. Four 
weeks after grafting, femora were histologically studied showing that zinc 
addition can encourage bone formation area by 51% in comparison to the 
free zinc composites (Ito et al., 2002). Later on, Dias et al assessed the 
implantation of two different glass compositions granules (45CaO–45 P2O5–
5MgO–5K2O and 45CaO–37P2O5–5MgO–13TiO2) into rabbit tibiae. This 
study showed that that glass solubility and degradation may influence the 
outcomes within in vivo study; the former titanium dioxide free glass 
composition degraded much faster compared to the phosphate glass 
containing titanium dioxide. Therefore, the first glass composition granules 
caused empty spaces in the newly formed bone, whereas the second 
composition was surrounded completely by bone (Dias et al., 2006). Other 
studies included the implantation of various compositional quaternary P2O5–
Na2O–CaO–TiO2 glasses in rabbit models. This study revealed that the 
incorporation of 0.5 mol% TiO2 in the glass might result in the best bone cell 
88 
 
growth, whereas adding a higher content of titanium dioxide may be 
associated with reduced bioactivity (Monem et al., 2008). These results were 
quite similar to Abu Neel et al (2007) study that examined the implantation of 
different compositions of titanium phosphate particles in the calvaria of rats. It 
was found that when the TiO2 content was 5 mol%, bone formation was more 
significant (Abou Neel E et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
89 
 
1.4 Bone scaffolds 
1.4.1 Scaffolds requirements  
Scaffolds are materials that are designed and engineered in a specific way 
so as they can fulfil the biological and physical requirements of the repaired 
organ. The use of biomaterials to produce a bone scaffold is not a simple 
stage. It can be considered that there are three various generations or 
stages. The difference among these generations of scaffolds is explained as 
technical, where many modifications and adjustments were made to improve 
the scaffold properties (Navarro et al., 2008). The first generation was mainly 
concerned about using inert materials having physical properties matching 
that of the replaced bone. Metals such as titanium and stainless steel, 
ceramics and polymers such as silicone rubber, polypropylene, and 
polymethylmethacrylate were examples of the first generation of materials. 
One of the drawbacks in this generation was the formation of fibrous tissue in 
the interface area between the implant and body tissue. This fibrous tissue is 
formed as an immune response of the body to the implants which occurs as 
an inflammation process of body ending in shielding the implant from the 
surrounding tissue by fibrous wall (Morais et al., 2010). 
The second generation was introduced to overcome the undesirable immune 
reaction in the previous generation. In this generation, bone graft substitutes 
were modified by for example making them with either bioactive or 
biodegradable materials. The structure was by using materials designed to 
encourage mineralisation such as HA or TCP or by bioglass. The other type 
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of implant was by making the scaffolds from biodegradable materials that 
have degradation rate similar to that of the normal healing process. For 
example, making the implants from polymers such as polylactide, poly(ε-
caprolactone), and polyglycolide can offer a controlled material degradation 
(Polo-Corrales et al., 2014). 
According to Hench and Polak, the third-generation scaffold was aimed at 
enhancing the physiological cellular response at the molecular level. This 
was proposed by creating a scaffold that has mechanical and spatial features 
that facilitates the recruitment of progenitor cells and at the same time 
enhancing these cells to proliferate and differentiate to other types of cells by 
incorporation of some molecules that are known to be growth activators   
(Hench and Polak, 2002). Hence theses scaffolds should acquire some of 
the following properties (Amini et al., 2012):- 
1-Mechanical integrity, structure and mechanotransduction: one of the most 
important scaffold features is to offer a transient mechanical strength in the 
replaced bone site that permits for bone repair and regeneration and fulfil the 
physical needs of the surrounding bone during the healing process (Bauer 
and Muschler, 2000). The normal mechanical properties of bone differs 
between cortical and cancellous bone; it was found that the compressive 
strength of cortical bone is between 90 and 230 MPa (tensile strength is 
between 90 to 190 MPa), while the cancellous bone compressive strength 
ranges between 2 and 45 MPa (An and Draughn, 1999). These scaffolds 
should possess mechanical properties similar or close to that of repaired 
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bone. Apart from mechanical integrity, scaffold should be produced in a way 
that permits for mechanical transduction. Mechanical transduction can be 
considered as an osteoinductive factor controlling cell response and 
enhancing cell differentiation through the mechanical flow of the fluid through 
the whole scaffold. It was determined that the optimum scaffold permeability 
that can lead to successful implant in regard to vascularisation and 
mineralisation is about 3 × 10−11 m2 (Jones et al., 2009). These mechanical 
properties should be varied according to the replacement site to prevent any 
complication such as stress shielding and subsequent refracture. These 
mechanical properties are generally controlled by scaffold composition and 
structure. For example, HA and TCP have elastic modulus and compressive 
strength similar to that of the compact bone, but they are brittle. On the other 
hand, polymers mechanical properties resemble those of human cancellous 
bone. for this reason, producing composite scaffolds that have both 
bioceramics and polymers can give the required properties of these two 
materials in one scaffold (Rezwan et al., 2006). Other  methods can be used 
to enhance polymer mechanical properties, for example  by adding carbon 
nanotubes (CNT), bioglass particles or alloy particles (Mikael and 
Nukavarapu, 2011, Wong et al., 2010).  
2-Scaffold porosity:  porosity is considered as an important factor in 
successful scaffold production. Its role is mainly linked to the scaffold 
osteoconductivity or permeability  as it will offer the scaffold internal spaces 
that permits for cell growth, nutrient flow, vascularisation and spatial cellular 
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organization (Zeltinger et al., 2001). Hing (2005) stated that scaffold 
permeability is mainly dependent on pore interconnection size which is 
basically the net result of both pore size and the degree of scaffold porosity 
(porosity percentage) (Hing, 2005). 
However, there is no clear consensus concerning the ultimate porosity 
requirements such as (porosity percentage, pore size), and many studies 
were performed to ascertain the appropriate dimensions. One study was 
performed on porous hydroxyapatite and revealed that a scaffold with pore 
size between 300-400 µm had better results on enhancing the rate of bone 
formation (Tsuruga et al., 1997). Other later studies were done on glass 
scaffolds in which they tested different scaffolds with different pore sizes and 
with different percentage of porosities. These studies showed that it is 
recommended for the scaffold to have a pore size of about 100-500 µm and 
suggested that a porosity that is more than 40% may be  applied in bone 
tissue engineering (Yuan et al., 2001, Sepulveda et al., 2002, El‐Ghannam, 
2004). It is believed that bone graft substitutes should have two important 
types of pores sizes:  microporous (<5 μm‎ pores)‎ and‎ macroporous‎
(>100 μm‎pores).‎Although both of them are  important for the biodegradation 
(bioresorbility) of the material, the latter type is more required for appropriate 
osteoconductivity  (Hannink and Arts, 2011). Concerning porosity 
percentage, it was found that increasing scaffold porosity may have a 
potential effect for bone growth. A previous study was done by implanting 
silicate bioceramics with different porosities (22%, 36% and 47%) in an ovine  
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model and assessing their ability to enhance bone growth, the outcome 
showed that better bone growth  was related with the highest porosity (Chan 
et al., 2012). 
Generally, controlling pore size and porosity for scaffolds is an imperative 
factor. Concerning pore size,  it is more preferable to have larger than 100 
µm pores sizes as this will enhance bone formation while the unmineralised 
or fibrous tissues may interpose into the small size pores (10-100 µm), these 
results are because large size pores may permit better vascularisation and 
nutrient delivery while for porosity percentage it was also believed that there 
is an indirect relationship between porosity and mechanical properties; 
increasing porosity by 10-20% can decrease the mechanical features by 4 
times, for this reason it is not advisable to prepare high degradation rate 
ceramics with 90% porosity because this may  compromise the mechanical 
integrity for the scaffold (Karageorgiou and Kaplan, 2005).  
3. Nano-Featured Scaffolds: Scaffolds are a model of extracellular matrix 
(ECM) that is intended to support the defective bone.  It is known that normal 
bone cells interact usually with osteoinduction related factors such as 
proteins like collagen type 1 and mineral nanoparticles such as HA which are 
components of the ECM. As a result of that, it is highly favourable to include 
nanoparticles within the scaffold. These may add nanotopographical features 
to an implant material and enhance osteoinduction and osteointegration 
properties (Laurencin et al., 2009, Harvey et al., 2010). Studies have showed 
that scaffold surface modification by nanoparticles boosts an osteoblasts 
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ability to adhere, differentiate and secrete many osteogenic markers such as 
alkaline phosphatase and osteocalcin (Smith et al., 2010).  
1.4.2 Fabrication techniques of scaffolds for bone tissue engineering 
1.4.2.1 Bioactive glass scaffold techniques  
1.4.2.1.1 Sol –gel process 
 It is the process entitling the production of inorganic bioglass scaffold by 
using the sol -gel process. In this process, glass precursors are mixed with 
alkoxides such as Tetraethylortho-silicate (TEOS) or triethylphosphate (TEP) 
with the addition of surfactant and catalyst as a gelling agent. As the gelling 
point of this mixture is approached, the whole mixture is cast  into moulds, 
then  aged at (60°C), dried (130°C) and thermally stabilised 
(600°C)(Sepulveda et al., 2002). As a result of this technique, porous 
scaffolds can be produced  with different pore sizes as mesopores ( 2-50nm) 
and macropores (10-500 µm) (Chen et al., 2008a).  
Many studies were performed on these types of scaffolds, and the results 
were promising as they were found to promote cell proliferation, metabolism 
and  mineralisation activities (Gough et al., 2004, Solgi et al., 2017). 
1.4.2.1.2 Foam replica technique 
This technique involves the use of custom made polymer as a template 
(green body) for the bioglass. The polymer template is custom made from 
polyurethane with desired foamy internal macrostructure. The template is 
immersed in slurry made by bioglass powder. After the immersion process, 
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the slurry dries and infiltrates between the polymer forming an homogenous 
layer of bioglass coating the polymer framework. This will be followed by 
burning the polymer using high temperature (>450°C) leaving empty sites of 
the burned polymer that represent the scaffold pores. After the polymer 
removal the glass is sintered to the desired density (Figure 1-8)(Chen et al., 
2006). 
Chen et al (2008) stated that this technique has many advantages over other 
methods of scaffold manufacturing such as the ability to form highly porous 
scaffolds (>90%) in different irregular shapes by using non-toxic chemicals 
(Chen et al., 2008a). The main drawback of scaffolds synthesised by this 
techniques is the lack of mechanical properties that limits their application to 
be used only in the repair of low-load bone defects (Fu et al., 2011).  
In vitro studies displayed that these scaffold macrostructure may enhance 
cellular penetration inside the scaffold construct and promote cellular 
metabolic responses (Chen et al., 2008b). 
 
Figure ‎1-8 Foam replica technique. Reprinted from the journal of Biomaterial, volume 27, (Chen 
et al 2006) 45S5 Bioglass-derived glass–ceramic scaffolds for bone tissue engineering, page 
2414-2425 
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1.4.2.1.3 Polymer coated bioceramics 
 This technique involves coating of bioceramics (HA, Bioactive glasses) by 
dipping these ceramics in biodegradable polymer solution for specific time to 
improve the mechanical properties of the porous bioceramics (Kim et al., 
2005a). Apart from enhancing the strength of material, the coating material 
may enhance the surface bioactivity (Mohamad Yunos et al., 2008).  A recent 
study has suggested that coating bioactive glasses (BAG) scaffolds designed 
for bone repair applications with polymer may enhance the expression of 
vascular endothelial growth factor (VEGF) (Björkenheim et al., 2017). Xiao et 
al (2017) examined material strength of polymethylacrylate (PMMA) polymer 
-coated silicate bioglass and found that the strength of the coated bioceramic 
was significantly improved in comparison with the non-coated samples (Xiao 
et al., 2017). 
1.4.2.2 Polymer scaffolds techniques  
1.4.2.2.1 Solvent casting and particle leaching  
This technique entitles dissolving polymer alone or with ceramic granules in 
organic solvent, water soluble salts are added also to the polymer solution. 
Then the whole polymer solution is casted in fabricated 3D moulds and left 
for a time to allow for solvent evaporation. After the solvent is evaporated, 
salt particles are leached out forming pores in their position (Liu and Ma, 
2004). Rezwan et al (2006) stated that there are main drawbacks related to 
this technique which are related to the limitation of producing scaffolds in 
different shapes, the possibility of retention of some toxic particles of solvent 
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within the polymer that may cause denaturation of proteins (Rezwan et al., 
2006). Parsad et al (2017) stated that porosity of scaffolds manufactured in 
this procedure are mainly dependent on the shape and sizes of the leached 
particles and there is possibility of retention of some particles within the 
scaffold that may affect the pores interconnectivity.  Therefore, most of 
scaffolds produced in this technique are limited up to 3-4mm in thickness 
(Prasad et al., 2017). 
1.4.2.2.2 Thermally induced phase separation (TIPS)/ freeze casting 
This technique has been used first to produce porous polymer scaffolds. In 
this technique, the polymer is dissolved by solvent at specific temperature, 
inorganic ceramic can be added also to the solution.  After that, the whole 
mixture is sonicated in a flask and then exposed to low temperature using 
liquid nitrogen for a specific time. As a result of that, the solution is 
crystallised (solidified). This will be followed by transferring the whole frozen 
construct into a cooling bath that is connected to a vacuum pump to aid in 
solvent sublimation. The space that was taken by solvent crystals become 
pores (Rezwan et al., 2006).Generally the pores formed in these scaffolds 
are tubular in shape with variant diameter (>100 µM) with small 
interconnecting networks between them (≃ 10 µM). The diameter size of 
pores is mainly dependent on the type of polymer, solvent and the 
concentration of polymers(Chen et al., 2008a).  
Although the main advantage of this technique is the ability to produce a 
scaffold with high porosity, the disadvantages relate to the produced pores 
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having small sizes and the produced scaffold morphology not being 
controlled (Prasad et al., 2017). 
1.4.2.2.3 Solid freeform fabrication (SFF) (rapid prototyping) 
This technique involves the use of various techniques in manufacturing the 
scaffolds in a layer-by-layer fashion using computer aided design (CAD) 
without using the conventional methods such as moulds. The produced 
scaffolds have predesigned structure and morphology that are modelled 
previously in a computer (Fu et al., 2011). The main positive aspect of this 
technique is that the synthesised scaffolds have complex structure and 
satisfactory mechanical properties. However, the drawbacks are limitation of 
the used polymers and the high expenses of the equipment (Prasad et al., 
2017). 
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1.5 Carbon nanotubes (CNTs) 
 Since the discovery of  these macromolecules in 1991 by Lijima by using the 
arc-discharge evaporation method (Iijima and Ichihashi, 1993), these 
nanotubes have attracted attention around the world. Generally they are  
cylindrical in shape with a few nanometres diameter and length extending 
from a few micrometres up to 20 cm (Ajayan et al., 2009). Their walls are 
formed from carbon atoms that are organized in a hexagonal shape and 
usually occur as two types either single walled (SWCNT) which they are 
formed from one cylinder or multiple walls (MWCNT) that formed from 
multiple cylinders that are organized inside each other. In the latter form their 
diameter can be up to 100 nm (Figure 1.9)(Balasubramanian and Burghard, 
2005, Loos, 2015),  
 
Figure ‎1-9 Schematic diagram of a (a) single-walled carbon nanotube, (b) double-walled carbon 
nanotube, and (c) multi-walled carbon nanotube. Reprinted from Carbon Nanotube Reinforced 
Composite  (Loos, 2015). Chapter 3, Allotropes of Carbon and Carbon Nanotubes, page 76.  
Carbon nanotubes can be produced by three different procedures the (i) 
Electric arc discharge (ii) Laser ablation and (iii) the catalytic chemical vapour 
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deposition (CCVD) which has a high production rate and control of the type 
produced (Scott, 2004, Dupuis, 2005, Farhat and Scott, 2006).  
Carbon nanotubes have excellent mechanical, electrical and chemical 
properties because of their structural composition (Zhang and Zhang, 2017). 
This has encouraged many studies to test their application in biomedical 
fields such as the drug delivery or imaging fields (Son et al., 2016, Puett et 
al., 2017). Moreover, it has been identified that carbon nanotubes could form 
hydroxyapatite crystals on their surface when they are immersed in 
stimulated body fluid (SBF) and this has encouraged many studies to 
investigate them as a potential biomaterial in bone tissue engineering 
(Akasaka et al., 2006, Harrison and Atala, 2007).  
A lot of work was done to produce and biologically examine carbon 
nanotubes and polymer composites. Luo et al (2017) produced and 
examined biodegradable composite from CNTs and polycaprolactone (PCL) 
polymer both in vitro and in vivo environment. The findings of this study 
stated that addition of CNT to PCL enhanced the mechanical properties of 
the polymer and led to apatite layer formation. Furthermore, the 0.5 
wt/volume % CNT to polymer ratio resulted in the most acceptable results 
(Luo et al., 2017). Another study was also performed but with a different 
polymer, polyvinyl alcohol (PVA) polymer suggested  that adding these 
nanoparticles to this polymer may enhance MG63 cell viability (Zhang et al., 
2012a). 
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Adding CNTs to ceramics has been studied also.  In one study, multiwall 
carbon nanotube (MWCNT) were added to a collagen and hydroxyapatite 
composite. Mesenchymal stem cells were seeded on this modified bone 
biocomposite material. The results showed that carbon nanotubes 
significantly enhanced the mechanical properties of the scaffold and also 
improved the proliferation and differentiation of the seeded stem cells (Jing et 
al., 2017). Other experiments intended to test a CNT scaffold both in vitro 
and in vivo revealed promising results for using carbon nanotube 3 D scaffold 
for bone repair applications (Katz and Willner, 2004, Hu et al., 2004, Tanaka 
et al., 2017). It has been assumed that these positive results for using CNT in 
bone tissue engineering field is not only because of the good mechanical 
properties‎of‎ this‎material‎but‎also‎because‎CNT’s‎ tend‎to‎ increase surface 
roughness that may enhance osteoblast adhesion and proliferation (Sinha 
and Yeow, 2005). 
The cytotoxic effect of CNT needs to be addressed. Carbon nanotube 
physical and chemical features can affect their biocompatibility and result in 
cytotoxicity; it was found that SWCNT showed lower in vivo- related 
undesirable effects compared to MWCNT. The reason behind that is that the 
simple shape of SWCNT made them easily to be phagocytosed and 
transferred to the lymphatic while the MWCNT can form large aggregates 
that prevents human immune cells from processing them (Aillon et al., 2009). 
Other studies correlated CNT shape with cell death.  CNT sharp end may act 
as a lance traumatising the cellular plasma membrane causing cellular death 
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(Hirano et al., 2008). Moreover, it was stated that the longer CNTs about  
(≥ 20 µm) may be more destructive  and inflammatory than the short CNT 
(Poland et al., 2008). Other researchers correlated the chemical 
functionalisation of CNT with their toxicity. Non-functionalised CNT (Pristine 
CNT) are hydrophobic and are more susceptible to form aggregates and 
accumulate in different organs causing inflammatory responses. Also, it is 
difficult to be eliminated from human organs because of their aggregation 
status (Sayes et al., 2006, Aillon et al., 2009). 
It has been known that the exposure to these nanoparticles may trigger cells 
to produce a reactive form of oxygen as a way of self-defending. Oxygen 
may be produced in the form of superoxide anion radicals (O2∙
−), hydrogen 
peroxide (H2O2)‎and‎hydroxyl‎radicals‎(∙HO),‎these‎have‎high‎redox‎reaction‎
potential. This process is called oxidative stress which is considered the most 
likely mechanism of CNT toxicity (Pacurari et al., 2016). Veetil and Ye (2009) 
mentioned that cellular death caused by CNTs occurs only in the cases of 
exposure to high concentration of CNTs (Veetil and Ye, 2009). Many studies 
were performed to investigate CNT toxicity and it showed contradictory 
results. While some studies revealed they are highly cytotoxic and can cause 
reduction in cellular viability (Cui et al., 2005), other studies mentioned that 
CNT are biocompatible if they were used in low concentration (25 µg/ml) and 
for short period (not exceeding 2 hours) (Kam and Dai, 2005). However, later 
an in vivo experiment which involved long duration (more than 3 months) 
CNT implantation in mice showed a low toxicity effect with no apoptosis 
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(Yang et al., 2008a). The recent comparative study on SWCNT aimed to 
investigate the cytotoxic effect and biocompatibility of these nanoparticles on 
osteoblasts revealed that functionalised CNTs can easily be dispersed in the 
osteoblast cytoplasm resulting in promoting cellular activity such as the 
expression of collagen type 1 while the pristine type remained on the cellular 
periphery wall. This study showed that using CNT in concentration less than 
100ug/ml does not show unwanted or harmful cellular effects (Tong et al., 
2014). 
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1.6 Bioreactors: 
These can be defined as the mechanical apparatus made to mimic the 
physiological and functional properties of the human body in order to 
enhance cell culture growth and stimulate extracellular matrix production 
(Obregón et al., 2017). Bioreactors should require the ability to provide cells 
with nutrients such as glucose and growth factors and remove all the cellular 
product in a continuous way at the same time. Moreover, bioreactors should 
be designed to work for long periods of time (3-4 months) in an aseptic and 
disinfected environment (Korossis et al., 2005). All the cell culture 
parameters such as temperature, pH, biochemical gradients and mechanical 
properties should be controlled over the whole period of cell culture within the 
bioreactor because of their important role in cell culture growth (Chen and 
Hu, 2006). Temperature is considered the most important factor. If it 
decreases below the optimum range, cellular growth will be affected 
negatively. Whereas if it was higher than the normal value, cellular death 
might occur (Taya and Kino-oka, 2011). pH is also important since any 
decrease in its level may cause more acidity. pH level is mainly maintained 
by buffering through the presence of sodium bicarbonate NaHCO3 or sodium 
hydroxide NaOH in the culture media through the addition of CO2 to the 
culture media. Hence controlling the level of CO2 throughout the whole 
period of bioreactor working time will ensure suitable environmental 
conditions for cell growth (Birla, 2014). Mechanical stimulus is another 
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significant factor in bioreactors. This stimulus is presented by the shear 
stress that is formed due to media flow within the system. Studies have 
mentioned that shear stress can help in the differentiation of mesenchymal 
stem cells to an osteogenic lineage and also aid in bone health and 
maintenance through upregulation of prostaglandin and nitric oxide levels 
(Ng et al., 2017, Chen et al., 2017). However, there is some controversy 
about it, and some studies has showed the positive role of mechanical or 
shear stress on the cell growth while others explained that higher shear 
stress levels can be harmful for cell growth especially for stress sensitive cell 
species (Taya and Kino-oka, 2011, Korossis et al., 2005). It has been 
calculated previously that shear stress of 5 X 10 
-5 Pa can encourage bone 
cell proliferation whereas any shear stress above that may lead to an 
increase in bone markers gene expression (Porter et al., 2005). Other 
attempts have found that the magnitude of shear stress is affected by 
scaffold pore size while porosity percentage affects only the stress 
distribution within the scaffold (Boschetti et al., 2006). Generally, Birla (2014) 
mentioned that each bioreactor design should fulfil four main aspects: 1- 
presence of stimuli that are planned to be applied to cells to enhance their 
proliferation and differentiation. 2- control of environmental variables which 
are important for cellular growth such as pH, temperature and gaseous 
environment. 3- presence of sensors to screen and monitor the 
environmental variables. And 4- the ability to apply the stimulus protocol, for 
example the ability to control frequency, amplitude of stimulus and time 
(Birla, 2014).  
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Bioreactors used for bone cell culture applications can be classified 
according to the method of their action into four types: 1- Spinner-flask 
bioreactor, 2- Rotating wall vessel, 3- Wave bioreactor, 4- Perfusion 
bioreactor which can be subdivided into parallel plates, hollow fibers and 
fixed and fluidized beds (Rauh et al., 2011) . 
1.6.1 Spinner bioreactors:  
 The design of this type of bioreactor involves the presence of multiple 
scaffolds which are either seeded into microcarrier or suspended by needle-
supplied metal holders. These holders are suspended from the top of the 
flask preventing the cell culture scaffold from falling. The culture media flow 
is maintained by magnetic stirrer in the bottom of the flask which is stirred at 
the appropriate speed. Whereas oxygen and culture medium exchange take 
place from the top angled side arms (Figure 1.10) (Sikavitsas et al., 2002, 
Stich et al., 2014). Shear stress is governed by the stirring velocity. One 
study showed that the use of 30 rpm speed in 120ml spinner flask bioreactor 
has led to favourable outcomes with regard to the osteogenic differentiation 
(Sikavitsas et al., 2002). Other later studies tested the use of 50 rpm velocity 
in spinner flask and revealed the enhanced osteogenic and chondrogenic 
differentiation of bone marrow stem cells (Meinel et al., 2004). The formation 
of turbulent waves associated with fluid stirring motion may have harmful 
effects on cell culture and is considered as the main drawback associated 
with this type of bioreactors (Gooch et al., 2001). It has been suggested that 
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these waves may cause shear stress that is very difficult to adapt to by the 
cells (Taya and Kino-oka, 2011). 
 
Figure ‎1-10 Schematic view of a spinner flask bioreactor. The cell/scaffold constructs are 
attached to a needle, and shear stress is applied by convection of medium. Reprinted from 
Tissue Engineering Part B Rev, volume 17, issue4, (Rauh et al., 2011).  Bioreactor systems for 
bone tissue engineering, page 263-280, with the permission from Elsevier. 
1.6.2 Rotating-wall vessel bioreactors (RWV) 
These types of bioreactor have vessels that rotate continuously around 
horizontal axis in a way that prevent the scaffold from contacting the 
bioreactor wall. whereas the oxygen is supplied through filtered membrane ( 
Figure 1.11) (Obregón et al., 2017). The shear stress associated with this 
type of bioreactor is much lower than that of other types because they cause 
less turbulence than that of a spinner flask bioreactor (Zhao et al., 2016). 
Many cellular studies were achieved by using (RWV) and showed 
controversial results; one study revealed that using spinner flask bioreactor 
for biodegradable scaffold may encourage rat marrow stromal cells to 
produce calcium at about 6.6 times higher than the RWV bioreactors 
(Sikavitsas et al., 2002). Other studies showed different results using RWV 
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bioreactors ended in better results than that of spinner bioreactor in regard to 
cellular morphology, viability and ability to form bone (Song et al., 2007). 
The disadvantages related to this type of bioreactor are that they are more 
compatible with small size scaffolds and the possibility of scaffold collision 
with the vessel wall which may harm cell culture (Rauh et al., 2011).  
 
Figure ‎1-11 Schematic drawings of rotation-based bioreactor systems. Reprinted from Tissue 
Engineering Part B Rev, volume 17, issue4, (Rauh et al., 2011). Bioreactor systems for bone 
tissue engineering, page 263-280, with the permission from Elsevier. 
1.6.3 Perfusion bioreactors 
Although there are many different systems that have been produced, they 
share the same basic design. Most of these systems consist of media 
reservoir, a pump, a tubing circuit, and a perfusion cartridge where the 
scaffolds are packed (Yeatts and Fisher, 2011). They can be divided into 
direct and indirect medium perfusion. In the indirect system, scaffolds are not 
tightly attached to the perfusion cartilage which permits fluid to flow with less 
resistance and low shear stress. Whereas the direct system permits fluid to 
be forced through the scaffold and increasing the shear stress levels 
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resulting in improved cell viability and better cell enzymes expression (Figure 
1.12) (Rauh et al., 2011, Volkmer et al., 2008). 
 
 
Figure ‎1-12 (A, B) Schematic drawings of perfusion flow principles. (A) shows indirect perfusion 
where medium flows around and only partly through the scaffold. (B) In direct perfusion, 
medium flow is forced through the scaffold and shear stress is directly transferred to the cells 
within the scaffold. Arrows illustrate the magnitude and direction of fluid flow. Reprinted from 
Tissue Engineering Part B Rev, volume 17, issue4,   (Rauh et al., 2011). Bioreactor systems for 
bone tissue engineering, page 263-280, with the permission from Elsevier. 
Many studies used this type of bioreactor by using different scaffold materials 
such as titanium, calcium phosphate ceramics and polymer composites. One 
of these studies utilised the perfusion bioreactor to assess the proliferation of 
marrow stromal cells that were seeded onto a titanium scaffold and a 
continuous flow rate of 0.3–3.0 mL/min was used. Results revealed that both 
calcium matrix deposition and the rate of late osteoblastic differentiation were 
enhanced through analysing both ALP and osteopontin as bone tissue 
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markers (Bancroft et al., 2002). Another study was performed by using 
bovine demineralised bone scaffolds which were seeded by preosteoblasts 
cell line MC3T3-E1. These scaffolds were placed in the perfusion bioreactor 
and compared with other scaffold samples but with a static environment. The 
results showed the perfusion bioreactor can enhance the oxygenation of cells 
within the scaffold especially for the cells which are centrally located 
(Volkmer et al., 2008). Polymer based scaffolds were assessed after seeding 
with stem cells and incubating in a perfusion bioreactor. The data showed 
that the perfusion bioreactor played an important role in enhancing cell 
viability and mineralisation (Kleinhans et al., 2015). Other attempts used 
perfusion bioreactors for engineering generated grafts that were implanted 
later in the mouse head. The study aimed to prepare composite scaffolds of 
hydroxyapatite, TCP and poly lactic acid polymer. Then these scaffolds were 
seeded with bone marrow stromal cells and incubated for 10, 20 days before 
in vivo implantation. The results showed that perfusion engineered scaffolds 
displayed more acceptable results than the free cell scaffolds. However the 
effect of the engineering time period was insignificant (Ding et al., 2016b). A 
similar study was done by preparing HA and TCP scaffolds which were 
implanted in a sheep’s‎femur‎(Ding et al., 2016a). This study displayed that 
bioreactor engineered results were slightly less than those of the allograft 
control samples. Another study used mouse pre-osteoblastic MC3T3-E1 cell 
lines as a model. These cells were seeded into a composite scaffold that is 
composed of Thai silk fibroin (SF)/gelatine (G)/hydroxyapatite (HA). The 
whole cell culture with the scaffold was incubated in a custom made 
111 
 
perfusion bioreactor under different flow rates of 1, 3 and 5 ml/min. the 
results showed that a flow rate of 5 ml/min can cause cell detachment while a 
flow rate of 3 ml/min resulted in promising results (Sinlapabodin et al., 2016). 
Other studies suggested that the optimum flow rate that can enhance 
osteogenic differentiation of mesenchymal stem cells is about 1.5 ml/min 
(Egger et al., 2017). 
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1.7 Statement of the problem:  
Bone injury in the head and facial area is multifactorial and can affect 
functional and cosmetic aspects negatively. However, the repair of the 
severe defects could be undertaken by following various radical surgical 
procedures that may necessitate the aid of implant applications to repair and 
substitute the missing bony part. These implants could be natural or 
synthetic. 
Until now, bone autografts are considered the most popular and common 
implant,althoughh it has certain drawbacks especially surgery- related 
complications such as pain, bleeding, discomfort and mortality. 
Other options for implant materials are the allografts which have a negative 
side regarding cross infection and immune rejection. Xenografts are 
considered a good choice for bone repair applications, athough there are 
some ethical, personal and religious concerns related to their application. 
As a result of the limitation of the previous natural implant materials, many 
attempts were madwe to produce synthetic bone implants that should 
possess accepted biological and mechanical characteristics. The first 
synthetic materials that was used for this purpose were the calcium 
phosphate bioceramics materials such as tri calcium phosphate (TCP) and 
hydroxyapatite (HA). Although these ceramics have good osteoconductive 
properties, their mechanical properties were unsatisfactory as they are very 
brittle. Polymers are considered as an alternative flexible synthetic material 
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for bone tissue engineering applications. But their downside can be linked to 
their poor mechanical properties.  
Glasses are considered as another type of bioceramics used for bone tissue 
engineering. There are three main types of glasses; silicate glass, borate 
glass and phosphate glass. Silicate glasses were the first produced type and 
have showed acceptable results with regard to its application in tissue 
engineering. Its slow biodegradation rate is the main concern limiting its use. 
Borate glass exhibited better degradation rate and HA layer formation ability 
than silicate bioglass but with poor mechanical properties. Phosphate glass 
has been shown to have better properties than silicate and borate glass 
because its biodegradation rate is higher than silicate glass and can be 
controlled to be lower than borate glass. It has been shown to have a good 
potential to function as an implant material for bone tissue engineering, even 
though brittleness remains as an obstacle in the way of producing the proper 
material with the optimum composition and optimum mechanical, chemical 
and biological properties.  
Based on what has been explained previously about the limitation of all 
synthetic bony implant choices, it is essential to produce other biocomposite 
materials that combine all the positive characteristics and overcome the 
individual downsides. For this reason, some of these biocomposites were 
made of polymer and phosphate glass where polymers were the main 
component and glass powder has been added in low percentage as fillers to 
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enhance the mechanical properties of composite. However, there are no 
known implant biomaterials that are made mainly of phosphate glass. 
1.8 Aim of and objectives  
The aims of this study are: 
1- Determine the optimum composition of both zinc and strontium phosphate 
glasses that can be applied as an implant material for bone tissue 
engineering. 
2- Surface modification of glass surface by coating the glass surfaces with 
CNT-PCL layer.  
3-Development of phosphate-based 3D scaffolds that exhibit the appropriate 
mechanical, chemical, morphological and biological properties. 
4- Designing and installing perfusion bioreactors to mimic the physiological 
environment. Hence, assessment of the effect of mechanical stimulation that 
results from the culture flow on the cells seeded on the developed 3D 
scaffolds.  
The objectives are: 
1-Production of two main groups of phosphates-based glass discs based on 
composition (zinc group and strontium group). Each group is subdivided into 
four subgroups according to the variation in concentration.  
2-Production of two main groups of phosphate-based glass beads based on 
the composition (zinc group and strontium group). Each group is subdivided 
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into two groups according to the most acceptable results found using glass 
discs.  
3- Producing scaffolds and assessing cell seeding efficiency by using 
different reagents and different procedures.  
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1.9 Null hypothesis 
The general Null hypothesis of this thesis stated the following: 
1-There are no significant biological and cellular differences between the 
different compositions of developed zinc and strontium phosphate-based 
glass discs and control groups (tissue culture plastic or silicate glass beads). 
2-There is no clear difference of cellular response to the CNT-PCL coated 
glass discs in comparison to the control tissue culture plastic. 
3-There is no mechanical and morphological variation between different 
scaffolds produced by different sintering temperatures. 
4- There is no cellular response difference in term of cellular attachment 
between cells seeded on different scaffolds (CNT-PCL coated glass 
scaffolds, uncoated glass scaffolds, BioOss scaffolds). 
5- There is no cellular response difference in term of mineralisation between 
cells seeded on different scaffolds (CNT-PCL coated glass scaffolds, free 
coated glass scaffolds, BioOss scaffolds) under both static and dynamic 
environment. 
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Chapter 2 Assessment of physical, chemical and biological 
properties of strontium phosphate-based glass 
2.1 Introduction 
Phosphate-based glasses are a type of bioceramic material that has specific 
properties for use in bone tissue engineering applications. The preference for 
using phosphate glasses have increased because phosphate glasses are 
more controllable in regard to their degradation rate (Knowles, 2003). The 
degradation rate of phosphate glass can be varied from 2 h to >1 year and 
this is mainly dependent on the variation of their compositions. The addition 
of specific oxide modifiers such as TiO2 may improve the glass network 
stability and may help in reducing  the degradation rate (Lakhkar et al., 
2011). Hence, it is  possible to obtain a precise tuning of the degradation rate 
and also to control the release of ions that are known for their role in 
promotion of bone formation such as calcium, phosphate and strontium 
(Lakhkar et al., 2013). The inclusion of Ca2+ and Sr2+ ions in biomaterials has 
gained more interest over the last decades because they are generally 
identified to stimulate osteoinduction and osteogenesis (Bose et al., 2013).  
Strontium has been shown to aid in bone health due to its apparent dual 
anabolic and anticatabolic mechanisms of action. Through these synergistic 
processes, Strontium simultaneously upregulates mineral deposition by 
osteoblasts and inhibits bone resorption by osteoclasts. This will result in a 
net gain in mineralised tissue. Hence many studies have investigated the 
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addition of strontium to different types of glass that are intended to be used 
for bone defect repair applications (Mentaverri et al., 2012).  
One study investigated the addition of strontium oxide to silicate glass in the 
formula of (SiO2)46.5–(P2O5)1–(Na2O)26.4–(CaO)(23.1-x)–(SrO)x (x = 0, 2.3, 
11.5 or 23.1) (mol%). This addition of strontium oxide resulted in upregulation 
of both cell proliferation and normalized alkaline phosphatase (ALP) activity 
in human osteosarcoma cell line Saos-2 (Gentleman et al., 2010). 
Sriranganathan et al (2016) investigated different composition of silicate-
based glasses containing different calcium and strontium contents (Ca35Sr0, 
Ca17Sr17, Ca0Sr35). The main aim of the study was to assess the effect of 
substituting strontium with calcium on the formation of hydroxyapatite layer. 
The results showed that the addition of strontium in favour of calcium might 
result in less apatite formation (Sriranganathan et al., 2016).    Other in vivo 
studies on strontium containing silicate glasses was carried out to establish 
the efficiency of the Sr-containing bioglass in encouraging bone formation in 
rabbits. The results suggested that implants containing strontium presented 
more promising results than those free of strontium (Newman et al., 2014). 
Other series of studies inspected the incorporation of strontium into tertiary, 
quaternary and quinternary phosphate glasses where Sr concentration varied 
as 0, 1, 3 and 5 mol% and Ti concentration was 0, 3 and 5% (Abou Neel et 
al., 2008a, Lakhkar et al., 2009, Lakhkar et al., 2011). Generally, the results 
of these studies showed that direct increase in glass stability and 
cytocompatibility occurred when TiO2 content was increased. Whereas 
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regarding SrO, the inclusion of 1 mol% of SrO to the glass seemed to disrupt 
the glass network and cause more rapid degradation than was observed in 
SrO-free compositions. This will subsequently cause a decline in cell 
proliferation on the surface of the materials. Conversely, increasing of SrO 
content to 3 or 5 mol% led to a decline in glass degradation rate, therefore, 
enhancing cytocompatibility.  
Although many studies have been carried out to investigate adding strontium 
oxide to phosphate-based glass, little information is available on adding high 
levels of strontium oxide to phosphate glass. The purpose of this chapter is 
to discuss the production of high strontium oxide content quinternary 
phosphate-based glasses and examine their properties. Glass was produced 
in the formula of (P2O5)50–(Na2O)10–(TiO2)5–(CaO)(35-x)– (SrO)(x) when x 
= 0, 3.5, 17.5 or 35 (mol%). Titanium dioxide content was fixed at 5 mol% to 
control glass degradation. While calcium oxide content was substituted with 
strontium oxide (up to 35 mol%, compared with SrO content in the previous 
studies at 5 mol%).   
The results of this chapter could be useful in recognising the effect of 
incorporation of high strontium oxide concentration in phosphate glass and 
identify the potential of the produced material in biomaterial applications. 
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2.2 Materials and methods  
2.2.1 Materials  
 Different composition of strontium-containing phosphate-based glass discs 
were prepared by using the following chemical precursors: diphosphorus 
pentoxide (P2O5, 98%, VWR, Lutterworth, UK), sodium dihydrogen 
phosphate (NaH2PO4, 99%, VWR, Lutterworth, UK), titanium oxide (TiO2, 
99%, VWR, Lutterworth, UK), calcium carbonate (CaCO3, 98.5%, VWR, 
Lutterworth, UK) and strontium carbonate (SrCO3, 98.5%, BDH Laboratory 
Supplies, Poole, UK).  
2.2.2 Glass precursors calculation  
Four different quinternary strontium-containing phosphate-based glass 
(P2O5–CaCO3–NaH2PO4– SrCO3TiO2) were made. The details of glass 
composition codes and weight are listed in (Table 2.1). 
Table ‎2-1 Glass compositions 
Glass code     and composition             Concentration (grams) 
P2O5 NaH2PO4 TiO2 CaCO3 SrCO3 
SrO0 P50Na10Ti5Ca35 56.8 24 4 35 0 
SrO3.5 P50Na10Ti5Ca31.5Sr3.5 56.8 24 4 31.5 5.16 
SrO17.5 P50Na10Ti5Ca17.5Sr17.5 56.8 24 4 17.5 25.8 
SrO35 P50Na10Ti5Sr35 56.8 24 4 0 51.66 
 
Mole concentration of the precursors were calculated as follows: using the 
SrO17.5 glasses as an example ((P2O5 = 50 mol%; Na2O = 10 mol%; TiO2 = 
5 mol%; CaO = 17.5 mol%; SrO= 17.5 mol%). 
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A. Sodium dihydrogen orthophosphate (NaH2PO4) 
                                      2NaH2PO4                               Na2O + P2O5 + 2H2O 
Mol. wt. (g.mol–1)                    240                                      62        142       36 
Relative mol. wt. (g.mol–1)                                              0.258       0.59      
0.15 
To get 10 mol% Na2O, the needed amount of NaH2PO4 is: 
= [(mol. fraction of Na2O) × (mol. wt. of Na2O)]/ (relative mol. wt. of Na2O) 
= (0.10 × 62)/ (0.258) = 24 g 
B. Phosphorus pentoxide (P2O5) 
Amount of P2O5 produced in the above reaction 
= (amount of NaH2PO4 required) × (relative mol. wt. of P2O5) 
= 24× 0.59 = 14.16 g 
Amount of P2O5 required to produce 50 mol% P2O5 
= 0.50 × 142 = 71.00 g 
Therefore, actual amount of P2O5 to be added 
= 71.00 – 14.14= 56.8 g 
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C. Calcium carbonate (CaCO3) 
                                                CaCO3                                              CaO + CO2 
Mol. wt. (g.mol–1)                      100                                 56          44 
Relative mol. wt. (g.mol–1)                                              0.56        0.44 
To get 17.5 mol% CaO, the required amount of CaCO3 is: 
= (0.175 × 56)/0.56 = 17.5g 
D. Titanium(IV) dioxide (TiO2)  
Mol. wt. of TiO2 = 47.90 + (2 × 16) = 79.9 
To get 5 mol% TiO2, the needed amount of TiO2 is: 
= 0.05 × 79.9 = 4g 
E. Strontium carbonate (SrCO3) 
                                               SrCO3                                         SrO +   CO2 
Mol. wt. (g.mol–1)                    147.63                         103.62     44 
Relative mol. wt. (g.mol–1)                                             0.7        0.29 
To get 17.5 mol% SrO, the needed amount of SrCO3 is: 
= (0.175 × 103.62)/0.7= 25.8g 
2.2.3 Glass preparation  
The required amounts of precursors powders were weighed according to 
proportions by two decimal electronic balance (Sartorius). Then all the 
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powder mixture was mixed by using a blender (Stomacher 400 
circulator/Seward) for one minute. Once the mixing step had been finished, 
the precursor mixture was introduced into 200 ml volume Pt/10%Rh crucible 
type 71040 (Johnson Matthey, Royston, UK) which was placed in a furnace 
(Carbolite) at 1350oC for four hours. Afterwards, the melted glass was taken 
out from the furnace and casted into (15mm diameter) rods graphite moulds. 
The mould was preheated at 420oC. Then, the graphite mould was 
introduced again into a furnace for one hour at 420oC which then left in the 
furnace to cool down gradually to room temperature overnight to remove the 
residual stress. The   glass rods were removed from the mould the following 
day and were cut into 2mm thick glass discs using a diamond saw (Accutom 
50 electric diamond saw, Struers, Catcliffe, UK) (Figure 2.1) which were 
prepared for different experiments. Other samples of glass powders were 
prepared by grinding each glass composition with (MM 301 Mixer Mill, 
Retsch GmbH, Hope, UK) grinder. These glass powder samples were used 
as samples for XRD. 
              
A                                                                         B                                                                                                                      
                                                                                                                                                                
Figure ‎2-1(A, B) Pictures explained the prepared glass (A) glass rods (B) glass discs 
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2.2.4 Materials characterisation  
2.2.4.1 Density determination  
For Measuring density, an analytical balance and density determination 
apparatus (AG 204 & MS-DNY-43, Mettler Toledo, Beaumont Leys, UK) 
were‎ used‎ according‎ to‎ Archimedes’‎ principle.‎ The‎ immersion‎ liquid‎ was‎
ethanol (99.8%, Sigma- Aldrich, Dorset, UK) to avoid phosphate glass 
dissolution in water. Each glass disc was initially weighted in air then 
weighed again in the ethanol. 
The density of each composition was determined and calculated using the 
equation 1. 
𝑃𝑔𝑙𝑎𝑠𝑠 =
𝑀 𝑎𝑖𝑟
𝑀 𝑎𝑖𝑟−𝑀 𝑒𝑡ℎ𝑎𝑛𝑜𝑙 
𝑋 𝑃 𝑒𝑡ℎ𝑎𝑛𝑜𝑙…………………………1 
Where‎ρglass is the density of the specimen (g.cm
-3),‎ρethanol is the density of 
ethanol at the environment temperature in (g.cm-3) at which the 
measurement was performed, mair is the mass (g) of the specimen in air and 
m ethanol is the mass of the specimen under ethanol.  
2.2.4.2 X-ray diffraction 
X-ray diffraction of each glass composition was performed by using XRD 
device (D8 Advance diffractometer, Bruker, Coventry, UK) to ensure the 
amorphocity of the produced glasses. All the glass powder specimens were 
placed in flat plate geometry which was loaded in the x-ray machine. X-ray 
was‎ filtered‎by‎Ni‎ to‎give‎Cu‎Kα‎ radiation.‎After‎ loading‎ the‎samples‎ in‎ the‎
machine,‎ diffraction‎ was‎ measured‎ over‎ an‎ angular‎ range‎ of‎ 2θ=10o-100o 
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and a count time of 12 seconds. Afterwards, x-rays were detected using a 
Lynx eye detector that was used to collect the data. 
2.2.4.3 Thermal analysis 
Differential thermal analysis was performed for the four compositions by 
using powder of each glass disc composition that was prepared by using 
(MM 301 Mixer Mill, Retsch GmbH, Hope, UK) grinder. About 45 mg of 
powder‎ of‎ each‎ glass‎ composition‎was‎ loaded‎ into‎ 10‎μl‎ platinum‎ crucible‎
that was afterward placed in the DTA Analyser (Setaram differential thermal 
analyser, France). These samples were heated from the room temperature to 
about 1000°C at a rate of 20°C. min-1. An empty platinum crucible was used 
as a reference and air was used as the purge gas. 
Three thermal parameters were measured: (1) Tg the glass transition thermal 
temperature, (2) Tc the glass crystallization temperature and (3) Tm the 
melting temperature.  
2.2.5 Chemical, physical studies of strontium phosphate bioactive 
glass discs 
2.2.5.1 Degradation study (Mass loss) 
Triplicates of each composition were initially weighed then stored in plastic 
vials (Sterilin tube) and immersed with 25ml high-purity deionized water 
(resistivity‎ =‎ 18.2‎ MΩ.cm–1) gained from a PURELAB UHQ-PS (Elga 
Labwater, Marlow, UK). The pH of the deionized water was preadjusted to 
pH 7 by (HCl or NH4OH) over the whole experiment. All the samples were 
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incubated at 37oC. After 1, 4, 7 and 14 days, the solution was removed and 
kept for ion release and pH measurement. Glass discs were dried for 1 hour 
and weighed at each time point to determine the mass loss. The mass loss 
was done in cumulative with the previous mass loss reading.   Following 
weighing, the discs were stored again in new fresh deionized water for the 
next time point. Mass loss was calculated at every time point by dividing the 
mass difference by the surface area of discs. Disc surface areas were 
measured individually by the equation 2. 
A= 2r2 + 2 rh   ………………………………….2 
When A: surface area of disc, r= radius of the disc (mm) and h= height of 
disc (mm). 
2.2.5.2 Ion release  
Ion release measurement was performed for each stored sample from the 
degradation study, this was done for the anions (PO4
3-, P2O7
4-, P3O9
3-, 
P3O10
4-) and the cations (Na+, Ca2+, Sr2+) by using the ion chromatography 
systems ICS 2500, ICS1000 (Dionex, Thermo scientific, Hemel Hampstead, 
UK) respectively.   
2.2.5.2.1 Anion release 
Ion chromatography (ICS 2500) system was used for measuring the anion 
release. Samples were prepared by pipetting 550 µl from each sample and 
load it into labelled plastic vials. The labelled vials were arranged in specified 
metal vials tray that was inserted into the machine for ion release detection.  
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Calibration for anion chromatography was done prior each time point 
measurement. The calibration (standards) solutions were prepared in five 
dilutions (0 ppm, 1ppm, 5ppm, 25ppm, 50ppm). A calibration curve was 
determined from these five samples reading. this curve was used by the 
Chromeleon® software as a reference for other sample calculations. These 
calibration samples were formed by using the following reagents: sodium 
phosphate monobasic, trisodium trimetaphosphate, sodium tripolyphosphate 
(Sigma–Aldrich, Dorset, UK) for PO4
3-, P3O9
3-and P3O10
5- respectively, and 
tetrasodium pyrophosphate (BDH, Poole, UK) for P2O7
4-. Ultrapure water was 
the solution for preparing the basic stock solution of 100 ppm concentration. 
This was followed by subsequent dilutions to prepare the five standard 
solutions. 
Anions detection was carried out using a 4 × 250 mm Ion Pac® AS16 anion 
exchange column which is packed with an anion exchange resin. The 
background was decreased by a Dionex regenerative suppressor Dionex 
(Anion Self- Regenerating Suppressor (ASRS®)) which was used at a 
current of 223 mA.  A potassium hydroxide cartridge was equipped with 
Dionex EG40 eluent generator which its main functions are: transport of the 
samples through the system, and to contribute in the selection of ion 
separation and provoke time reproducibility. The sample was injected using a 
25µl injection loop. 
 The running program setting were fixed at 30 minutes run time for each 
sample in which KOH concentration was variables as follows: initial 
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concentration at 30 mM KOH for 6.5 minutes, followed by rising 
concentration to 55mM KOH for 15.5minutes, then maintaining concentration 
at 55mM KOH for 6 minutes and finally concentration decrease 30 mM for 2 
minutes. 
2.2.5.2.2 Cation release 
A Dionex Ion chromatography (ICS 1000) system was used for measuring 
the cation release. Sample preparation was similar to the anion 
chromatography except that there are extra filtration steps which was done to 
all the samples prior measurement to remove the anions (OnGuard II, 
Dionex) which bind to the cation detection column.  
Calibration standards were prepared as well by using ultrapure water using 
the following reagents: Sodium chloride (Sigma–Aldrich, Dorset, UK), 
calcium chloride and strontium chloride (BDH, Poole, UK). The basic 
standard stock was prepared were used as reagents to prepare a 50ppm 
stock solution that was further diluted to prepare five standards solutions (0 
ppm, 0.1ppm, 1ppm, 5ppm, 25ppm). The resultant calibration curve was 
used by the Chromeleon® software for the other sample concentration 
calculations. The eluent was prepared by using 30 mM methanesulphonic 
acid (Fluka, Dorset, UK) and cation detection process was carried out 
through a 4 × 250 mm Ion Pac® CS12A separator column. The sample 
injection volume was done by 25 µl injection loop.  
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2.2.5.3 pH measurement  
At all the time points, pH was measured for each stored solution from the 
degradation study using a pH meter (Orion star A111Thermo Scientific, UK). 
the pH electrode of the pH meter was calibrated by using the standard 
solutions of pH 4 and 7 before usage. 
2.2.6 Cell studies 
2.2.6.1 Cells preparation 
MG63 osteoblast-type cells were gained from in-house stocks at Eastman 
Dental Institute of University College London. These cells were kept at -80°C 
in liquid nitrogen. Cells were taken out from the liquid nitrogen tank, then 
were revived by thawing in a water bath at 37°C. The thawed cells were 
dispersed in a 15-ml falcon tube containing 5 ml of 37°C culture media and 
then centrifuged later for 5 minutes at 1000rpm speed at 20°C. After the 
centrifugation process, the supernatant culture media was removed from the 
falcon tube and the MG63 pellet in the bottom of the centrifugation were 
dispersed‎ in‎ 1‎ ml‎ of‎ Dulbecco‎ Modified‎ Eagles’‎ Medium‎ (DMEM) (Sigma 
Aldrich, D5546).  Later, the cells were introduced into a 150 cm2 flask 
containing low-glucose‎ Dulbecco‎ Modified‎ Eagles’‎ Medium‎ (DMEM)‎ which‎
was supplemented previously with 10% foetal bovine serum (FBS) (Gibco) 
and 1% penicillin-streptomycin (PAA Laboratories, GE Healthcare, Chalfont 
St. Giles, UK). 
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Cell proliferation measurement in the flask was carried out in a 37°C/ 5%CO2 
incubator till the cells were 80–90% confluent. Cells confluency was checked 
daily under a light microscope (Olympus CK 2). When cells reached 
confluency of 80%-90%, they were washed with phosphate buffer solution 
(PBS) and then trypsinised by adding 6 ml of 0.025% trypsin-EDTA to the 
flask and incubated at 37°C/ 5%CO2 for 3–4 minutes to ensure cell 
detachment from the flask surface.  Cell detachment was checked under light 
microscope by identifying the floating cells. Then trypsinisation process was 
prohibited by adding 6 ml of fresh media to the trypsinised live cells. The 
whole 12 ml cell suspension was then pipetted from the flask and added to 
15 ml falcon tube which was centrifuged subsequently at a speed of 1000 
rpm for 5 minutes. After this centrifugation process, gentle removal of the 
12ml supernatant was done to avoid disturbing the cell pellet. Finally, cells 
were suspended in 1 ml of media prior to the cell counting procedure, this 
procedure was done by using the Trypan blue dye following the 
recommended protocol (Strober, 2001). 
2.2.6.2 Metabolic activity study 
Metabolic activity was measured by using the alamar blue assay. For this 
study, cells were seeded on triplicate of glass discs of each composition at a 
density of 10000 cells per disc in 24 well plates. This was followed by adding 
1 ml of DMEM culture media to each well plate then incubation at 37oC in an 
atmosphere of 5%CO2 for 7 days. Cell culture medium was replaced every 3 
days.  Tissue culture plastic (TCP) was used as control group.  
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 Cytocompatibility assay was done at three times points (days 1, 4 and 7) in 
which a 10% solution of water soluble tetrazolium salt-8 (alamar blue, ABD 
Serotec) was added to the aspirated culture then stored in the incubator for 
four hours at 5 % CO2. Alamar blue is a cell viability assay reagent which 
contains the cell permeable, non-toxic and weakly fluorescent blue indicator 
dye called Resazurin which is used as an oxidation-reduction (REDOX) 
indicator that undergoes colorimetric change in response to cellular 
metabolic reduction. The reduced form Resorufin is pink and highly 
fluorescent, and the fluorescence produced is proportional to the metabolic 
activity of cells and was detected at 570 nm by a fluorimeter (Infinite M200, 
Tecan, Männedorf, Switzerland).  
Metabolic activity was measured by calculating the percentage of alamar 
blue stain reduction in comparison to the fully reduced alamar blue. To 
perform this step, the first step was the full reduction of alamar with culture 
media which was done by autoclaving the mixture (culture media with alamar 
blue) at 121°C for 15 minutes. To correlate the fluorescence reading with that 
of the full reduction the following equation was used. 
 %  𝑜𝑓 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 𝑎𝑙𝑎𝑚𝑎𝑟 𝑏𝑙𝑢𝑒 =
𝑓𝑙 𝑠𝑎𝑚𝑝𝑙𝑒−𝑓𝑙 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 
𝐹𝑙 𝑜𝑓 100% 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 𝑎𝑙𝑎𝑚𝑎𝑟𝑏𝑙𝑢𝑒−𝑓𝑙  𝑐𝑜𝑛𝑡𝑟𝑜𝑙  
𝑥 100 
Where fl sample is fluorescence reading for sample, fl control is fluorescence 
reading of the untreated culture media and fl of 100% is the fluorescence of 
the fully reduced alamar blue. 
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2.2.6.3 Alkaline phosphatase activity 
 The alkaline phosphatase (ALP) activity analysis was carried out by using a 
p-Nitrophenyl phosphate-based assay (SensoLyte pNPP Alkaline 
Phosphatase Assay Kit, AnaSpec, Seraing, Belgium). Initially, MG63 cells 
were seeded on triplicates of all the discs samples and controls tissue culture 
plastics (TCP) at a density of 30000 cells/disc and alkaline phosphatase 
activity were measured at three different time points (day 4, 7,14).  
At each time point, culture media was aspirated first. This was followed by 
rinsing disc and cell complexes with assay buffer (prepared by dilution of the 
assay buffer with ultrapure water ten folds) and repeated twice. Then, a 
prepared solution of 0.002 Triton x-100 (20 µl of Triton x -100 in 10 ml of 
assay buffer) was added to lyse the cells membrane which was followed by 
using cell scrapers to scrap cells from the discs. The scraped cells were 
aspirated and collected in small plastic tubes which were agitated at 4°C for 
10 minutes. After that, cells were separated from their culture media 
suspension by centrifuging them at (2500 X g, 10 min, 4 °C). Then triplicate 
of 50 µl of supernatant solution from each vial was aspirated in 96 well plate. 
Another 50 µl of pNPP solution was added to each sample.  
Calibration was done by preparing a sequence of ALP standard (10 µg/ml) 
dilutions. Seven dilutions (100, 50, 25, 12.5, 6.25, 3.1, 0 ng /ml) were 
prepared by diluting the alkaline phosphatase standard reagent with the 
buffer solution (Figure 2.2). Triplicate of 50µL of each standard was added to 
50µL pNPP substrate in a 96 well plate. 
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After adding the pNPP solution to both sample and standard substrate, 
incubation of 96 well plates were carried on at 37°C for 30 minutes. Finally, a 
stopping reagent was added into each well before taking triplicate 
absorbance measurements of each glass disc by (Infinite® M200, Tecan) at 
405 nm wavelength.  
The calibration curve was obtained from the standards readings. The 
equation of this curve was used to relate the absorbance reading with the 
ALP concentration in the samples (Figure 2.2).  
 
Figure ‎2-2 Calibration curve of ALP assay. Done by preparing different concentrations of ALP 
and correlate the corresponding fluorescence reading with each of the concentration. 
2.2.7 Statistical analysis  
Cell work data for both cells counting and alkaline activity assay studies were 
statistically assessed by Kruskal-Wallis to examine the null hypothesis 
stating that there is no clear biological and metabolic difference between the 
produced strontium oxide containing glass discs and the control TCP group 
where p<0.05 has been used as a significance degree estimation. 
y = 53.547x2 + 13.689x + 2.2186 
R² = 0.9967 
0
20
40
60
80
100
120
0 0.2 0.4 0.6 0.8 1 1.2 1.4
A
L
P
 c
o
n
c
e
n
tr
a
ti
o
 (
n
g
/m
l)
 
Absorbance   
135 
 
2.3 Results  
2.3.1 Density measurement 
As is shown in (Table 2.2), glass density increased as the content of 
incorporated strontium oxide had increased. The density was ranging from 
2.6 ± 0.017 g.cm-3 in the quaternary glass (strontium free glass) to stand at 
3.0 ± 0.011 g.cm-3 for SrO 35. 
Table ‎2-2 Density measurement of all strontium containing phosphate glass compositions 
Glass code  SrO0 SrO3.5 SrO17.5 SrO35 
Density (g/cm3) 2.63   2.68    2.82    3.03 
 
2.3.2 X-ray diffraction 
The XRD patterns for all the prepared glass samples are shown in (Figure 
2.3). All the XRD patterns were free from any detectable peaks due to 
crystalline phases and displayed a broad peak was observed as expected in 
each‎spectrum‎at‎2θ‎values‎of‎around‎20–40°. 
 
Figure ‎2-3 X-ray diffraction showing the amorphous nature of the prepared glasses 
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2.3.3 Thermal analysis 
Table 2.3 explains the Tg values of the observed glasses. It showed that the 
incorporation of strontium oxide had led to decrease Tg value from 483 °C for 
the SrO 0 to 468°C for the SrO35.  
Table ‎2-3 DTA for strontium containing phosphate-based glasses measured in °C 
Glass code  SrO0 SrO3.5 SrO17.5 SrO35 
Tg (°C) 483 480 475 468 
Tc (°C) 775 715 706 701,647 
Tm (°C) 850 840 833 752 
 
DTA spectra of the glasses are presented in (Figure 2.4). The Tc trend 
exhibited a clear variation between SrO35 and the other three compositions; 
SrO35 seemed to have two crystallisation peaks at of 647°C and 701°C, 
whereas the other three compositions has one peak which was higher than 
that of SrO35. A similar trend was observed for the Tc and Tm values which 
both showed that temperature values decreased in a trend from free 
strontium glasses to the higher strontium compositions. 
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Figure ‎2-4 Differential thermal analysis showing the glass transition temperature (Tg) which is 
the midpoint of the first slope in each composition , crystallisation temperature (Tc) which is the 
upward  peak in each line and melting temperature (Tm) which is the last downward peak in 
each line . Showing that these parameters declined as SrO content increased 
2.3.4 Degradation study (mass loss) 
 Both (Table 2.4) and (Figure 2.5) show the mass loss per unit area 
measured in (mg.cm-2) for a two weeks period. However, there was 
continuous mass loss over the time frame, but the highest increase was in 
the compositions with higher metal oxide substitutions. In other words, the 
higher mass loss was in SrO35 for the whole-time points. In day 1, mass loss 
of SrO 0 and SrO3.5 was about 0.052±0.01 (mg.cm-2) which was about half 
of that of SrO35 at 0.103±0.013 (mg.cm-2) while SrO 17.5 was slightly less 
than SrO 35 at about 0.074±0.013 (mg.cm-2). This pattern remained the 
same for the other time points. In day 14, the maximum mass loss was 
0.266±0.03 (mg.cm-2) for SrO35 whereas the minimum loss was about 
0.164±0.025 (mg.cm-2) for SrO0. 
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Table ‎2-4 Mass loss in (mg.cm-
2
) for all glass compositions in four different time point 
 
 
Figure ‎2-5 Mass loss in (mg.cm
-2
) for all glass compositions over 14 weeks 
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Time (day) 
SrO 0
SrO 3.5
SrO 17.5
SrO 35
Glass composition  Mass loss (mg.cm-2) 
 Day 0  Day 1 Day 4 Day 7 Day 14 
SrO 0% 0 0.052 0.096 0.134 0.164 
SrO 3.5% 0 0.051 0.104 0.141 0.185 
SrO 17.5% 0 0.074 0.134 0.164 0.209 
SrO 35% 0 0.103 0.185 0.229 0.266 
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2.3.5 pH measurement  
pH measurements are displayed in (Figure 2.6).  Generally, pH trend was 
similar for all the glass compositions in that it dropped sharply for the first day 
from 7 at day 0 to  5.5-5.9 at day 1. This was followed by continuous gradual 
decrease for the next time points, however it increased slightly for the last 
week to finish at 5.5-6. The general view indicated that the free strontium 
composition was the more acidic (lowest pH) 5.75 at the end of the time 
frame just slightly less than the other strontium compositions. 
 
Figure ‎2-6 pH measurement 
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2.3.6 Ion release measurement 
2.3.6.1 Anion release 
Strontium glass anion release is shown in (Figure 2.7). Anion release was 
measured for four different anions (PO4
3-, P2O7
4-, P3O9
3-, P3O10
5-). All the ions 
released for all the compositions showed a cumulative increase with time. 
Concerning PO4
3- ions release, SrO0 glass compositions were found to have 
the highest release in comparison with the other compositions over the whole 
study. It was nearly two times that of high strontium oxide content glasses 
(SrO17.5 and SrO35) over the whole time, whereas SrO3.5 glasses showed 
slightly less release from that of the strontium free glass. For P3O9
3-, the ion 
release was similar to that of PO4
3- ions.  At day 1, the release was about 
0.67±0.08 for SrO0 samples clearly higher than the other three composition 
release which was around 0.04-0.06 ppm. This relation remained the same 
for the whole experiment and ended at day 14 at about 2.8 ±0.3 ppm for SrO 
0 that was more than the high strontium (SrO35) at 2.1 ±0.1 ppm. The 
highest release was with strontium free glasses and the release starts to be 
down regulated gradually as strontium content has risen. Regarding both 
P2O7
4-, P3O10
5- ions, these ions witnessed the highest rise for SrO0 in which 
there was a clearly significant variation between it and the other strontium 
oxide containing glasses. Generally, it was found that phosphate ions release 
was inversely proportional to strontium oxide content in glass.  
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Figure ‎2-7 Anion release showing higher release of phosphates ions (PO4
3-
, P2O7
4-
 , P3O9
3-
, 
P3O10
5-
) in the free strontium oxide based glass in comparison to strontium oxide containing 
glass 
2.3.6.2 Cation release 
Figure 2.8 displays the cation release for all glass compositions. Regarding 
calcium and strontium ions, the trend for both of them was opposite to each 
other because it was varied in relation to the glass composition and was 
directly correlated to the percentage of these ions within the glass. In other 
words, high strontium content glass displayed the maximum strontium ion 
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release and the lowest calcium ions. Concerning sodium ions, it was found 
that sodium concentration declined as a function of increasing SrO content in 
the glass. This relationship, however, was inversely correlated with weight 
loss (Figure 2.4). 
     
 
Figure ‎2-8 Cations release for all glass compositions a Sr
2+
, b. Ca
2+
 and c. Na
+
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2.3.7 Biocompatibility study  
 The measurement of the cellular metabolic activity is presented in (Figure 
2.9).  The results were measured at three different time points (day 1,4,7). 
They were represented by the percentage of the samples alamar blue 
fluorescence reduction in relation to the fully reduced alamar blue when the 
higher reduction percentage is related to the higher metabolic activity and 
vice versa. At day 1, TCP displayed around 11.8 ± 0.9% of fluorescence 
reduction which was about similar to that of SrO 0, SrO 3.5 and SrO17.5 and 
about double the reduction of SrO 35. At day 4, TCP reduction rate rose by 
three times to stand at about 30% which was significantly different from SrO 
3.5 and SrO 35 (P <0.05).  
After one week, the pattern of reduction remained similar to the previous two 
times points where the TCP (54 ± 1.5 %) showed the ultimate amount of 
reduction followed by SrO0 (46 ± 2.7 %), SrO 3.5 (40.6± 0.9 %) and SrO17.5 
(43.1 ± 4 %) and SrO 35 (39.4 ±1.5 %) respectively.  
 
Figure ‎2-9 Cell metabolic activity results determined by using alamar blue assay 
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2.3.8 Alkaline phosphatase activity 
Figure 2.10 illustrates the ALP activity of MG63 on different glass 
compositions. At day 4, there was insignificant difference between glass and 
the control (TCP) results. However, clear variation was noticed in day 7,14.  
Interestingly, Sr17.5 showed an unexpected rise in the 14 days which was 
highly significant from the other glass compositions. Cells cultured on TCP 
displayed the lowest ALP activity at day 14 at about 0.27±0.04 ng in 
comparison to 1.27±0.21 ng to SrO17.5 glass discs and around 0.65 ng for 
the other disc samples. 
The general pattern of ALP showed that all the glass samples had good ALP 
activity which was significantly higher than that of TCP (p value < 0.05) at 
days 4 and 7.  
 
Figure ‎2-10 Alkaline phosphatase (ALP) activity of MG63 on different glass composition 
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2.4 Discussion 
This chapter focused on the doping of strontium oxides for the development 
of phosphate-based glasses for tissue engineering applications. Many 
studies leading up to the present work have been carried out. One of the 
earliest studies hypothesised that there is poor cytocompatibility when 
seeding human osteosarcoma cells (HOS) on ternary (Sr free glasses) and 
quaternary phosphate glasses that have low strontium contents in their 
compositions (1, 3 or 5) (mol%). The explanation was  because of the rapid 
degradation rate  of these strontium glasses (Abou Neel et al., 2008a). In a 
follow-up study, inclusion of 3 mol% Ti in quaternary and quinternary 
(P2O5)50–(Na2O)17–(TiO2)3– (CaO)(30-x)–(SrO)(x) (x = 0, 1, 3 or 5) (mol%) 
glasses were revealed to reduce the degradation rate and enhance 
cytocompatibility compared to Ti-free compositions (Lakhkar et al., 2009). 
The substitution of CaO with SrO, has yielded an increase in the degradation 
rate, but with an inverse trend as follows: Sr0 < Sr5 < Sr3 < Sr1. These 
degradation results were directly correlated with a decrease in 
cytocompatibility where Sr0 supported best cell growth: Sr0 > Sr5 > Sr3 > 
Sr1. A subsequent study of (P2O5)50–(Na2O)15–(TiO2)5–(CaO)(30-x)– 
(SrO)(x) (x = 0, 1, 3 or 5) (mol%) composition suggested that increasing TiO2 
into 5mol% was shown to decline degradation rates by more than two times 
than the previous prepared compositions containing 3mol% TiO2.  This 
slower dissolution rate also enhanced cell attachment. Again, degradation 
146 
 
was highest in the composition with low Sr content, reaffirming the prominent 
Sr0 < Sr5 < Sr3 < Sr1 trend observed previously (Lakhkar et al., 2011). Other 
research investigated the addition of high strontium oxide contents to silicate 
glass and it was found that addition of strontium oxide at 17.5 mol % or 35 
mol% might yield in enhancing HOS cells proliferation as these amounts of 
strontium are similar to the concentration of strontium ranelate drugs that is 
used for osteoporosis and may work as an optimum concentration for bone 
repair therapy applications (Gentleman et al., 2010). 
According to the previous studies, the production of the strontium phosphate 
glass in this study was planned; by adding TiO2 in 5 mol% to control 
degradation and enhance cellular proliferation and metabolism, adding SrO 
in higher contents since the low content SrO showed higher degradation and 
poor cytocompatibility in previous studies.  
Many comprehensive studies were carried out in the present study to 
investigate the chemical and biological characterization of the produced 
glass. 
Based on the density results, CaO replacement with SrO yielded an increase 
of glass density. These results can be explained by considering the fact that 
density of strontium is (2.64 g/cm-3) which is higher than that of calcium at 
(1.54 g/ cm-3), and this was clearly compatible with the results. XRD data 
confirmed the amorphous nature of the produced glass. Depending on these 
two results, it seemed that the production phosphate-based glasses 
containing up to 35mol% was successful. 
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On the other hand, DTA data showed that the thermal properties reduced as 
incorporation of strontium oxide increased. The thermal properties presented 
in terms of glass transition, glass crystallisation and melting temperatures 
were reduced. This reduction is likely due to the weaker strontium bonds with 
other glass compositions. Usually the main factors that control both thermal 
properties and degradation of material is the atom size and the bond length 
and when these features increase the degradation will be enhanced and 
make the material easily to be affected by thermal effects. The strontium 
atom (200pm) is larger than that of calcium (114 pm). This may decrease the 
attraction force between the nucleus and the outer shell (valent level) and 
make their ionic bonds more susceptible to be affected by the change in 
thermal changes comparing to the calcium ions. Similarly, these weakly 
formed bonds affect the dissolution rate in the same pattern as the thermal 
changes resulting in high degradation rate for the high strontium oxide 
composition both of them (Sr0 < Sr 3.5< Sr17.5 < Sr35). Hence, the inclusion 
of a larger ionic radius cation may make the glass network more susceptible 
to hydrolysis. 
 Another obtained finding was that the anion release trend was opposite to 
the degradation rate pattern and that could be explained as degradation is 
more governed by the heavy strontium ion Ions release data for the strontium 
oxide containing glass was compatible with the mass dissolution. These 
findings were similar to previous data that hypothesised that fully strontium 
substitution may not yield the highest phosphate ions release (Maçon et al., 
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2017). Regarding Ca2+ and Sr2+ cations, strontium and calcium release were 
compatible with percentage of these atoms in the glass composition. For the 
sodium data, the values of Na+ release were all nominally very similar. 
interestingly some Ca2+ ion was detected in the totally replaced Calcium 
phosphate‎ glass,‎ it’s‎ source‎ is‎ likely‎ from‎ the‎ fresh‎ strontium‎ carbonate‎
which can contain as much as 0.7 weight %. pH results were compatible with 
anion release data, it can be hypothesised that the higher release of 
phosphates ions may lead to the formation of phosphoric acid that can cause 
pH decline which could be the most suitable explanation for pH data. 
All glass formulations were shown to have good metabolic activity. The 
metabolic activity after one day was similar in all formulations and the TCP 
control. Although there was clear statistical difference between TCP and SrO 
35 (p value < 0.05) at day 4 and 7, this did not neglect the biocompatibility of 
SrO 35. The results of ALP activity of cells seeded on glass discs of all 
formulations were promising, approximately double that of the control at each 
time point. The one exception to this was Sr17.5, which induced similar ALP 
activity per cell to other glass formulations at all time points except day 14, by 
which time it had doubled. The higher ALP activity of cells cultured on Sr17.5 
fits with previous data concerning the optimal concentration of Sr for 
induction of osteogenic differentiation of bone marrow stromal cells (Lopa et 
al., 2013) . A concentration of 5 µg/ml SrCl2 was shown to induce higher 
levels of COL1A1 expression and calcified matrix deposition than 1 or 10 
µg/ml. In the present study, the concentration of Sr2+ in extracts of Sr0, Sr3.5, 
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Sr17.5 and Sr35 after 14 days was 0.0, 1.1, 4.5 and 8.1 µg/ml, respectively. 
The concentration of Sr2+ released from Sr35 is therefore higher than optimal 
and explains the lower ALP activity induced by Sr35 than Sr17.5. These 
results explained that null hypothesis was not rejected for the glass discs 
formulations studied here.  
In summary, strontium oxide and calcium oxide containing titanium dioxide 
stabilised glasses were successfully produced via melt quenching technique 
All formulations displayed controlled rate of degradation due to the 
incorporation of TiO2 that may play a significant role in crosslinking the glass 
network. Moreover, glasses displayed acceptable cytocompatibility and ALP 
activity due to the incorporation of both strontium oxide and calcium oxide.  
SrO 17.5 glass formulation was considered the best composition that 
induced ALP activity which was about 3.5 times that of the control because of 
its degradation rate of strontium might be similar to the optimum Sr rate of 5 
mg/ml as has been identified by previous studies (Lopa et al., 2013).  
Further work is needed to be carried on some of the strontium compositions 
and on other compositions of phosphate glass that may be with good 
potential for bone growth such as zinc oxide containing phosphate glass.  
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Chapter 3 Assessment of physical, chemical and biological 
properties of zinc phosphate-based glass 
3.1 Introduction 
 Zinc is considered as an essential element for bone health and growth 
(Yamaguchi, 2010). It plays an influential role on bone mineralisation through 
different mechanisms. One of these mechanisms is by enhancing the 
synthesis of aminoacyl-tRNA synthetase enzyme in osteoblasts. This 
enzyme is important for proteins production and genes expression The other 
mechanism is by the suppression of osteoclast proliferation and activity 
through its inhibitory action to special genetic and inflammatory molecules 
such as RANKL, PTH and  PGE2 that are known to play the important role in 
osteoclastogenesis (Kishi and Yamaguchi, 1994, Park et al., 2013b). 
Moreover, zinc has a favourable effect in stimulating ALP activity and 
collagen production (Seo et al., 2010a). 
As a result of all the identified advantages of zinc to human bone, many 
studies were done to incorporate zinc in glasses for bone biomedical 
applications. One research examined zinc-containing phosphate-based glass 
of different compositions, it was shown that zinc containing glasses has 
enhanced osteoblast like cells (HOB) cellular proliferation and attachment 
especially when it was added to a ternary phosphate glass at less than 
5mol% of glass composition (Salih et al., 2007). Other researchers 
hypothesised that adding zinc to bioactive glasses may be necessary for 
hydroxyapatite formation on the glass surface after soaking in simulating 
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body fluid (SBF) (Lusvardi et al., 2008). A comprehensive study, carried out 
on a quaternary phosphate glass, suggested that adding zinc in more than 
10% of glass composition may yield poor biocompatibility and cell death 
because of its high dissolution rate (Abou Neel et al., 2008c). Other 
correlated work concerned with the production of zinc containing silicate-
based glasses which assessed different concentrations of zinc that did not 
exceed 5 mol%. The results were promising in regards to glass durability and 
cellular activity (Haimi et al., 2009). These results were confirmed later by 
other researchers who found that adding zinc containing silicate glass to 
biphasic calcium phosphates (BCP) which is composed of hydroxyapatite 
and‎ β-tricalcium phosphate showed a positive impact on rat calvarium-
derived osteoblast cell proliferation and behaviour (Badr-Mohammadi et al., 
2014).  
Despite all the studies that were performed on zinc incorporation in glass, 
there is very little work has been done on zinc containing quinternary 
phosphate glasses that have a controllable and fixed degradation rate.  
The main aim of this chapter is to discusses the production of different zinc 
phosphate-based glasses that have a stabilised dissolution rate and examine 
their physical and cytocompatibility properties. Glass was produced in the 
formula of (P2O5)50–(Na2O)10–(TiO2)5–(CaO)(35-x)– (ZnO)(x) when x = 0, 5, 
10 or 15 (mol%). Titanium dioxide content was fixed at 5 mol% to control 
glass degradation. While zinc oxide content was added in a sequential way 
up to 15 mol%.  
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This study may lead to better understanding of zinc action in phosphate glass 
and its effect on the cellular activity that might be helpful in identifying their 
potential as a new biomaterial. 
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3.2 Materials and Methods 
3.2.1 Materials 
Four different glass compositions of phosphate glass were made by using 
phosphorus pentoxide (P2O5 98%, VWR, Lutterworth, UK), sodium 
dihydrogen phosphate (NaH2PO4, 99%, VWR, Lutterworth, UK), titanium 
dioxide (TiO2, 99%, VWR, Lutterworth, UK), calcium carbonate (CaCO3, 
98.5%, VWR, Lutterworth, UK) and zinc oxide (ZnO, 99.95%, Sigma-Aldrich, 
Dorset, UK) as precursors.  
3.2.2 Glass precursors calculations  
Four different quinternary zinc oxide containing phosphate–based glasses 
(P2O5–CaCO3–NaH2PO4–ZnOTiO2) were made. The details of glass 
composition codes and weight are listed in (Table 3.1). 
                                      Table ‎3-1 Glass compositions 
Glass code     and composition             Concentration (grams) 
P2O5 NaH2PO4 TiO2 CaCO3 ZnO 
ZnO0 P50Na10Ti5Ca35 56.8 24 4 35 0 
ZnO5 P50Na10Ti5Ca30Zn5 56.8 24 4 30 4 
ZnO10 P50Na10Ti5Ca25Zn10 56.8 24 4 25 8.14 
ZnO15 P50Na10Ti5Ca20Zn15 56.8 24 4 20 12.21 
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Molar concentration of the precursors was calculated as follows: using the 
ZnO15 glasses as examples (P2O5 = 50 mol%; Na2O = 10 mol%; TiO2 = 5 
mol%; CaO = 20 mol%; ZnO= 15 mol%). 
A. Sodium dihydrogen orthophosphate (NaH2PO4) 
                                           2NaH2PO4                               Na2O + P2O5 + 
2H2O 
Mol. wt. (g.mol–1)                    240                                      62        142       36 
Relative mol. wt. (g.mol-1)                                              0.258       0.59      0.15 
To get 10 mol% Na2O, the required amount of NaH2PO4 is: 
= [(mol. fraction of Na2O) × (mol. wt. of Na2O)]/ (relative mol. wt. of Na2O) 
= (0.10 × 62)/ (0.258) = 24 g 
B. Phosphorus pentoxide (P2O5) 
Amount of P2O5 produced in the above reaction 
= (amount of NaH2PO4 required) × (relative mol. wt. of P2O5) 
= 24× 0.59 = 14.16 g 
Amount of P2O5 required to produce 50 mol% P2O5 
= 0.50 × 142 = 71.00 g 
Therefore, actual amount of extra P2O5 to be added 
= 71.00 – 14.14= 56.8 g 
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C. Calcium carbonate (CaCO3) 
                                                CaCO3                                              CaO + CO2 
Mol. wt. (g.mol–1)                      100                                 56          44 
Relative mol. wt. (g.mol–1)                                              0.56        0.44 
To get 20 mol% CaO, the needed amount of CaCO3 is: 
= (0.20 × 56)/0.56 = 20 g 
D. Titanium(IV) dioxide (TiO2)  
Mol. wt. of TiO2 = 47.90 + (2 × 16) = 79.9 
To get 5 mol% TiO2, the needed amount of TiO2 is: 
= 0.05 × 79.9 = 4 g 
E. Zinc Oxide (ZnO) 
Mol. wt. of TiO2 = 65.4 + 16 = 81.4 
To get 15 mol% ZnO, the needed amount of ZnO is: 
= 0.15 × 81.4 = 12.21 g 
3.2.3 Glass preparation  
This is explained previously in 2.2.3. 
3.2.4 Materials characterization 
3.2.4.1 Density Measurements 
This is explained previously in 2.2.4.1. 
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3.2.4.2 X -ray diffraction  
This is explained previously in 2.2.4.2. 
3.2.4.3 Thermal analysis 
This is explained previously in 2.2.4.3. 
3.2.5 Chemical and physical studies 
3.2.5.1 Degradation study (mass loss) 
   This is explained previously in 2.2.5.1. 
3.2.5.2 Ion release  
Ion release measurement was performed for each stored sample from the 
degradation study, this was done for the anions (PO4
3-, P2O7
4-, P3O9
3-, 
P3O10
4-) and the cations too (Na+, Ca2+, Zn2+) by using the ion 
chromatography systems (ICS1000, ICS 2500, Dionex, Thermo scientific, 
Hemel Hempstead, UK).   
3.2.5.2.1 Anion release  
This is explained previously in 2.2.5.2.1. 
3.2.5.2.2 Cation release 
This is explained previously in 2.2.5.2.2. except there is no strontium release.  
3.2.5.2.3 Transition metal ion release 
 Ion chromatography (ICS 2500) system was used for measuring the 
transition ion (Zn2+)‎ release.‎ ‎This‎ system‎was‎ supplied‎by‎ a‎25‎μl‎ sample‎
loop for sample injection and Ion Pac® CS5A cation ion exchange column in 
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combination with a CG5A guard column for transition and lanthanide metals 
ions detection. The program was set to run for 10 minutes.  
The used eluent was Met Pac® PDCA (Dionex, UK), in which pyridine-2,6-
dicarboxylic acid (PDCA) functions as a complexing agent for metal complex 
separation via anion exchange. This eluent was passed through reaction coil 
as a diluent for 4-(2-pyridylazo) resorcinol (PAR). This diluent has a 
controlled pH and low metal contamination and reacts with a wide range of 
metals, allowing detection limits in the parts per billion (ppb) range. 
The calibration was done by preparing 100 ppm zinc stock solution. this was 
further diluted by deionized water into five different concentrations of 0, 1, 5, 
25, 50 ppm. 
3.2.5.3  pH measurements  
This is explained previously in 2.2.5.3. 
3.2.6 Cell Studies  
3.2.6.1 Cells preparation  
 This is explained previously in 2.2.6.1. 
3.2.6.2 Cell proliferation  
 Initially, sterilisation of three discs of each glass group was performed by 
immersion in ethanol then exposure to ultra-violet light for 10 minutes on 
each side. The sterilised glass discs samples were moved to 24 well plates 
on which MG63 cells were seeded evenly over the glass surface at a density 
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of 10000 cells per disc. To ensure the even distribution of cells on glass 
discs, 50µl of culture media with cells was used for seeding to ensure that 
the culture media would cover the glass discs with a meniscus only and not 
flow away from them. Then, the seeded cells were left for about 30 minutes 
in the incubator to permit for the proper attachment of cells to the glass discs. 
Afterwards, culture media was added to end up with 1 ml of culture media for 
each glass discs.  After that all the samples were incubated at 37oC in an 
atmosphere of 5%CO2 for 7 days, Standard plastic glass cover slides were 
used as controls. Cell culture medium was replaced every 3 days.  
At each time point, Live and dead assay was done for all the compositions by 
using calcein AM (4mM) as an indicator for live cells and Ethidium 
homodimer-1 (2mM) for dead cells. The working concentration of the both 
reagents was assigned by doing an initial calibration for both of them to get 
the most appropriate molarity that result in the optimal fluorescent colour. 
This calibration was carried out by seeding MG63 cells on 10 glass slide 
discs (five for calcien and five for ethidium). Various concentrations of 
reagents were prepared as recommended by the protocol. To determine the 
proper concentration of ethidium, triton x-100 was added to five calibration 
discs to aid in pre-treating and killing the cells. The best results were found 
with 1 µM calcien and 2 µM ethidium. Which were considered as the working 
concentration.  
 At each time point, the media was aspirated, and the cells were then 
washed gently with Dulbecco’s‎phosphate‎buffered‎saline‎(D-PBS). After the 
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washing procedure, 3 mL of calcien and ethidium mixed working solution was 
added to each well plate and incubated for about 45 minutes. Following that, 
the solution was removed, and the samples were ready for the cell counting 
BioRad Radiance 2100 Confocal Laser Scanning Microscope (Bio-Rad 
Laboratories Ltd, Hemel Hempstead, Hertfordshire, UK) with the help of 
BioRad LaserSharp2000 v.6 software (Bio-Rad Laboratories Ltd, Hemel 
Hempstead, Hertfordshire, UK). 
 The direct cell counting was performed on 13 different pre-identified 1 mm 
squares on each glass discs. These squares were positioned on 15mm circle 
template which was made by transparent paper as is shown on (Figure 3.1). 
Live and dead cell counting was performed at three-time points (day 1, day 4 
and day 7) using the Image J software program.  
 
Figure ‎3-1 Transparent paper circular template 
3.2.6.3 Measurement of metabolic activity of cells 
This was explained previously in 2.2.6.2. 
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3.2.6.4 Cell imaging by scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) images were done for MG63 cells over 
all glass discs composition. Cells were seeded according to the protocol 
discussed in 2.6.2.1. This was done for each sample at three-time points.   
(days 1,4 and 7). The procedure involved removing the culture media initially. 
Then, the cells with the glass discs were transferred to new 24 wells plate 
where they were fixed by adding 1 ml of 3% glutaraldehyde (Sigma 
Aldrich,UK) and leftover night for fixation.  A dehydration step was the 
following step in which the glutaraldehyde was removed first, then cells were 
passed through a sequential process of washing. This washing step was 
carried out by using graded ethanol (50, 70, 90 and 100%) then drying by 
hexamethyldisilazane (Aldrich, UK). 
3.2.7 Statistical analysis 
Cell work data for both cells counting and metabolic activity studies were 
statistically assessed by hierarchal ANOVA to examine the null hypothesis 
stating that there is no clear biological and metabolic difference between the 
produced zinc glass discs and the control TCP group where p<0.05 has been 
used as a significance degree estimation. 
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3.3 Results 
3.3.1 Density measurement 
As is shown in (Table 3.2), glass density increased as the content of 
incorporated zinc oxide had increased. The density was ranging from 2.61 ± 
0.004 g.cm-3 in the quaternary glass (zinc free glass) to stand at 3.16 ± 0.039 
g.cm-3 for ZnO 15. 
Table ‎3-2 Density measurement of all zinc containing phosphate glass compositions 
Glass code  ZnO 0 ZnO 5 ZnO 10 ZnO 15 
Density (g/cm3) 2.61   2.7    2.95    3.16 
 
3.3.2 X -ray diffraction  
The XRD patterns for all the prepared glass samples are shown in (Figure 
3.2). All the XRD patterns were free from any detectable crystalline phases 
and‎displayed‎‎‎a‎broad‎peak‎was‎observed‎in‎each‎spectrum‎at‎2θ‎values‎of‎
around 20–40°. 
 
Figure ‎3-2 X-ray diffraction showing the amorphous nature of the prepared glasses 
1900
2000
2100
2200
2300
2400
2500
10 20 30 40 50 60 70 80 90 100
In
te
n
s
it
y
 (
a
.u
.)
 
2θ (o) 
 
ZnO 15 
 
 
Zn O10 
  
ZnO 5 
 
ZnO 0  
163 
 
3.3.3 Thermal analysis 
Table 3.3 explains the Tg values of the observed glasses. It showed that the 
incorporation of zinc oxide had led to decrease Tg value from 483 °C for the 
ZnO 0 to 429°C for the ZnO 15.  
Table ‎3-3 DTA for zinc containing phosphate-based glasses measured in °C 
Glass code  ZnO 0 ZnO 5 ZnO 10 ZnO 15 
Tg (°C) 483 461 443 429 
Tc (°C) 764 739 715 703 
Tm (°C) 850 835 819 793 
 
DTA spectra of the glasses are presented in (Figure 3.3). Similarly to Tg, Tc 
and Tm were also indirectly correlated with zinc oxide content in the glass. 
Regarding Tc, it was about 764 °C for ZnO 0% and declined as ZnO content 
increased to 703°C for 15mol% ZnO. The same trend was displayed for the 
melting point in which it declined with the extra incorporation of zinc oxide, it 
extended between the wide endothermic peak at 850°C for the zinc oxide 
free glass to about 793°C for ZnO15 %. 
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Figure ‎3-3 Differential thermal analysis of glasses showing the glass transition temperature (Tg) 
which is the midpoint of the first slope in each composition , crystallisation temperature (Tc) 
which is the upward  peak in each line and melting temperature (Tm) which is the last downward 
peak in each line . Showing that these parameters declined as SrO content increased 
 
3.3.4 Degradation study (mass loss)  
Both (Table 3.4) and (Figure 3.4) show the mass loss per surface area 
measured in (mg.cm-2) for two weeks period. There was a general cumulative 
mass loss per unit area measured (mg.cm-2) over the whole-time frame for 
the all formulations. Though, the highest mass loss rate was in the 
compositions with higher zinc oxide contents. In other words, there was clear 
direct relation between zinc content in glass and mass loss rate.  
For the whole-time frame, ZnO 15 formulation displayed the high mass loss 
rate. At day one, its degradation rate seemed to be seven times higher than 
that of ZnO0. This degradation pattern continued for the other time points to 
end up in day 14 at about 0.65 ± 0.013 mg.cm -2 for ZnO 15 comparing to 
ZnO0 which was about 0.22± 0.021 mg.cm-2 at the same time point. Both 
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ZnO 5 and ZnO 10 revealed similar degradation rates at all the time points 
which was between that of ZnO0 and ZnO15. 
Table ‎3-4 Mass loss in (mg.cm
-2
) for all glass compositions in four different time points 
 
 
Figure ‎3-4 Mass loss in (mg.cm
-2
) for all glass compositions over 14 days 
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ZnO0 ZnO 5 ZnO10 ZnO15
Glass composition Mass loss (mg.cm-2) 
Day 0 Day 1 Day 4 Day 7 Day 14 
ZnO 0 0 0.037 0.119 0.164 0.223 
ZnO 5 0 0.156 0.274 0.312 0.378 
ZnO 10 0 0.171 0.283 0.321 0.410 
ZnO 15 0 0.214 0.370 0.466 0.659 
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3.3.5 Ion release  
3.3.5.1 Anions release measurement 
Zinc glasses anions release is displayed in (Figure 3.5). Anion release was 
measured for four different anions (PO4
3-, P2O7
4-, P3O9
3-, P3O10
5-).  All the 
glass compositions exhibited continuous cumulative increase for all the 
anions release with time. Regarding PO4
3-release, ZnO15 glass compositions 
was found to have the highest release in comparison with the other 
compositions. It started at about 4.9 ±0.5 ppm in day 1 and ended at about 
24 ±1.2 ppm after two weeks. The other compositions exhibited the same 
trend but with lower levels of anions release that did not exceed that of 
ZnO15. P3O9
3- ions release displayed the same trend where the highest 
release was found in ZnO15 which was nearly three times more than other 
glass compositions over the whole study.  
Regarding both P2O7
4-, P3O10
5- ions, the maximum release was found in 
ZnO15 similar to the previous ions in which there was a very highly 
significant variation between it and the other types of glasses. 
Generally, it was found that phosphate ions release was directly related with 
zinc content in glass and the sequence of the anions release was as follow 
(ZnO15>ZnO10>ZnO5>ZnO0). 
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Figure ‎3-5 Anion release showing higher release of phosphates ions (PO4
3-
, P2O7
4-
 , P3O9
3-
, 
P3O10
5-
) in the high concentration zinc based glass (ZnO15) in comparison to other prepared 
glass compositions 
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3.3.5.2 Cations release measurement 
Figure 3.6 displays the cations release of all glass compositions. Concerning 
sodium release, it was compatible with that of mass degradation and anions 
release in which the highest released Na+ ions were found with the highest 
zinc content (ZnO15). This release rate dropped as zinc content declined in 
the glasses to be the lowest for the free zinc glasses (ZnO0). For Calcium ion 
release, its pattern was directly linked with calcium concentration in glasses; 
in other words, the highest free Ca 2+ ions in water was detected in glasses 
that had the highest calcium content and the lowest zinc contents.  
   
Figure ‎3-6 Cations release for all glass compositions Na
+
 and Ca
2+ 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 2 4 6 8 10 12 14
Io
n
s
 r
e
le
a
s
e
 (
p
p
m
) 
Time (days) 
Na + ions 
ZnO0 ZnO5
ZnO10 ZnO 15
0
0.5
1
1.5
2
2.5
0 2 4 6 8 10 12 14
Io
n
s
 r
e
le
a
s
e
 (
p
p
m
) 
Time (days) 
Ca 2+ 
ZnO0 ZnO5
ZnO10 ZnO 15
169 
 
3.3.5.3  Transition metals ions release measurement  
Zinc ion release is presented in (Figure 3.7). Its pattern generally followed 
that of degradation rate and anion release where it was directly related with 
the zinc percentage in glasses. The ultimate release was identified in ZnO15. 
It initiated at 0.3±0.13 ppm in day 1 and ended at about 1.3 ±0.22 ppm after 
two weeks. The second composition in the list was ZnO10 that commenced 
at 0.08 ±0.008 ppm and finished at about 0.59±0.03 ppm. This was followed 
by ZnO5 and ended with the free zinc formulations.  
 
 
Figure ‎3-7 Transition metal Zn 
2+
 ions release showing the highest release for glasses with the 
highest zinc concentration. 
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3.3.6 pH measurements  
pH measurements are displayed in (Figure 3.8).  Generally, pH trend was 
similar for all the glass compositions in that it dropped sharply for the first day 
from 7 at day 0 to about 5- 5.5 at day 1. Although there was some slight 
fluctuation in pH values, it remained within the same range for the whole set 
of experimental time points.  
Generally, as the amount of zinc oxide increased, the pH dropped, so the 
more acidic media was with the glass containing 15mol% zinc oxide followed 
by ZnO10, ZnO5 and ZnO 0.  
 
Figure ‎3-8 pH measurement 
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3.3.7 Cell proliferation  
Figure 3.9 describes the cells proliferation data. Regarding the live cells 
results, cells were initially seeded at about 10000 cells per disc. Although this 
number has increased over the three -time points for all the compositions, 
there was a statistically significant difference between the produced glass 
discs and the control samples (TCP). The highest cells number was seen 
with TCP which was around 25972± 971 cells in day 1 and 125680± 23127 
cells in day 7. These results were highly significant (p < 0.05) from all the 
samples especially ZnO15 glass discs samples which showed the lowest 
proliferative activity at around 13292±573 cells and 51894 ±15261 cells for 
day 1 and day 7 respectively. ZnO5 and ZnO0 glass formulation showed 
acceptable cellular proliferation activity but was less than that of control.  
 
Figure ‎3-9 Live cells counting 
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The dead cell counting is displayed in (Figure 3.10). The data was clearly 
opposite to that of live cells counting where high content zinc composition 
(ZnO15) exhibited the highest number of dead cells over the time frame that 
was ranging from 873 ± 136 cells in day 1 to about 6057±1339 cells in day 7. 
TCP, ZNO0 and ZnO5 showed lower numbers of dead cells which were 
around half of that of ZnO15 in day 7. Dead cell number on ZnO10 glass disc 
was slightly closer to that of ZnO15 in day 7. ZnO15 was significantly higher 
than the all other composition over the whole study (p value<0.05). 
 
Figure ‎3-10 Dead cells counting 
3.3.8 Measurement of metabolic activity 
The measurement of the cellular metabolic activity is presented in (Figure 
3.11).  The results were measured at three different time points (day 1,4,7). 
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vice versa. Apart from ZnO15, all the compositions including the control 
displayed acceptable metabolic activity.  
At day 1, TCP displayed around 6 ±1.2% of fluorescence reduction which 
was about double the percentage of all of ZnO0, ZnO5 and ZnO10 and about 
four times more than that of ZnO15 which had the lowest reduction value. At 
day 4, TCP reduction rate rose by three times to stand at about 16% which 
was significantly different from ZnO0, ZnO5 and ZnO10. This statistical 
difference cannot neglect the existence of enhanced metabolic activity that 
happened in these glass formulations whereas ZnO15 show sign of 
significance compared to the other remaining groups (P <0.05). 
After one week, the pattern of reduction remained similar to the previous two 
times points where the TCP (42 ± 3.3 %) showed the ultimate amount of 
reduction followed by ZnO0 (40 ±1.1 %), ZnO5 (35±2.2 %) and ZnO10 (33 
±1.12 %) respectively. ZnO15 continued to give the lowest values at about 
2.5 ± 0.9 % fluorescence reduction.  
            
Figure ‎3-11 Metabolic activity estimation showing the percentage of alamar blue reduction as 
an indication for cellular metabolic activity 
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3.3.9 SEM Imaging  
SEM images of MG63 cells attachment on glass discs are displayed in 
Figure 3.12.  On day 1, MG63 cells did not have uniform shape and were 
generally evenly distributed over the glass disc surface. Though, cells on 
ZnO15 were slightly smaller in size. On day 4, more intercellular connections 
can be identified, and nucleus are more pronounced in their shape.  Apart 
from ZnO15 discs, the images of all glass discs in day 7 displayed that   cells 
were consistently spread over the surface. Moreover, there was a clear 
growth in cell numbers which were mostly interconnected with each other 
forming a semi-complete cellular layer. The only exception was in ZnO15 in 
which there was a low number of cells which were small in size and 
separated from each other. 
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Figure ‎3-12  Scanning electron microscope images showing that the lowest number of attached 
cells was found with ZnO15 at all time points 
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3.4 Discussion  
This chapter is mainly concerned with the development of different zinc 
containing phosphate-based glasses for hard tissue (bone) engineering 
applications since zinc is well known for its role in bone metabolism and 
structure (Seo et al., 2010b). This was performed by adding ZnO ions in 
different amounts to the quaternary glasses in place of CaO ions. 
 Previous studies have been carried out to analyse various zinc phosphate 
glass formulations of (P2O5-Na2O-CaO-ZnO). The results of these studies 
suggested that zinc contained phosphate glass might have poor 
cytocompatibility because of its fast dissolution rate. This rate was enhanced 
as ZnO content increased within the glass network (Salih et al., 2007, Abou 
Neel et al., 2008c).  
The results of this study were designed initially to confirm the successful 
production of glass discs. This was determined through density and XRD 
results. Density data displayed the positive relation between the increase in 
glass density and the incorporation of zinc content within glass which is 
mainly related to the difference between zinc density (7.14 g.cm-3) and 
calcium density (1.54 g.cm -3). Whereas XRD findings showed the 
amorphous nature of the prepared glass discs.   
The differential thermal analyses data revealed that all the thermal variables 
had declined with the increasing incorporation of zinc oxide. This could be 
linked to the difference in bond enthalpies. When zinc oxide bond enthalpy is 
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about 284 Kj/ mol is less than that of calcium oxide bond 464 Kj/mol. Hence, 
less thermal energy is needed to break Zn-O bonds. 
 Degradation findings were similar to the DTA where adding ZnO to the glass 
composition has yielded a faster dissolution rate. This could be explained by 
two points. The first one is the difference of bond enthalpy and the second 
one may be due to the difference of bond electronegativity. Both of Zn-O and 
Ca-O bonds have pure ionic bonds (Ghadah S. Alghamdi, 2013). There is 
clear variation in electronegativity between both of Zn-O and Ca-O; Ca-O 
seems to be more electronegative (3.44-1=2.44) than that of Zn-O (3.44-
1.65= 1.79) when 3.44, 1.65 and 1 are the electronegativity of O, Zn and Ca 
respectively. As a consequence, Ca-O bond polarity and bond strength are 
greater than that of Zn-O which may explain the glass susceptibility to 
dissolution when more zinc oxides percentage were added. This could affect 
the whole glass compositional structure and resulted in this pattern of weight 
loss seen (ZnO0< ZnO5< ZnO10< ZnO15). 
Regarding ion release, it was found that adding zinc oxide content in the 
glass composition might be correlated with the high release of different 
phosphate anions and this may be due to the weak bond formation in a zinc 
phosphate glass as explained previously. Concerning cations, Na+ and Zn2+ 
ion release was comparable with the anion and mass degradation (ZnO0< 
ZnO5< ZnO10< ZnO15). The only exception was for Ca2+ ions which was 
released at higher levels in the glass with ZnO 0mol% glass and this result 
was the opposite to the previous findings, but that can be interpreted as this 
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composition has no CaO substitution, and its CaO content is higher than the 
others. Hence, it may release more calcium ions. pH results were clearly 
related with the anion results and that could be explained as phosphate ions 
are released at high levels and more phosphoric acid may be produced that 
can decrease the pH.  All of these findings were  consistent with that of Salih 
et al (Salih et al., 2007).  
In regard to cell studies, the proliferation study was carried out through the 
direct counting of live and dead cells using confocal microscopy. This was 
done with the aid of a template. Many previous studies used live and dead 
fluorescent stain as a subjective tool for cell proliferation estimation. Though, 
this technique can have visual bias and poor sample presentation. The main 
aim in this study was to objectively establish the accurate live and dead cells 
number, and this was achieved by using the template. Only 13 identified 
squares per each sample were chosen for the cells counting measurements. 
Although the total area of these 13 squares composed only 7% of the whole 
disc area, their positions were selected in a way that ensure the full 
distribution over the whole central area of the disc to prevent repeated 
readings and give a valid picture of cell distribution over the disc since each 
of the selected squares was surrounded by non-interpreted squares. Cells 
number counting was performed only in the empty areas inside the square 
and avoiding the square borders that were fluorescent.  
Seeding technique for cells was performed gently to attain a uniform cell 
distribution over the whole discs samples. This was performed through the 
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preparation of the intended seeding cell density in 50 µl of culture media 
which was found to be the optimum media volume to cover the whole disc 
surface area.  The main outcomes of this experiment revealed that live cell 
number was mostly significantly different between the zinc glasses and 
control sample for all time points, this does not cancel the positive impact of 
these two compositions on cell proliferation. Conversely, cells number was 
apparently low for ZnO15 and ZnO10 formulations and were significant when 
they were compared with the control group having about half the cell number 
of the control samples.  This was further confirmed by the dead cell counting 
data which was linked to zinc oxide content 
(ZnO15>ZnO10>ZnO5>ZnO0>control) which suggested that the glass with 
higher dissolution rate gave poorer cellular related data. Findings from 
ZnO15 dead cells numbers showed that they composed about 10% of live 
cell numbers on the same day for the all times points which signified 
cytotoxicity (Figures 3.9, 3.10). 
 Alamar blue assay is a useful tool for cell metabolic activity through its ability 
to be fluorescently influenced by the main by-products of reduction–oxidation 
(Redox) reaction because  the live  metabolic cells tend to produce H+ ions  
that have the capability to  reduce the weakly  purple fluorescent Resazurin 
salt to strongly  red fluorescent Resorufin (Lancaster, 1996). The alamar blue 
findings were concurrent with cell proliferation (live and dead cells counting) 
as it showed that ZnO15 had very low impact on MG63 metabolic activity and 
they were again clearly significantly different in comparison to the other glass 
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formulations at all time points. For ZnO10 data showed little variation from 
control samples (TCP) and were slightly different with ZnO10 live and dead 
cells findings. Though it showed an acceptable metabolic activity with time. 
The other two formulations (ZnO0 and ZnO5) appeared to have slightly lower 
levels of effect on metabolic activity compared to the control samples which 
matched that of live and dead cells data. The general trend of alamar blue 
metabolic activity was (Control>ZNO0>ZNO5>ZnO10>ZnO15). Although 
there was clear statistical difference (P<0.05) between the control and ZnO0 
and ZnO5, these two compositions had a sign of metabolic activity 
enhancement that might indicate their benign effect on cellular activity.  
SEM images emphasized the previous cellular related results; ZnO15 SEM 
images revealed that there was a decline in cell number with poor cellular 
interconnection.  
All of these findings may be explained as a result of the fast rate of glass 
dissolution of ZnO15. This fast degradation rate has yielded high zinc ion 
release that could have a negative impact on cell proliferation by suppression 
of the expression of mRNa as was found in previous studies (Aina et al., 
2007, Kwang Hwan Park et al., 2013).‎Interestingly,‎this‎study’s‎results‎were‎
very comparable with the previous study which reported that incorporation of 
zinc content >1.2 % wt. can lead to cytotoxic effects on osteoblastic MC3T3-
E1 cells (Ito et al., 2000). In the present study, Zn composed about 1% wt. of 
the total glass weight in ZnO15 samples which may explain the undesirable 
cellular effects seen with this composition. These results described that null 
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hypothesis was rejected in regard to ZnO15 glass compositions as they 
showed signs of poor cytocompatibility. Whereas as it was not rejected in 
regard to the other zinc glass formulations (ZnO10, ZnO5) and the free zinc 
glass formulation (ZnO0) that possessed acceptable biological and cellular 
properties in comparison to the control groups.  
In conclusion, although the development of zinc containing phosphate-based 
glass was successful, adding zinc oxide at 15mol% of the whole glass may 
have cytotoxic effects. However, adding zinc oxide in the percentage of 5-10 
mol% may show better outcomes when compared to the ZnO15 samples.  
Further work is needed to be carried on some of the ZnO5 and ZnO10 
formulations to fully understand their cellular response. Moreover, 
development of glass in other features that may be more clinically relevant 
may be needed to carry out as well. 
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Chapter 4 Development of strontium and zinc phosphate- 
based glass microcarriers for biomedical applications. 
4.1 Introduction 
The use of bone graft substitute (BGSs) as biomaterials for orthopaedics and 
craniofacial bone tissue engineering applications is attracting a lot of interest. 
However, these biomaterials should acquire specific chemical and structural 
requirements that may provide these biomaterials with osteoinductivity which 
is needed to stimulate stem cells and growth factors (Hing, 2004). Beads 
were found to be one of these substitutes  that might  act as a good cell 
microcarrier (Sautier et al., 1992) and glass can be  readily produced as 
beads for this type of application. One study assessed the in vivo application 
of bioactive glass (BAG S53P4) beads as a biomaterial for bone defect repair 
that resulted from osteomyelitis. This type of bioglass beads had shown good 
characteristics as both a filler material and as an antibiotic drug reservoir 
(Lindfors et al., 2010). BAG S53 P4 Bioglass beads were also used for many 
craniofacial defects repair such as orbital floor repair, nasal septal perforation 
repair, frontal sinusitis treatment and maxillary sinus augmentation. Most of 
these studies were clinically followed for an acceptable period of time by 
clinical and radiological investigations and it was found that they may be 
beneficial in some bone repair applications (van Gestel et al., 2015). Other 
research observed the development of 200-300 µm diameter silicate based 
micro beads by the sol gel technique. This research assessed many aspects 
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including: incorporation of biological proteins, cell adhesion and reaction to 
the microbeads and in vivo evaluation of the effect of these beads.  The 
results hypothesised that these beads were potentially useful regarding their 
drug delivery and their ability to support mesenchymal stem cell attachment 
and proliferation (Perez et al., 2014).  
Phosphate-based glasses beads were produced in the formula of (50P2O5, 
40 CaO, (10-x) Na2O, x TiO2 mol 5) where x was 3, 5 ,7 mol. This study has 
found that producing glass beads with 5mol% TiO2 was successful and may 
offer advantages for bone repair applications (Lakhkar et al., 2012). This 
study may be the only study that has been done on phosphate glass beads. 
Hence, further information is needed to understand the nature of cells 
biological reaction to phosphate-based glass. 
The present chapter discusses the manufacturing of quinternary titanium 
phosphate-based glasses that contain zinc and strontium ions depending on 
the previous chapter results. The glass bead formulations were as follows 
(P2O5-Na2O-TiO2-CaO – ZnO or SrO). Where TiO2 was fixed to 5mol% to 
control glass degradation, CaO was substituted by ZnO or SrO in proportions 
determined in the previous study.  
This study may aid in recognising the useful aspects of phosphate beads as 
a potential material for dental or craniofacial applications.  
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4.2 Materials and methods 
4.2.1 Materials  
 Four different glass compositions of phosphate glass were made by using 
phosphorus pentoxide (P2O5 98%, VWR, Lutterworth, UK), sodium 
dihydrogen phosphate (NaH2PO4, 99%, VWR, Lutterworth, UK), titanium 
dioxide (TiO2, 99%, VWR, Lutterworth, UK), calcium carbonate (CaCO3, 
98.5%, VWR, Lutterworth, UK), zinc oxide (ZnO, 99.95%, Sigma-Aldrich, 
Dorset, UK) and strontium carbonate (SrCO3, 98.5%, BDH Laboratory 
Supplies, Poole, UK) as precursors. 
4.2.2 Glass precursors calculations  
This was explained previously in 2.2.2 and 3.2.2. 
4.2.3 Glass beads preparation 
Development of four different formulations of phosphate glass beads was 
carried out to examine their physical, chemical properties and the cellular 
ability to proliferate, adhere and penetrate through them. Initially, glass 
formulations were divided into zinc and strontium groups. Both zinc and 
strontium groups were designed to have two compositions. Zinc formulations 
were as follows: 50 P2O5-10Na2O-5TiO2-(35-x) CaO – x ZnO (mol %) where 
x (zinc oxide) was 5 mol% and 10 mol%. Strontium formulations were as 
follow:  50 P2O5 - 10Na2O - 5TiO2 – (35-x) CaO – x SrO   where x (strontium 
oxide) was 17.5 mol% and 35 mol%. Precursor powders were weighed by 
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electronic balance (Sartorius) (Table 4.1). This was followed by powder 
mixing by using a Stomacher 400 blender (Seward). Following that, the 
mixture was then placed into a 200-ml volume Pt/10%Rh crucible type 71040 
(Johnson Matthey, Royston, UK) which was placed in a furnace (Carbolite) at 
1350oC for four hours afterward. Then the melted glass was quenched on a 
metal plate to cool down.  The cooled glass was then ground into small 
pieces and then further milled by (MM 301 Mixer Mill, Retsch GmbH and 
Hope, UK). 
Table ‎4-1 phosphate glass beads composition 
Glass code     and composition             Concentration (grams) 
P2O5 NaH2PO4 TiO2 CaCO3 SrCO3 ZnO 
ZnO5 P50Na10Ti5Ca30Zn5 56.8 24 4 30 0 4 
ZnO10 P50Na10Ti5Ca25Zn10 56.8 24 4 25 0 8.14 
SrO17.5 P50Na10Ti5Ca17.5Sr17.5 56.8 24 4 17.5 25.8 0 
SrO35 P50Na10Ti5Sr35 56.8 24 4 0 51.66 0 
 
Glass bead production was done by  following Lakhkar protocol (Lakhkar et 
al., 2012). This was done by passing the powder through high flame source 
(methylacetylene-propadiene propane (MAPP) gas cylinder that was 
attached to torch) that can reach the 2925°C (Figure 4.1).  
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                         a                                                                b 
Figure ‎4-1 Glass beads production. a. image showing the whole complex apparatus including 
flame torch, glass beads dispenser and glass beads collector. b. image displaying glass 
powder burning through the flame 
The flame melted the glass and surface tension causes the beads to become 
spherical in shape. The glass beads were collected in a glass container. 
They were visualised under light microscope to confirm their production 
(Figure 4.2). Other samples of glass powder were prepared by grinding each 
glass bead formulation with (MM 301 Mixer Mill, Retsch GmbH, Hope, UK) 
grinder. The produced powder samples were used for XRD and FTIR 
analyses.     
                               
Figure ‎4-2 Glass beads under light microscope 
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4.2.4 Material characterization  
4.2.4.1 Glass beads size distribution 
Around 50 mg was taken from each composition of the produced glass 
beads; this amount was distributed on sticky dark tabs which were placed on 
an SEM stub for particle size measurement. The powder was slightly blown 
by compressed air to ensure its retention and dispersion on the dark tabs. 
Following this, coating with gold was done and visualisation under scanning 
electron microscope (SEM) (Philips XL30 FEGSEM) was performed. Five 
SEM images were chosen from various sites from stub (centre, left, right, up 
and down), the diameter size in micrometres for each bead in the SEM 
images were measured by using the Saturn software. The diameter 
measurement was done by using the software ruler function. Each bead 
reading was counted and used to measure the frequency distribution of the 
produced glass beads. For the frequency measurements, ten-diameter 
periods were designed starting between 25 µm-115 µm. Each period was 
extending for 10 µm, for example, (25-34 um), (35-44 µm). Each glass bead 
was added and included according to its diameter.  
4.2.4.2 X-ray diffraction  
This was described previously in 2.2.4.2. 
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4.2.5 Chemical and physical studies 
4.2.5.1 Glass degradation  
 Glass degradation study was performed by incubating 300 mg of each 
composition of glass beads in 3 ml of ultrapure 18M .cm-2 water at 37oC for 
(day 1, 4, 7, 14). About 50 mg was taken out at each time, these were left for 
one day to dry in the desiccator. This was followed by spreading the dried 
glass beads on black stub stickers which were stuck on the stub to 
subsequently be visualised under SEM to assess the degradation and the 
surface changes. The ratio between glass bead weights to their immersion 
fluid volume was fixed in the whole study time which was 100mg.ml-1 or its 
equivalent by taking out 0.5 ml of water at each time point.  
4.2.5.2 Ion release  
Ion release was carried out for each glass beads formulation. This was done 
by using triplicate of 100 mg of each glass bead composition. These 
triplicates were immersed in 1ml of ultrapure 18M /cm2water and incubated 
at 37oC for four times points (1, 4, 7 and 14 days). At each time point, the 
deionised water was taken out and stored for ion release study and replaced 
with fresh deionised water for the next time point. Then anion release was 
measured for the anions (PO4
3-, P2O7
4-, P3O9
3-, P3O10
5-), cations (Na+, Ca2+) 
and the transition metals ions (Zn2+) by using the ion chromatography 
systems (ICS1000, ICS 2500, Dionex, Thermo scientific, Hamel Hampstead, 
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UK).  The ion concentration was calculated at each time point and 
accumulated with the previous time point. 
4.2.5.2.1 Anions release                                                 
This is explained previously in 2.2.5.2.1. 
4.2.5.2.2 Cations release 
This is explained previously in 2.2.5.2.2. 
4.2.5.2.3 Transition metal ions release 
This is explained previously in 3.3.5.3.  
4.2.5.3 pH study 
 pH measurement was determined by using triplicates of 200 mg glass beads 
in 2ml DMEM culture media (Gibco, Life Technologies, UK, code 11960-085) 
in 24 well plates for (day 1, 4, 7, 14). The glass beads were incubated at 
37oC for the whole times period and changed every three days to mimic the 
cell culture study environment. At each point, the culture media was 
aspirated out and its pH was measured with an Orion star A111 PH meter 
(Thermo scientific, Hemel Hempstead, UK) and then replaced by fresh 
culture media for the next study time point. Culture media alone (pure culture 
media without glass beads) was used as a control for the whole-time course 
and was changed at each time as well. The pH electrode of the pH meter 
was calibrated by using the standard solutions of pH 4 and 7 before usage.  
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4.2.6 Cell Culture Studies 
4.2.6.1 Cells preparation  
Two types of cells were used for cell culture studies. The first type was 
human osteoblast-like osteosarcoma cell line (MG63, European Collection of 
Cell Cultures, Porton Down, UK) which were selected to undertake the 
preliminary routine screening of the cytocompatibility properties for the 
phosphate glass beads. The second type was human mesenchymal stem 
cells (hMSCs) (passage 3) which were chosen for performing the studies 
related to the ability of osteogenic lineage differentiation since these types of 
cells are considered the golden standard for such studies. Both of the cells 
were prepared by the same procedure. Initially, the cells were taken out from 
the liquid nitrogen tanks in which they were stored. Following thawing they 
were transferred to 15ml falcon tubes where they were suspended in 5 ml 
Dulbecco’s‎ modified‎ Eagle‎ medium‎ (DMEM,‎ Gibco,‎ Life‎ Technologies,‎
Paisley, UK). This was followed by centrifuging the suspended cells at 1000 
rpm at 20C for 5 minutes to separate cells from media. Following the 
centrifugation process, the supernatant culture media was removed from the 
falcon tube and the MG63/hMSCs pellet in the bottom of the centrifugation 
were‎ suspended‎ in‎ 1‎ ml‎ of‎ Dulbecco‎ Modified‎ Eagles’‎ Medium‎ (DMEM).‎‎
Later, the cells were introduced into a 150 cm2 flask containing Dulbecco 
Modified‎Eagles’‎Medium‎(DMEM). 
Cell proliferation process in the flask was carried out in a 37°C/ 5%CO2 
incubator till the cells were 80–90% confluent. Cells confluency was checked 
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daily under light microscope (Olympus CK 2). When cells reached a 
confluency of 80%-90%, they were washed with phosphate buffer solution 
(PBS) and then trypsinised by adding 6 ml of 0.025% trypsin-EDTA to the 
flask and incubated at 37°C/ 5%CO2 for 3–4 minutes to ensure cell 
detachment from the flask surface.  Cell detachment was checked under light 
microscope by identifying the floating cells. Then, the trypsinisation process 
was inhibited by adding 6 ml of fresh media to the trypsinised live cells. The 
whole 12 ml cell suspension was then pipetted out from the flask and 
introduced into 15 ml falcon tube which was centrifuged subsequently at 
speed of 1000 rpm for 5 minutes. After this centrifugation process, gentle 
removal of the 12ml supernatant was done to avoid disturbing the cell pellet. 
Finally, 1 ml of media was added to the cell pellet prior to the cell counting 
procedure, this procedure was done by using the Trypan blue dye following 
the recommended protocol (Strober, 2001). 
For cell culture studies, two types of media were used. For the MG63 cell 
cytocompatibility studies, Dulbecco’s‎ modified‎ Eagle‎ medium (Gibco, Life 
Technologies, UK, code 11960-085 ) supplemented with 10% foetal bovine 
serum (Gibco) and 1% penicillin/streptomycin (PAA Laboratories, GE 
Healthcare, Chalfont St. Giles, UK) was used. Whereas for hMSCs 
osteogenic differentiation studies, osteogenic medium (OM) was prepared as 
used in previous work (de Girolamo et al., 2007) by using low glucose 
Dulbecco’s‎ modified‎ eagle‎ medium‎ (DMEM)‎ ,‎ supplemented‎ with‎ foetal‎
bovine‎ serum‎ ,‎ 1%‎ penicillin/streptomycin,‎ dexamethasone‎ (0.1‎ μM),‎
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ascorbic acid 2-phosphate (0.2 mM), and glycerol 2-phosphate (10 mM; last 
three chemicals procured from Sigma–Aldrich, Dorset, UK). 
Seeding procedure was preceded by glass bead sterilisation. Sterilisation 
was done firstly by bead immersion in 99.9 % ethanol (Sigma- Aldrich, 
Dorset, UK) and then exposing beads to dry heat at 180°C for 1 hour. The 
seeding procedure was similar for both cell types. A quantity of 100 mg of 
each glass bead composition was used as a sample. This amount was firstly 
coated by bovine fibronectin in PBS (10 µg. ml-1) for one hour to aid in initial 
cell attachment. The coated beads were then transferred into an ultra-low 
attachment 24-well plate (Corning, USA) in which the plate bottom surface 
was covered with beads completely. Later on, these glass beads were 
incubated in culture media overnight at 37oC. The next day, the culture 
media was taken out from the glass beads and the cell seeding step was 
carried out on the glass beads according to the preferred seeding density in 
which cells were left for 30 minutes in an incubator to allow cell attachment. 
After that the glass beads were transferred into 6.5 mm inserts in 24 well 
plates. Nondegradable commercial silica based glass microspheres 
(Polyscience Inc., USA) were used as a control for all the cell culture studies. 
4.2.6.2 Metabolic assay (CCK assay) 
A CCK study was carried out through using MG63 cells. Seeding density was 
3000 cells per 100mg of glass beads. The glass beads were placed in trans-
well insert in 24 well plates. Triplicates of each composition were used for 
this study.  The 24 well tissue culture test plate was left in a 37°C/ 5% CO2 
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incubator for three times points (1, 4 and 7 days). The control group (silicate 
beads) were seeded according to the same procedure.  In parallel, cells were 
seeded in a second test plate at different densities (0, 5000, 10000 and 
25000 cells) for calibration. The calibration was done by correlating the cell 
number with the yielded absorbance reading prior to exposing them to the 
CCK agent. The equation that resulted from the calibration procedure was 
used to establish the approximate cell number of the study samples groups 
(Figure 4.3). At each time point, CCK8 (Cell Counting Kit 8, Sigma-Aldrich, 
Dorset, UK) was added to each well in a 10% proportion of the culture media 
then incubated for 3 hours. Afterwards, absorbance measurement was 
performed for each well plate in triplicate by using a plate reader (Infinite® 
M200, Tecan) at 450 nm wavelengths. The resultant absorbance data were 
applied in the calibration equation to obtain the quantified cell number. 
 
Figure ‎4-3 CCK calibration correlating cell numbers with their fluorescent readings 
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4.2.6.3 Alkaline phosphatase Assay 
An alkaline phosphatase assay was carried out by using human 
mesenchymal stem cells (hMSCs). Seeding density was 25000 cells per 
100mg of glass beads. The glass beads were placed in a trans-well insert in 
24 well plates. Triplicates of each composition were used for this study, and, 
as before, silicate beads were used as control group.  The 24 well tissue 
culture test plate was left in a 37°C/ 5% CO2 incubator for two-time points (7 
and 14 days). At all the time points, the culture media was aspirated initially 
following the protocol of (Alkaline Phosphatase Assay, SensoLyte® pNPP). 
This was followed by rinsing the glass beads and cell mixture with assay 
buffer (prepared by dilution of the assay buffer with deionized water for ten 
time) for two times. Then, a prepared solution of 0.002 Triton x-100 (20 µl of 
Triton x -100 in 10 ml of assay buffer) was added to lyse the cell membranes. 
Afterwards, the glass beads were pipetted vigorously for 1 minute to aid in 
cell permeability, cells were lysed further by two cycles of freeze-thawing 
cycle (- 80oC for 20 min, followed by 37oC for 12 min). Then the glass beads 
with the permeabilised cell complex were aspirated and collected in small 
plastic tubes which were agitated at 4°C for 10 minutes. After that, cell 
separation from their suspension was performed by centrifuging at (2500 G, 
10 min, 4 °C). Then triplicates of 50 µl of supernatant solution from each vial 
was aspirated in a 96 well plate. Another 50 µl of pNPP solution was added 
to each sample.  
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Calibration was done by preparing a sequence of ALP standard (10 µg/ml) 
dilutions. Seven dilutions (100, 50, 25, 12.5, 6.25, 3.1, 0 ng /ml) were 
prepared by diluting the alkaline phosphatase standard reagent with the 
buffer solution. Triplicate of 50µL of each standard was added to 50µL pNPP 
substrate in a 96 well plate (Figure 4.4). After adding the pNPP solution to 
both sample and standard substrate, incubation of 96 well plates were 
carried on at 37°C for 30 minutes. Finally, a stopping reagent was added into 
each well before taking triplicate absorbance measurements of each trans-
well by (Infinite® M200, Tecan) at 405 nm wavelength.  
A calibration curve was obtained from the standards reading. The equation of 
this curve was used to relate the absorbance reading with the ALP 
concentration in the samples (Figure 4.4).  
 
Figure ‎4-4 Calibration line of ALP assay. Done by preparing different concentrations of ALP and 
correlate the corresponding fluorescence reading with each of the concentration. 
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4.2.6.4 Ca assay (mineralisation assay) 
 Mesenchymal stem cells (hMSCs) were used for the Ca assay. The cells 
were seeded at density of 25000 cells per 100mg of glass beads. The glass 
beads were placed in trans-well insert in 24 well plates. Triplicates of each 
composition were used for this study, and silicate beads were used as 
control group as well.   The 24 well tissue culture test plate was left in a 
37°C/ 5% CO2 incubator for two times points (14 and 21 days). At each time 
point, the culture media was firstly taken out and the glass beads were 
washed with phosphate buffered saline (PBS) three times following the 
protocol (QuantichromTM, Calcium Assay Kit (DICA-500), Bioassay System). 
This was followed by transferring the beads to 24 well plate where 1ml of 1M 
HCl addition was carried out.  The plate then was agitated for 40 minutes by 
shaker. The agitation with HCl step aimed to help in cell lysis. After the lysis 
step, triplicates of 5µl of each trans-well aliquot was transferred to 96 well 
plate and about 200µl of prepared Ca working agent was added to each 
triplicate. 
Fresh Ca working agent was prepared at each time point. The preparation 
was made by mixing 5ml of each of the provided reagent A and B. The 
mixing of these reagents was done in 15 ml falcon tube covered with 
aluminium foil to prevent the light affecting the working reagent.  
Calibration was done by preparing six gradual dilutions of Ca standard 
(100µL, 80µL, 60µL, 40µL, 20µL, 0µL) which were made for calibration 
following the protocol (QuantichromTM, Calcium Assay Kit (DICA-500), Bioassay 
198 
 
System). Triplicate of each standard was introduced into a 96 well plate with 
the prepared 200µl of the working solution (Figure 4.5). The slope of the 
calibration equation was used in determining the calcium concentration of 
glass beads sample according to the equation 1.  
𝐶𝑎 𝑐𝑜𝑛𝑐 =
OD sample−OB blank
slope 
…………………………………1 
Other triplicates of 100 mg of each composition were incubated alone without 
seeding cells to deduce the effect of glass composition on the final results. 
After adding the Ca working solution to both sample and standard substrate, 
the mixtures were left for two minutws and then absorbance was measured 
at a wavelength of 612 nm (Infinite® M200, Tecan). 
 
 
Figure ‎4-5 Ca calibration curve 
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4.2.6.5 SEM cells imaging 
This was performed for the MG63 cells and done for three times points (day 
1, 4,7) following the same procedure that is described previously in 3.2.6.5. 
4.2.6.6 Confocal microscope cells imaging 
hMSCs imaging was done by confocal microscopy using phalloidin (Alexa 
Fluor® 488 Phalloidin, Sigma-Aldrich, Dorset, UK) for cytoskeletal staining 
and propidium iodide (Sigma-Aldrich, Dorset, UK) for nucleus staining. The 
first step of this procedure was cell fixation in 3.7% formaldehyde followed by 
cell permalisation by using 0.5% triton X-100. This was succeeded by 
staining cells with the fluorescence stains. Staining with phalloidin was done 
by preparing it firstly through dilution 5 µl of stock solution in 200 µl PBS for 
each sample. Then cells were immersed with the prepared reagent for 20 
minutes in dark room to reduce evaporation and photo bleaching. After 
staining with phalloidin, samples were washed with PBS for two times (1x 1 
minute then 1 for 5 minutes) in the dark. Then staining with propidium iodide 
was done by immersing each sample with it in the concentration of (4 µg/ ml) 
for 10 minutes at dark. Finally, visualisation of samples was done using a 
BioRad Radiance 2100 Confocal Laser Scanning Microscope (Bio-Rad 
Laboratories Ltd, Hemel Hempstead, Hertfordshire, UK) with the help of 
BioRad LaserSharp2000 v.6 software (Bio-Rad Laboratories Ltd, Hemel 
Hempstead, Hertfordshire, UK). 
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4.2.7  Statistical analysis 
 Cell studies results  were statistically assessed by Kruskal–Wallis to 
examine the null hypothesis that stated that there is no apparent or 
significance variation between the prepared phosphate glass beads and the 
control silicate beads in regards to  the cellular proliferative ability and 
cellular osteogenic differentiation where p<0.05 has been used as a 
significance degree estimation. 
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4.3 Results 
4.3.1 X -ray diffraction  
The XRD patterns for the whole prepared glass samples are shown in 
(Figure 4.6). All the XRD patterns were free from any detectable crystalline 
phases and displayed a broad peak which was observed in each spectrum at 
2θ‎values‎of‎around‎20–40°.  
   
Figure ‎4-6 X- ray diffraction pattern for all the produced glasses 
 
4.3.2 Glass beads size distribution 
 Figure 4.7 illustrates the SEM image of beads and their distribution 
according to their sizes.  The analysis of different SEM images of the 
different glass beads groups revealed that the highest glass beads frequency 
was found in diameters between 65-84 µm. According to the results, glass 
beads frequency number did not exceed 10% for the diameters which are 
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less than 45µm. Though, this number was clearly higher for the diameter 
periods that are ranging between 65-84 µm where the frequency number 
reached 25 in some specific groups. Concerning glass beads with diameter 
more than 85 µm, their frequency number was less than 65-84 µm groups 
which was around 15.  According to all of these findings the majority of glass 
beads produced were between 65 µm-104 µm. 
  
                      A                                                         B 
Figure ‎4-7 A-SEM picture of glass beads   B- frequency distribution of glass beads 
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4.3.3 Degradation study  
 As shown in (Figure 4.8), SEM images were taken to investigate the impact 
of immersion of glass beads in deionised water on their surface structure. 
The data revealed that there was a continuous surface wear that increased 
within time. At day 1, there were no apparent surface changes in comparison 
with day 0. Though, there was a pronounced surface wear on the glass 
beads on day 7, this wear was very prominent and clear in the zinc oxide 
containing glasses and appeared as groups of multiple pits. While strontium 
oxide containing glasses displayed lower levels of changes especially with 
SrO17.5 groups which did not appear to be affected. On day 14, glass 
surface degradation was more prominent in zinc glasses as well as strontium 
glasses; there were more pits and small cracks appearing in the zinc oxide 
containing glasses, whereas for the SrO containing glasses, there was more 
surface wear in SrO35 and small pits occurred in SrO17.5. These results 
showed that the ZnO10 glass had the highest susceptibility to surface 
changes followed by ZnO5 then SrO35 and finally SrO17.5, which displayed 
the minimum level of surface changes. 
 
 
 
 
 
204 
 
 
          ZnO5        ZnO10      SrO17.5          SrO35  
 
Day 0 
    
 
Day 1 
    
 
Day 7 
    
 
Day14 
    
Figure ‎4-8 SEM pictures for glass beads after incubation in deionised water 
                    showing the least degradation was with ZnO10 in day 14. 
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4.3.4 Ion release 
4.3.4.1 Anion release  
Glass bead anion release is shown in (Figure 4.9). Anion release was 
measured for four different anions (PO4
3-, P2O7
4-, P3O9
3-, P3O10
5-). All the ions 
released for all the compositions showed an increase within time. Generally, 
SrO35 glass beads release of anions was apparently less compared to the 
other glass bead formulations. Whereas the anions release concentration of 
both zinc containing glass beads were approximately similar to each other 
over the whole study. 
Concerning PO4
3- release, ZnO5 displayed the highest rate of release of free 
phosphate over the time frame. At day 14, phosphate ions were released to 
about 4970 ±197 ppm just slightly higher than ZnO10 release which stood at 
4425±229 ppm and was about double that of SrO 17.5 and five times that of 
SrO35 which were 2456±271 ppm and 716±29 ppm respectively. Both P2O7
4- 
and P3O9
3- anions release followed the same pattern, the release of these 
two ions were highly pronounced in the ZnO10 formulation which was 
followed by ZnO5 and SrO17.5 that had about the same ion concentration 
release leaving the SrO 35 with lowest anion release which was about half 
that of ZnO10 at day 14. In regard to P3O10
5- ions release, its figure release 
was analogous to PO4
3- release which was again higher in the zinc oxide 
containing compositions. 
Generally, it was found that phosphate ion release was linked clearly with the 
incorporation of zinc oxide into the glass compositions. 
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Figure ‎4-9 Anion release showing higher release of phosphates ions (PO4
3-
, P2O7
4-
 , P3O9
3-
, 
P3O10
5-
) by zinc based glasses in comparison to strontium glass 
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4.3.4.2 Cation release  
Glass beads cations release is shown in (Figure 4.10).  Generally, cations 
release (Na+, Ca2+) acted in the same way as anions release where the 
maximum release was established with zinc glass formulations and the 
pattern of cations release was as follows ZnO5>ZnO10>SrO17.5>SrO35. 
Both Na+ and Ca2+ release was increased with time. Though, there was a 
clear difference in the rate of ions increase among the different compositions.  
While the release was in its maximum rate with ZnO5 glass beads, it was 
significantly low in other compositions such as SrO35. At day 1, Na+ and 
Ca2+ releases for ZnO5 was about 8.5 ± 0.08 and 16 ± 0.3 ppm respectively 
in comparison to day 14 which was 106 ± 5.5 and 92 ± 6.2 respectively. 
Whereas for SrO35, it rose up in day 1 from 0.7 ± 0.15 and 0.85± 0.03 for 
Na+ and Ca2+ respectively to about 8.6 ± 0.4 and 1.8 ± 0.03 in day 14.  
Sr2+ ion release was around 3 ppm for both SrO17.5 and SrO35 on day 1. As 
the study continued for the next time points, SrO35 tended to release more 
Sr 2+ ion than that of SrO17.5 to end around 33 ± 0.3 ppm on day 14 which 
was significantly higher than that of SrO17.5 at around 25± 0.6 ppm.  
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Figure ‎4-10 Cation release showing higher release of phosphates ions (Na
+,
 Ca
2+, 
Sr 
2+
) release 
4.3.4.3 Transition metals ions release 
As it can be seen in (Figure 4.11). Zinc ions exhibited variation in regard to 
their release that was controlled by their composition. Despite Zn2+ ions 
release was quite similar on day 1 at about 35 ppm, ZnO10 glass clearly 
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0
20
40
60
80
100
120
0 2 4 6 8 10 12 14
Io
n
 r
e
le
a
s
e
 (
p
p
m
) 
Time (days) 
Na+ 
ZnO 5 ZnO 10
SrO 17.5 SrO 35
0
20
40
60
80
100
120
0 2 4 6 8 10 12 14
Io
n
s
 r
e
le
a
s
e
 (
p
p
m
) 
Time(days) 
Ca 2+ 
ZnO 5 ZnO 10
SrO 17.5 SrO 35
0
5
10
15
20
25
30
35
40
0 2 4 6 8 10 12 14
Io
n
s
 r
e
le
a
s
e
 (
p
p
m
) 
Time (days) 
Sr2+ 
SrO 17.5 SrO 35
209 
 
385±23 ppm after two weeks that was about 100 ppm more than that of 
ZnO5 which ended at 280±10ppm on the same day point concluding that 
Zn2+ release is directly related with zinc content in glass composition. 
 
Figure ‎4-11 Zn
2+
 ions release revealing more zinc ions yielded from ZnO10 
 
4.3.5 pH Measurement 
pH measurements are displayed in (Figure 4.12).  Generally, pH results 
revealed an apparent difference in their level over the time course of the 
study. Initially pH readings were about 8.7 before the study was commenced. 
Alhough, it moved up in day 1 to reach around 9.2-9.3 for all groups,  this 
increase remained at that level until the second-time point (day 4) when a 
slight gradual decline was seen for all the formulations apart from the control 
that remained constant for the whole experiment.  
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Surprisingly, ZnO10 decreased significantly after day 4 and exhibited the 
lowest pH level for the whole period until the end of the study finishing just 
slightly higher than 8.2.  
 
Figure ‎4-12  pH level showing that ZnO10 was with the least pH level in comparison to the 
control which remained steady. 
4.3.6 Cell assays 
4.3.6.1 Metabolic assay (CCK assay)  
CCK data are illustrated in (Figure 4.13). the general outcomes of the CCK 
assay showed that the number of cells increased within the study time.  Initial 
cell seeding density was 3000 cells per trans-well. This number increased 
sharply to stand at 13000 cells / trans -well at day 1 for both ZnO5 and 
SrO17.5. The former was higher than the control and more than both of 
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and SrO17.5 were around 34000 cells which was significantly lower in 
comparison to the control that was about 38000 cells. At the last time point, 
cellular growth continued to increase and ended at around 40000 cells for 
ZnO5 and SrO17.5, which was about 5000 less than that of the control. 
Whereas ZnO10 and SrO35 displayed again the lowest level of 
cytocompatibility as indicated by the cell number.  
In general, SrO35 and ZnO10 showed the lowest cell numbers for all three 
times points. Whereas SrO17.5 and ZnO5 displayed more promising results 
over the same time frame.  
 
Figure ‎4-13 CCK assay for MG63 cells showing that both ZnO5 and SrO17.5 supported cell 
proliferation in comparison with the control 
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ZnO5 and SrO35 glass beads group which were statistically slightly higher 
than control. On day 14, there was a generally a clear rise in enzyme levels 
for all the produced glass beads. Though, the maximum level of ALP was 
shown in ZnO5 and SrO17.5 glass beads about (17.5 ng/ml) which was 
slightly less than the control (20 ng/ml). Both SrO35 and ZnO10 were 
significantly different from the control in the whole study time (p<0.05). 
 
 
Figure ‎4-14 Alkaline phosphatase for hMSCs measured by µg/ trans-well, displaying an 
acceptable enzyme concentration in ZnO5 and SrO17.5 in relation to the control. 
4.3.6.3 Mineralisation assay (Ca assay) 
 Figure 4.15 displays the Ca assay for day 14 and 21. The general summary 
of this assay revealed that all the strontium and zinc containing glass beads 
provoked calcium release.   At day 14, it seemed that ZnO5 and SrO17.5 
beads have stimulated hMSCs cells to produce calcium at levels of (13-14 
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mg/dl trans-well) which was clearly higher than that of the control that 
exhibited the lowest concentration of calcium (2 mg/dl trans-well).  ZnO10 
and SrO35 revealed promising results also (9-11mg/dl trans-well) but not as 
that of ZnO5 and SrO17.5. Although the control data showed a 4-fold 
increase on day 21 in comparison to day 14, it showed again the minimum 
concentration compared to the zinc and strontium-based glasses. ZnO5 and 
Sr17.5 results were highly significant (28 mg/dl trans-well) compared to the 
other compositions and the control. 
 
Figure ‎4-15 Ca concentration for hMSCs measured by µg/ trans-well for day 14 and 21, revealing 
that ZnO5 and SrO17.5 have the highest calcium concentration. 
4.3.6.4 SEM cell imaging 
SEM pictures are displayed in (Figure 4.16). The Figures displayed the ability 
of MG63 cells to attach to SrO17.5 glass beads.  At day 1, cells have the 
stability and the potential to interact with glass beads and adhere to them 
individually (Figure 4.16a). However, SEM images of cells on day 7 displayed 
the potential of MG63 to proliferate between glass beads and extend their 
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appendages to make a continuous layer of cells among the beads on day 7 
(Figure 4.16b).     
      
Figure ‎4-16 SEM pictures of MG63 on SrO17.5 strontium glass beads. a- day1, b- day7 
Similarly, confocal images for hMSCs showed that these cells could attach to 
the beads and even encapsulate these beads and take on their spherical 
morphology as shown in Figure 4.17. 
 
 
 
 
 
(a) (b) 
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Figure ‎4-17 Confocal images of hMSCs showing the cellular attachment on beads. Red 
resemble propidium iodide (nucleus). Green staining is Phalloidin (cells actin) 
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4.4 Discussion  
There were two main aims behind this chapter. The first one was to produce 
phosphate glasses in a form that is more relevant to the clinical applications 
where cells can attach to and penetrate and colonise through. The second 
aim was to comprehensively investigate the zinc and strontium formulations 
that were exhibiting some aspects of cytocompatibility in the previous 
chapters.  
Glass bead development was successful for all the compositions. This was 
confirmed through post spheriodisation SEM and light microscopy images. 
However, glass bead distribution showed that the majority of formed spheres 
was mostly limited to diameters of 65-106 µm and low cell frequency was 
found below or above this range. This may be interpreted as the 
agglomeration of glass powders can prevent small diameter beads to be 
produced, whereas the short time period of glass powder inside the flame 
may be the reason for the shortage in produced large diameter glass bead 
number. All of these findings were compatible with previous studies done by 
Lakhkar et al (Lakhkar et al., 2012). 
 Many physical, chemical and biological studies were performed in order to 
assess zinc and strontium phosphate glass beads behaviour. The initial 
study was the XRD study which was done to confirm the amorphous state of 
the glass beads and revealed that the produced beads are crystalline free 
and ready for carrying on the other studies. The degradation study was 
performed to find out the glass network stability when they are exposed to 
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fluid.  This was done by using SEM imaging for visual examination of bead 
surface degradation. Although this method had a lot of subjectivity with 
regard to its image data, it was chosen because of the difficulty and 
unpredictability of performing quantitative mass loss measurements. Images 
data provide us with general idea about the glass network stability through 
evaluating the produced surface changes after exposure to deionised water. 
After day 1, no clear difference has been found among the glass 
compositions overall. Though, surface erosion started to appear after a week 
of immersion. This erosion was more apparent in zinc containing phosphate 
glass beads than the strontium formulations which were less affected. This 
was displayed in the form of pores and faint cracks which were more 
noticeable in ZnO10 phosphate glass beads. Glass beads containing zinc 
were more affected after two weeks as more deep cracks and pores 
commenced to appear. The strontium glasses, in turns, started to show few 
pits with few surface changes on day 14. The trend of glass degradation 
seemed to be as follows (ZnO10>ZnO5>SrO35>SrO17.5). 
These results were compatible with previous findings of dissolution rate trend 
of both zinc and strontium glass where mass loss at day 14 was as follow 
ZnO10 =0.41 mg.cm-2, ZnO5=0.378 mg.cm-2, SrO35=0.2666 mg.cm-2and 
SrO17.5=0.209 mg.cm-2. This could be interpreted by relating this with the 
difference of the ionic bond strength. In the glass network, zinc and strontium 
combine usually with the oxygen via ionic bonds. However, the variation in 
these ionic bonds strength may be linked to the strength of the whole glass 
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system. The dissociation energy of Zn-O bond is (284 Kj. mol-1) which is 
lower than that of Sr-O bond is (454 Kj. mol-1). Hence, a glass containing zinc 
seems to be more susceptible to hydrolysis because of its weak bond 
strength. Furthermore, these results were previously emphasised by the 
differential thermal analysis findings where the thermal variables (Tg, Tc, Tm) 
has followed the trend of (ZnO10 < ZnO5 < SrO35 < Sr 17.5). 
The pattern of anions and cations release findings was parallel to the 
dissolution rate pattern where the highest level of released phosphate ions 
was detected with the glass formulation of the highest degradation rate. This 
may be interpreted by identifying the bond dissociation energies for both 
CaO and ZnO which are 383 Kj.mol-1 and 284 Kj. mol-1 respectively. 
Consequently, As ZnO ions substitute CaO ions, there are higher numbers of 
weaker bonds yielding an overall weaker glass network, more degradation 
and more ions are released. Conversely, ion release data of the strontium 
containing samples did not coincide with the mass degradation pattern as the 
more degradable SrO 35 phosphate glass produced fewer ions than that of 
SrO 17.5. The only exception was the Sr2+ ion release which was higher with 
SrO35 as it had double the amount of strontium than that of SrO17.5. 
Actually, this may give us a justification to interpret such unexpected results. 
Although SrO35 had more surface loss and higher degradation rate than 
SrO17.5, the majority of the released ions were Sr2+ which has a molecular 
weight of 87 more than other ions such as Na+, Ca 2+ and P5- that have 
molecular weight of 22, 40 and 30 respectively.  
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Concerning pH studies, Dulbecco Modified Eagles Medium (DMEM) with pH 
8.4± 0.1 was used as an immersion liquid for glass beads in order to copy 
the cell culture study conditions. Results exhibited an irregular trend where 
there was an initial increase in pH on the first day. This was followed by a 
period of stability in pH level which was succeeded by slow decline of pH 
level. The control and all the compositions showed an initial increase in pH 
after one day which remained stable until day 4 as a result of gas absorption 
effects (Brauer, 2015). This rise in pH was higher for the control group in 
comparison to the glass beads group. On day 7, however, there was a 
gradual continuous decline in pH until day 14 for all glass beads. The control, 
however, remained at the same level for the rest of the study period. 
Surprisingly, ZnO10 showed the lowest pH change followed by SrO35, which 
was slightly less than the other two groups. It appeared that the pH level was 
inversely related to the ion release, which was higher with ZnO10.  This may 
be as a result of the increase of phosphate ions release that might form 
phosphoric acid in the solution and hence increase the culture media acidity.  
Regarding the cell studies, there was a generally correlating pattern 
concerning all the results. CCK cell number findings suggested that the 
lowest cell number was found in ZnO10 glass beads group.  ZnO 5 and 
SrO17.5 showed cell number quite similar to the control. Furthermore, 
alkaline phosphatase for hMSCs results acted in a parallel way at day 7 and 
day 14 as ZnO5 and SrO17.5 exhibited insignificant difference in enzyme 
levels from control. Finally, Ca assay demonstrated that both ZnO5 and 
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SrO17.5 resulted in higher rates of mineralisation than other remaining 
groups of ZnO10 and SrO35. While control group had the lowest 
mineralisation level.                               
 The explanation of these results studies could be done by understanding the 
biological effect of the released ions on the cells as shown by other studies 
(Lakhkar et al., 2013). The most positive promising effects were found to be 
with ZnO5 and SrO17.5 in comparison to ZnO10 and SrO35 glass beads 
group that showed poor cytocompatibility. Concerning the calcium and 
sodium ions, the present experiment measurements revealed that the 
highest released concentration of these two ions among all glass 
compositions was about 95 ppm and 106 ppm respectively, which is below 
the cytotoxic concentration suggested in previous studies (i.e. for Ca2+ =400 
ppm, Na+= 220 ppm) (Hallab et al., 2002, Maeno et al., 2005). Consequently, 
the release of Ca2+ and Na+ ions from these glass systems should not have 
any harmful impact on cell function.  
Although phosphate ions can play an important role in cell proliferation and 
metabolism, it was difficult to investigate their actual effect due to the 
presence of high phosphate ion content in the medium.  
Regarding the strontium-containing glass beads, it was found that its Sr2+ 
release was about 30 ppm and 25ppm for SrO35 and SrO17.5 respectively. 
In a previous study, the optimum concentration of SrCl2 to induce calcified 
matrix deposition was 5 µg/ml, however, data showed that concentration of 
10 to 20 µg/ml could also stimulate ALP and matrix deposition. There is a 
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decline in the positive effect of Sr2+ions as the concentration increase from 
10 to 20 µg/ml. Based on ion degradation results, the actual Sr2+ions 
concentration in the deionised water is 25 ppm. Although we cannot depend 
on this result in interpreting the ions release in culture media, this can give us 
an idea about what is happening. If it assumed that ion release was about 25 
ppm in culture media which was replaced by half every two days. So, the real 
concentration of strontium in culture media is probably about 15 ppm (µg/ml) 
and 12.5 ppm for SrO35 and SrO17.5 respectively based on our assumption. 
This was within an acceptable range and following the same pattern of 
cellular activity as discussed previously (Lopa et al., 2013).  
Concerning  zinc ion release, the current results confirmed previous findings 
that showed substitution of calcium with zinc at 10 mol% can result in 
unfavourable and cytotoxic effects. Hence, adding more than 10 mol% ZnO 
may cause catastrophic effects as it can increase the release of lactate 
dehydrogenase and induce oxidative stress (Aina et al., 2007, Abou Neel et 
al., 2008c). According to all of these results it seems that the null hypothesis 
was rejected in some cellular findings that are related to both ZnO10 and 
SrO35 glass beads formulation. 
In conclusion, the present study revealed that glass beads production was 
successful. It suggested that ZnO5 and SrO17.5 phosphate glass beads 
exhibited acceptable results regarding cellular studies which were apparently 
significant comparing to the ZnO10 and SrO35 glass beads concluding that 
ZnO5 and SrO17.5 may be more suitable for bone tissue engineering. 
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Though, more studies are needed to be carried out to further assess the 
cellular impact of glass compositions. Moreover, surface glass functionalising 
is required to be performed to enhance the cellular attachment and also 
provoke the mechanical and chemical characteristics of glass. 
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Chapter 5 Surface functionalisation of phosphate-based 
glasses 
5.1 Introduction  
Bioactive glasses are considered promising biomaterials for craniofacial hard 
tissue engineering (Gage et al., 2010). Many studies, both in vivo and in vitro 
were performed using various forms of bioglasses to test their applicability to 
repair craniofacial defects. One study used bioglass granules within an in 
vivo environment to repair facial bone defects such as frontal sinus defects 
and orbital wall reconstruction (Suominen and Kinnunen, 1996). These 
defects were assessed clinically and radiographically and then compared 
with autogenous bone graft results. The outcome was very encouraging as 
there was no evidence of any immunological or inflammatory responses. 
Another in vivo study examined the implantation of bioglass – coated PMMA 
(poly methyl methacrylate) for skull defect repair and the clinical results were 
shown to be acceptable without complications and with good evidence of 
bone adhesion to the implant surface (Peltola et al., 2012). Though, most of 
these applications need bioceramic glasses to be modified using other 
techniques in order to produce new biocomposite material that has improved 
properties (Chen et al., 2008a). 
Bearing this in mind, some techniques suggested other materials such as 
carbon nanotubes (CNTs) and polycaprolactone (PCL) that can be used to 
improve the mechanical and the biological outcomes of the implanted 
biomaterial applied (Akasaka et al., 2006). As most synthetic bone 
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substitutes have osteoconductive properties, tissue engineering facilitated 
making 3D scaffolds to provide the main structural support and guidance to 
both osteoblasts and mesenchymal stem cells as well as to ease the transfer 
of nutrition, oxygen and waste products (Sitharaman et al., 2008). Although 
the cytotoxicity of CNTs has not been studied thoroughly yet, CNTs 
demonstrated good osteoconductive properties, cell attachment and 
proliferation capacity as well as the ability to retain growth factors (Tanaka et 
al., 2017). In a more comprehensive study, multi-walls CNTs were 
incorporated in PGLA (Poly-lactic-co-glycolic-acid) biocomposite for bone 
repair application. This material was studied within an in vitro environment 
and was shown to be beneficial for cell growth provoking and enhancing 
MSCs differentiation into osteoblasts (Lin et al., 2011). Misra et al. (2010) 
developed bone related biocomposite using a complex of Poly(3-
hydroxybutyrate) polymer, bioactive glass particles and multiwall carbon 
nanotubes (MWCNTs) where CNT concentrations were varied. This 
biocomposite was cultured within MG63 cells and then studied biologically 
using both alamar blue and live and dead assays and SEM imaging.  The 
results suggested that this combination of biomaterials has a promoting 
effect on MG63 cellular metabolic activity. This study also hypothesised that 
CNT incorporation enhanced cellular attachment through the formation of a 
rough topographical layer on the biocomposite surface layer, the most 
favourable outcome was at a CNT concentration of 2 wt. % (Misra et al., 
2010).  
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Polycaprolactone (PCL) is a high molecular weight degradable polymer that 
has controlled slow degradation rate (Rezwan et al., 2006). PCL was studied 
thoroughly as a biopolymer for bone regeneration. One of the earlier 
attempts conducted was to develop a biocomposite material from PCL and 
fibrin hydrogel. This was studied at 2D and 3D constructs and results showed 
an enhancement in the cellular osteogenesis ability (Schantz et al., 2003).  
Other study investigated the addition of polycaprolactone polymer to 
multiwall carbon nanotubes (MWCNTs) in order to produce a biocomposite 
scaffold which was seeded later with rat bone-marrow-derived stromal cells 
(BMSCs). Cellular attachment, proliferation and differentiation were all 
assessed. The findings suggested that MWCNTs/PCL composite scaffolds 
have an acceptable capability of bone growth enhancement when the 
preferred MWCNTs amount was 0.5 wt.% (Pan et al., 2012). In more recent 
and advanced in vivo trial, polycaprolactone 50% and -TCP 50% were 
combined to develop special scaffolds implanted in porcine mandible. 
Following histological and immunofluorescence studies the good clinical 
potency of such biocomposite scaffolds was seen (Konopnicki et al., 2015). 
Despite many studies performed on other biomaterials; bioglass, CNT and 
PCL, there is no study, to the best of our knowledge, that examined the 
combination of all these materials together with phosphate-based glass. It is 
worth mentioning that there were some studies in the literature that involved 
applying bioglass with either CNT or PCL with the assessed bioglass being a 
silicate based glass. In the present chapter, a novel study was planned to 
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investigate the fabrication of two different (zinc and strontium) containing 
phosphate-based glass compositions that was coated with both PCL/CNT 
and PCL to investigate the biological impact of coating layer on cellular 
attachment, proliferation and metabolism. The presented work may have 
potential implication in the development of 3-D scaffolds for bone tissue 
engineering. 
5.2  Materials and methods 
5.2.1 Glass discs preparation  
Two different compositions of phosphate glass discs were developed to 
check the initial ability of surface functionalisation by PCL and CNT, and to 
evaluate the cellular reaction to the functionalisation by measuring 
cytocompatibility and metabolic activity. The compositions were ZnO5 %(50 
P2O5 - 10Na2O - 5TiO2 – 30CaO –5ZnO) and SrO17.5% (50 P2O5 - 10Na2O - 
5TiO2 – 17.5CaO –17.5SrO). They were made by using the same procedure 
and same weight (Table 5.1) described previously in 2.2.3 and 3.2.3.  
Table ‎5-1 Glass composition weight (gram) 
Glass composition  
P2O5 NaH2PO4 TiO2 CaCO3 SrCO3 ZnO 
ZnO5 P50Na10Ti5Ca30Zn5 56.8 24 4 30 0 4 
SrO17.5 P50Na10Ti5Ca17.5Sr17.5 56.8 24 4 17.5 25.8 0 
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5.2.2   CNT solution preparation 
CNT solution preparation enclosed three steps which were: 1- CNT 
carboxylation, 2- PCL (polycaprolactone) solution preparation and 3- CNT 
dispersion in PCL solution. 
1- CNT Carboxylation: Carbon nanotubes were chemically modified by 
adding carboxyl group to their structure forming a (COOH) attachment. This 
was performed by using 0.5g of multi-walled CNT that have the dimensions 
of 10nm x4.5nm x 3 m (> 98%, Sigma Aldrich). CNTs were primarily added 
to a 1 molar solution of H2SO4/HNO3 (Sigma Aldrich) 1:1 aqueous solution 
and then refluxed at 80oC for 48 hours following the procedure explained by 
(Ahn et al., 2015). Once the reflux procedure was accomplished, the black 
solution (CNT+ Acids mixture) was centrifuged by (Mistral 2000R) centrifuger 
at (1500rpm for 10 minutes) to separate the black CNT precipitated in the 
bottom of the centrifuge bottle from the light brownish supernatant acid which 
was then aspirated and dispensed. The remaining CNT sediment was further 
washed, shaken vigorously in high-purity deionised water (resistivity = 18.2 
MΩ.cm–1) gained from a PURELAB UHQ-PS (Elga Labwater, Marlow, UK), 
centrifuged two times to ensure the removal of any acidic residue on its 
surface after removal of the deionised water. The CNTs were then dried at 
80oC for five hours in a vacuum oven (Townson and Mercer) and milled down 
by mortar and pestle to be stored in a plastic container ready to be used for 
future applications. The efficiency of carboxylation was determined through 
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sonication of both raw CNT and functionalised CNT in 15mm of ethanol and 
examined at different time points to monitor its sedimentation rate.  
2-PCL solution preparation: PCL polymer (Sigma Aldrich) was dissolved in 
chloroform solvent  (> 99%, Sigma Aldrich) at a percentage of 2 wt / volume 
% following the procedure previously described (Prabhakar et al., 2005). For 
this, 200mg of PCL were weighed and dissolved in 10 ml of chloroform in 
glass container for 2 hours with the use of stirrer to enhance the dissolution 
procedure.  
3-CNT dispersion in PCL solution:  the previously prepared carboxylated 
CNT and PCL solution were used in this step. A weight of 500 µg of 
carboxylated CNT were dissolved in 20 ml of the above PCL solution at the 
percentage of 25µg/ml. This dispersion step was performed initially by using 
the stirrer machine for 10 minutes to break down the agglomerated CNT 
powder and then by introducing the CNT solution glass container into a 
sonication bath for 1 hour to ensure the full dispersion of CNT in PCL 
solution. The final produced CNT solution was stored in special glass 
container for future applications.  
5.2.3 Glass discs coating. 
Discs from both compositions were cleaned initially with acetone and then 
left to be dried in two specific labelled glass containers. Two types of coating 
were performed (figure 5.1):  
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1-PCL coating: 10 ml of PCL polymer solution was used as an immersion 
solution for both zinc and strontium glass discs.  Immersion procedure was 
performed for 15 minutes under sonication.  
2-CNT-PCL coating: samples of each composition were immersed in 10 ml of 
the CNT-PCL solution in a sonication bath for 15 minutes to ensure that 
glass discs were coated with CNTs. Glass discs were removed from the 
immersion glass containers and left to dry in a desiccator over the night.  
 
 
 
 
 
 
Figure ‎5-1 ZnO15 glass discs. a- uncoated, b-PCL coated and C- CNT-PCL coated 
 
5.2.4 Characterisation of CNT coated glass discs  
The assessment of coating efficiency was performed at both physical and 
chemical levels. Regarding the physical stability of the coating, one coated 
glass disc was immersed in deionised water and treated in an ultrasonic bath 
for 10 minutes. The sample was dried for 24 hours in desiccator and then 
visualised via SEM. This imaging study was performed for both the ultrasonic 
treated and the control non-ultrasonic treated glass discs. 
Concerning the chemical stability assessment of CNT coating layer, coated 
discs were soaked in 25ml of deionised water in plastic vials (Sterilin tube) at 
a                  b                      c 
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a temperature of 37oC at three-time points (7, 14 and 28 days). At each time 
point, the discs were removed from their plastic containers, dried for 24 hours 
in desiccator, attached to SEM stubs, gold coated and then assessed under 
SEM. 
5.2.5 Hydrophilicity and hydrophobicity assessment  
 Water contact angle measurements were performed by using a CAM 200 
optical contact angle meter instrument (KSV co, Finland).  Special graduated 
needle (Hamilton co, Nevada, USA) was filled with distilled water to establish 
the hydrophobicity/hydrophilicity of the prepared and coated glass discs in 
the normal room temperature environment. Measurements were taken on 
triplicate samples of zinc glass discs (uncoated glass, PCL coated glass 
discs and CNT-PCL coated glass discs). The needle was placed in its clamp 
and was directed above the glass discs surface to ensure water droplet. The 
contact angle measurement was performed on the water bubble that 
dispersed on the glass discs surface by using the CAM200 shape analysis 
software and time lapse camera. This procedure was done by measuring the 
angle for 10 fast readings (40 ms intervals) and 10 slow readings (1 s 
interval).  
According‎to‎(Young’s‎equation)(equation‎1),‎the‎contact‎angle‎(θ)‎formed‎on‎
the solid surface is governed by three equilibrium forces: solid–vapor surface 
tension‎ (γsv ), solid–liquid‎ surface‎ tension‎ (γsl ) and liquid–vapor surface 
tension‎(γlv ) (figure 5.1) (Kwok and Neumann, 1999). The angle values  that 
are‎less‎than‎90°θ‎‎indicated‎surface  hydrophobicity while angle values that 
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are‎greater‎ than‎90°θ‎are‎known‎ for‎surface‎ ‎hydrophilicity‎ (Yuan and Lee, 
2013). 
                𝑦𝑙𝑣  𝐶𝑜𝑠𝜃 = 𝑦𝑠𝑣 − 𝑦𝑠𝑙  …………………equation1 
 
Figure ‎5-2 Contact angle measurement. Reprinted from Advances in Colloid and Interface 
Science journal, vol81, issue 3, D.Y.Kwok
 
 and A.W.Neumann. Contact angle measurement and 
contact angle interpretation, page 167, copyright (1999) with permission from Elsevier. 
5.2.6 Surface roughness measurement  
The surface roughness of the coated and uncoated glass discs was 
measured by using laser emitted from a Proscan 2000 non-contact 
profilometer instrument and Proscan software (Scantron Industrial Products, 
Ltd, Taunton, England). This was carried out in triplicate of each glass discs 
group.  The profilometer scan was done for 2 x 2 mm square area. The scan 
parameters were as follows: scan rate = 300 Hz, average = 4 and step size = 
0.005 mm. Ten representative readings from five different linear points were 
obtained from each sample and used for the calculation. 
Roughness average (Ra) was considered for surface roughness evaluation, 
this was calculated by measuring the absolute average of the distance 
extending from fixed mean line to elevations and depressions in the glass 
surface. 
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5.2.7 Cell culture studies  
5.2.7.1 Cell preparation  
Both MG63 cells and hMSCs preparation was described previously in 
4.2.6.1. 
5.2.7.2 Measurement of metabolic activity of cells 
Metabolic activity was performed by measuring the fluorescence reduction of 
alamar blue for predetermined time points (day 1, 4,7) following the same 
procedure that is described in 3.2.6.3.  
MG63 cells were seeded initially (10000 cells /discs) on triplicate of both zinc 
and strontium (plain, PCL coated, CNT-PCL coated) glass discs, tissue 
culture plastics (TCP) were considered as the control samples. DMEM used 
as a culture media for this study. 
5.2.7.3 DNA assessment  
Quantification of DNA study was performed by using hMSCs for two different 
time points (day 7, 14) at initial cellular seeding density of 25000 cells per 
disc. The determined cells density was prepared in 50µl of culture media to 
ascertain the even distribution of cells on the glass discs without flowing 
away from them. Then glass discs were incubated with the seeded cells in 
incubator at 37oC for 30 minutes to provide enough times for cell attachment 
on discs. This was followed by adding 1 ml of DMEM and incubation for the 
two-time points.  
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At each time point, DNA purification was carried out by using QIAamp® DNA 
Mini kit (Qiagen). The first step of the purification was cells detachment from 
the glass discs by using 750 µl of trypsin for 5 minutes at 37oC. then, trypsin 
was deactivated by adding 750µl of culture media. The resulted culture 
media solution was aspirated and centrifuged for 5 minutes at 300 x g in 2 ml 
microcentrifuge tube. Then, the supernatant was removed completely without 
any disturbance to the hMSCs pellet. At that point, cells pellets were 
suspended in 200 µl PBS and 20µl of proteinase K and 200 µl of provided 
buffer solution. The resulted 420 µl solution was vortexed for 15 seconds and 
incubated for 10 minutes at 56oC. This was succeeded by multiple steps of 
centrifuging, addition of 200 µl of ethanol, vortexing for 15 seconds and 
centrifuging again. The produced 620 µl of solution was then aspirated from 
the normal tubes, introduced in QiAamp spin tubes in a (2ml collection tube) 
without wetting the rim, centrifuged at 6000 x g for 1 minute. Then, the spin is 
removed and introduced in new collection tube after discarding the previous 
collection tube. This was followed by five consequent steps of washing and 
centrifuging by using different buffer solutions. Finally, elution of 200 µl of 
DNA was collected and stored at -20oC to be prepared for the next DNA 
quantification step. 
DNA quantification was performed by using Quant-iT™‎PicoGreen™‎dsDNA‎
Assay Kit (Fischer). The first step was the preparation of 1X of TE buffer 
solution from the original 20X TE buffer solution which was done by diluting 4 
ml of 20 X TE in 76 ml of DNASe-free water (Qiagen). The second step was 
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preparation of a 200 -fold of Pico Green dsDNA reagent by diluting 200 l of 
it in 38 ml of the prepared TE buffer. The resulted diluted solution was 
prepared in a dark plastic container and used for DNA detection of both the 
stored study samples and standards solution that were used for calibration. 
For DNA quantification, the frozen solutions of DNA samples were initially 
thawed in room temperature. Then triplicate of 50 µl of each DNA 
experimental solution was added was added to 950 µl of 1 X TE buffer to end 
up with 1 ml of experimental DNA solution. Then 1 ml of the 200-fold Pico 
Green solution was added to each sample and incubated for 5 minutes in 
light protected well plate at room temperature. The fluorescence reading was 
then determined by using spectrofluormeter (Infinite M200, Tecan, 
Männedorf, Switzerland) at wavelength of 520 nm. 
Calibration was done by preparing sequence of five low range dilutions of 
DNA (0, 25, 250, 2500 and 25000 pg/ml). the dilution was done by using the 
1 X TE buffer solution. One ml of the prepared Pico Green solution was also 
added to each standard dilution for five minutes to prepare it for the following 
fluorescence reading step at wave length of 520nm.  
Calibration curve was obtained from the standards readings. The equation of 
this curve was used to relate the absorbance reading with the DNA 
concentration in the samples (figure 5.3).  
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Figure ‎5-3 Calibration line of DNA assay. Done by preparing different concentrations of DNA 
and correlate the corresponding fluorescence reading with each of the concentration. 
5.2.7.4 Cells imaging by scanning electron microscopy (SEM) 
MG63 cells were seeded at density of 10000 cells / disc with use of DMED 
culture media for the SEM imaging. SEM imaging was performed for day 4 
and 7 following the same steps that are described previously in 3.2.6.4. 
5.2.7.5 Confocal microscope cells imaging 
Confocal imaging was performed for hMSCs that were seeded initially at 
density of 25000 cell/disc. The imaging was done for two-time points (day 7, 
day 14) following the same steps that are described previously in 4.2.6.6. 
5.2.8 Statistical analysis 
 Cell studies results were statistically assessed by one-way ANOVA to 
assess the null hypothesis stated that there is no apparent or significance 
variation between the control tissue culture plastics (TCP) in one side and 
the uncoated discs, PCL coated discs and CNT-PCL coated phosphate glass 
discs in the other side regarding both cellular metabolic and proliferative 
abilities where p<0.05 has been used as a significance degree estimation. 
y = 1778x2 - 851.09x - 26.932 
R² = 0.9985 
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5.3 Results  
5.3.1 CNT carboxylation validation. 
Figure 5.4 shows the sedimentation rate of both functionalised and non 
functionalised CNT after two hours. It demonstrated that sedimentation rate 
was faster for the non-functionalised CNTs in comparison to the slow rate for 
functionalised CNTs. 
 
Figure ‎5-4 Carbon nanotube sedimentation after 2 hours A: unfunctionalised  
  B: functionalised 
 
 
 
 
 
 
 
237 
 
5.3.2 Characterisation of CNT coated glass discs  
Figure 5.5 displays the SEM image of CNT coated glass disc layers for the 
ultrasonic treated and ultrasonic non-ultrasonic treated disc groups.  It 
showed the presence of the coating layer in both groups with no clear visual 
differences regarding coating efficacy between the two groups. 
 
Figure ‎5-5 SEM images of CNT- PCL coated ZnO5 discs (a) ultrasonic non- treated discs and (b) 
ultrasonic treated discs, showing the stability of coating layer after the mechanical ultrasonic 
stimulus. 
Figure 5.6 presents SEM images of coated glass discs after immersion in 
deionised water at three different time points (a) day 7, (b) day 14 and (c) 
day 28. It showed that the CNT coating layer was unchanged for the all-time 
points. Though, there was a clear surface and topographical changes in 
coating layer especially at day 28. These variations were related to cracks 
size and cracks numbers that may be due to the degradation of PCL 
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occurred after long time of incubation with deionised water or may be 
because of sample processing. 
                    
 
Figure ‎5-6 SEM images of coated SrO17.5 glass discs after three-time points: (a) day7, (b)day 14 
and (c)day28. CNT layer was present along all the whole study, but polymer layer exhibited 
more cracks within time. 
 
 
 
 
 
 
 
a b 
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5.3.3 Hydrophilicity and hydrophobicity assessment 
Figure 5.7 displays‎the‎contact‎angle‎(θ)‎for‎different‎coated‎and‎non-coated 
glass discs. Contact angle value was considered as a clear indication for 
glass surface wettability where 90 ° was used as the demarcation limit 
between hydrophilicity and hydrophobicity. Results suggested that uncoated 
glass discs are considered to be slightly hydrophobic as their contact angle 
were 97.4± 2.7, this was statistically significant with other groups (p < 0.05). 
Other PCL-coated and CNT-PCL coated glass discs groups showed signs of 
hydrophilicity since their contact angles values were 81.9± 1.4 and 76 ± 3.4 
respectively.  
 
Figure ‎5-7 Contact angle measurement explaining the difference in hydrophilicity and 
hydrophobicity of glass surfaces 
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5.3.4 Surface roughness  
 Surface roughness results are displayed in figure 5.8. The findings displayed 
that uncoated glass discs exhibited less roughness at around 1.29±0.28 µm 
which was significantly lower than the CNT-PCL coated discs at around 
1.99±0.36 µm. The PCL coated samples revealed roughness that is in the 
middle between the other two groups. These data are further clarified in 
figure 5.9 which shows the laser scan images of roughness.  
 
Figure ‎5-8 Roughness average (RA) for the different glass discs groups showing that CNT-PCL 
coated glass discs are more rough than other groups 
  
Figure ‎5-9 Laser scan images for a. uncoated glass discs, b- PCL coated discs and c. CNT-PCL 
coated discs 
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5.3.5 Measurement of metabolic activity of cells 
Alamar blue study results are displayed in figure 5.10. Generally, all the 
groups including the control (TCP) revealed acceptable values with time. At 
day 1, all the samples revealed a similar reduction of around 5% compared 
to the control. Though, the coated PCL and CNT-PCL were statistically 
significantly lower from the control (P 0.05). At day 4, there was general and 
prominent increase in the reduction values. This increase in its highest 
amount for the control (TCP) at about 25% which was also statistically higher 
than the coated sample which were around 20%. At the last time point at day 
7, the trend was similar to the earliest time points where the TCP displayed 
the highest percentage values at around 53% followed by the uncoated 
samples at 50% and lastly with the coated samples at around 46%. 
 
Figure ‎5-10 Alamar fluorescence reduction percentage for free coated, PCL coated and CNT-
PCL coated ZnO5 and SrO17.5 glass discs for three-time points (day 1, 4,7) 
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5.3.6 DNA assessment  
DNA concentration quantification results are demonstrated in figure 5.11. 
The general trend obtained from the DNA study showed that all groups have 
a similar cellular DNA content. At day 7, the overall DNA concentration was 
about 35000 pg/ml apart from the uncoated samples which was statistical 
different from other groups at around 22000 pg/ml. At day 14, DNA 
concentration rose in all samples as a result of cellular proliferation. Though, 
the ultimate upregulation was found in the control (TCP) at 192000 ± 54000 
pg/ml followed by CNT-PCL coated samples at 182000 ± 35000 pg/ml and 
ended in the other four groups displaying DNA concentration ranging from 
135000-143000 pg/ml.  
 
Figure ‎5-11 DNA concentration measured by pg/ml for the control and all glass disc groups 
displaying the acceptable detected concentration that was found in all groups after one week 
and two-week periods 
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5.3.7 Cells imaging by scanning electron microscopy (SEM) 
Figure 5.12 displaying SEM images of seeded MG63 on different non-
coated, PCL and CNT-PCL coated ZNO 5 and SrO 17.5 glass discs. At day 
4, cells were found to be stably attached to the different produce discs 
samples. At day 7, cells attachment was maintained with the appearance of 
more cellular density than day 4 in some parts of glass discs. SEM pictures 
revealed the ability of cells to use their appendages for attachment despite 
the presence of some coating layer discontinuity as a function of degradation 
after culturing in DMEM cell cultures. 
    
    
Figure ‎5-12 SEM images of MG63 cells seeded on CNT-PCL coated glass discs. a-ZnO5 (day4), 
b- SrO17.5(day4), c-ZnO5 (day7) and d-SrO17.5 (day7) 
c 
d 
a 
b 
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5.3.8 Confocal microscopy cell imaging 
Fluorescence confocal images of hMSCs at day 7 and 14 are displayed in 
figure 5.13. Generally, cell proliferation seemed to be more abundant in the 
CNT-PCL coated discs than the PCL coated and uncoated samples. At day 
7, cell proliferation on uncoated discs appeared to be less than the other 
coated samples which was clear through the presence of cell free areas on 
the discs (figure 5.13 a), this was followed by PCL coated discs (figure 5.13 
b), and the CNT-PCL coated discs showing the highest proliferation levels 
(figure 5.13 c). At day 14, the pattern of cell proliferation was similar to that of 
day 7 where CNT-PCL coated groups exhibited high levels of cell 
proliferation and cells looked to have grown in multilayers (figure 5.13 f). 
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                   Day 7                    Day 14 
 
  
 
  
 
  
Figure ‎5-13 Confocal images of hMSCs cells seeded on SrO17.5 glass discs.  a-uncoated discs 
(day7), b- PCL coated discs (day7), c-CNT-PCL coated (day7), d-uncoated discs (day14), e- PCL 
coated discs (day14) and f-CNT-PCL coated (day14) 
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5.4     Discussion 
This chapter aimed to determine the biological implication of coating the 
phosphate-based glass. Uncoated zinc and strontium glass discs were 
investigated in the previous chapter and was shown that the most acceptable 
findings were found in ZnO5 and SrO17.5 formulations. Many studies have 
focused on CNTs application for bone regeneration.  There are controversial 
opinions about what the optimum CNT concentration should be; some views 
hypothesised that this concentration should be around 25µg/ml (Kam and 
Dai, 2005), A comparison of three different carbon products: multi-walled 
carbon nanotube (MWCNT), graphene oxide (GO) and nano diamond (ND) 
was carried out. This study aimed to correlate the carbon type and the 
cellular uptake and  cytotoxicity and revealed that signs of toxicity for 
MWCNT started to appear at 20µg/ml (Zhang et al., 2012b). Other study 
suggested it can be increased up to 100µg/ml (Tong et al., 2014) .  
One of the recent experiments designed to fabricate CNT with hydroxyapatite 
(HA) where CNT was added in different concentrations, it suggested that 
functionalised CNTs are less cytotoxic than the non-functionalised CNTs and 
that increasing CNT concentration can lead to a decrease in viability of 
human osteoblast cells and a concentration of 62µg/ ml of functionalised 
CNTs was found to result in about 2% of cell death (Khalid et al., 2015). 
Multi-walled‎CNT’s‎were‎chosen‎ to‎be‎used‎rather‎ than‎single‎walled‎ types‎
because of their high elastic modulus (Mattioli-Belmonte et al., 2012). These 
f 
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CNTs were oxidatively functionalised by carboxylation through agitating in 
H2SO4/HNO3 solution since carboxylation may lead to add negative function 
groups to CNT surface which may promote  the hydrophilicity of CNT and 
also  facilitate its dispersion property within solvents (Shin et al., 2011). 
These functional groups can also help to hasten the growth of HA crystals as 
they work as calcium chelating sites  (Aryal et al., 2006). 
 In this study, CNT carboxylation was confirmed through examining the CNT 
dispersion in ethanol. The concentration of 25µg/ml of CNT was used 
according to recommended findings in previous studies of CNT toxicity while 
the use of 2% PCL was considered after performing a pilot study including 
different polymer and CNT mixture concentrations. 
Turning to the findings of this study, the first study was performed to 
thoroughly assess the coating potency after both physical and chemical 
stimulus treatment. The SEM images of this study suggested that the coating 
procedure was successful as CNT-PCL coating layer remained stable on 
glass discs surface data after treatment with ultrasonic bath and immersion in 
deionised water for 28 days. Therefore, it was a good indication to continue 
in the application of these CNT-PCL coated glass discs in the following cell 
culture studies.  
Wettability data showed that CNT-PCL coated discs were more hydrophilic 
than the other groups, this could be explained as CNT are functionalised by 
carboxyl groups that make surface more hydrophilic (TAKADA et al., 2010).  
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Surface roughness data showed that roughness has clearly been enhanced 
by CNT coating, this was also concurrent with other studies that linked CNT 
coating and enhancement of topographical features (Chen et al., 2008a).  
Concerning the cytocompatibility study, alamar blue results aimed to quantify 
the percentage of fluorescence reduction to serve as an indication of the 
cellular metabolic activity of which the higher reduction percentage indicates 
a higher metabolic rate. Although alamar blue findings revealed the presence 
of statistical differences between all the coated samples and the control 
samples at the all three-time points, that difference did not neglect their 
provoking impact on the metabolic activity of MG63 cells as the difference 
was slightly less than the control and the uncoated‎glass‎discs’‎samples. 
Regarding DNA quantification, the assay is considered an indirect way to 
quantify the number of cells. The findings showed that there was a significant 
difference on day 7 between the control and the uncoated discs while no 
difference seen on day 14. Regarding the coated discs, it seemed that CNT-
PCL coated glass discs compositions displayed higher DNA concentration 
which was slightly less than the control discs. According to that, it seemed 
that glass discs compositions did not have any clear effect on the cellular 
outcomes comparing to those of surface modification effects. In other words, 
it appears that coating is the governing factor in controlling the cell 
metabolism and the cellular proliferation. These results were further 
confirmed by SEM and fluorescence imaging; CNT-PCL coated glass discs 
seemed to promote cell proliferation and enhance cell density more than the 
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other glass discs samples. The explanation of the enhanced cellular 
response may be due to two factors: 1- the improved surface hydrophilicity 
by CNT and 2- the improvement in surface roughness which resulted from 
CNT-PCL coating. This has confirmed the previous results that correlate 
roughness and hydrophilicity with the enhanced osteogenicity (Boyan et al., 
2017) and link the potency of  functionalised CNTs to enhance stem cell 
proliferation and bone marker expression.  
In conclusion, coating phosphate glass discs with a CNT-PCL layer was 
successful and was shown to affect cell growth positively. According to the 
results of this chapter, a rejection in null hypothesis was determined 
regarding the metabolic and proliferative cellular activities that are yielded 
from seeding the same number of cells on differently modified glass discs 
surfaces. Other studies are needed to be carried out to assess the 
morphological, mechanical and biological impact of using a CNT-PCL coating 
layer on phosphate glass 3D scaffolds.  
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Chapter 6 Development of Zinc and Strontium Phosphate 
Based Glass Scaffolds 
6.1  Introduction 
Hard tissue regenerative medicine for craniofacial complex is focused on 
developing materials that can help clinicians to manage hard tissue loss and 
provide patients with a functional bone tissue. This is beneficial to patients 
suffering from trauma, neoplasms and congenital abnormalities on both 
clinical and psychological aspects (Smith et al., 2015a). Kaur et al. (2014) 
suggested that the ideal material should be biocompatible, does not 
demonstrate cytotoxicity or immunogenicity, can form a hydroxyapatite layer 
when in contact with simulated body fluid, has desirable mechanical 
properties, has a controllable interconnected porosity, and should be cost-
effective (Kaur et al., 2014b). Based on this, different materials have been 
developed including ceramics (e.g. synthetic bioactive glass and 
hydroxyapatite), polymers (e.g. poly methyl methacrylate and 
polycaprolactone) or composites (e.g. a combination of any of the above 
materials and more). The main aim of studying these materials is to achieve 
a better outcome in terms of physical properties (porosity and mechanical 
strength), biological responses and clinical outcomes.  
Regarding the physical properties, Gerhardt and Boccaccini (2010) stated 
that‎scaffolds‎require‎to‎have‎both‎micro‎pores‎(<50‎μm)‎and‎high‎pore‎sizes‎
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(>300‎ μm).‎ The‎ first‎ is‎ important‎ for‎ the‎ sake‎ of‎ direct‎ protein‎ and‎ cell‎
adhesion, cell migration and osseointegration whereas the latter is needed 
for angiogenesis as the small sized pores may cause hypoxia or induce 
osteochondral differentiation rather than osteogenic differentiation (Gerhardt 
and Boccaccini, 2010). It was suggested that high porosity percentage (> 
90%) in scaffolds structure is necessary and favourable for cellular migration 
and proliferation growth, however, this can affect the mechanical properties 
of the scaffold negatively (Hannink and Arts, 2011). 
Many studies were performed on scaffold manufacturing aiming to produce 
bioactive glass ceramic scaffolds or bioactive glasses incorporated 
biocomposite (Will et al., 2012). One of the earliest studies developed porous 
bioactive glass scaffold through sintering within hot vacuum conditions. The 
produced bioglass (silicate based) scaffolds promoted the osteogenic activity 
of osteoblasts (El‐Ghannam et al., 1995). Other studies performed on 
manufacturing silicate glass bioceramic scaffolds by coating polyurethane 
polymer by slurry of sintered silicate, and the produced silicate based glass 
scaffolds were then involved in both in vitro study of MG63 cells and in vivo 
study in rabbits. The results suggested the ability of MG63 cells to proliferate 
within the synthesised scaffold and the formation of new tissue containing 
collagen and blood vessels in the animal model (Wang et al., 2011). Other 
attempts were carried out to produce silicate porous glass scaffolds using 
both the polymer foam replica and the unidirectional freezing techniques. 
Scaffolds developed via both techniques were mechanically and structurally 
assessed prior to seeding them with mesenchymal stem cells and implanting 
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in rats. In vivo results revealed a bone like tissue formation in the stem cell 
seeded scaffolds while the cell free implanted scaffolds did not show any 
hard tissue deposition (Fu et al., 2010a). Other researchers produced 
titanium-stabilised porous phosphate glass scaffolds via foaming techniques. 
The porosity of the produced scaffolds was around 40-50% and the scaffolds 
did not show any sign of cytotoxicity (Navarro et al., 2004). 
One inevitable problem facing most scaffolds is optimisation of cell seeding. 
Although seeding cells is performed usually by preparing high 
concentrations, there is a possibility of cells to flow away from scaffolds 
within the medium  (Shimizu et al., 2006). Naturally, cells adhere to their 
physiological environment with the aid of integrins that attached to integrin 
bindings site such as Arg-Gly-Asp (RGD) of the extracellular matrix proteins 
such as collagen, fibronectin and vitronectin  through the integrin binding 
sites such as Arg-Gly-Asp (RGD) (Hynes, 1992). Hence, many attempts 
were accomplished to use the integrins to manage cell seeding and cell 
attachment associated problems. Previous studies aimed to visualise the 
effect of coating titanium implants with collagen, the results revealed the 
positive effects of collagen coating on promoting initial cellular attachment 
and enhancing osteogenic activity of titanium implants (Nagai et al., 2002, 
Rammelt et al., 2004, Costa et al., 2017). Other studies investigated the 
outcome of coating different calcium phosphate scaffolds with collagen on 
osteoblasts and stem cells adhesion, metabolic and proliferative activities. 
The outcomes of collagen coating suggested that the positive impact of 
collagen coating layers on cell proliferation and metabolism as well as 
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cellular-scaffold adhesion, as the collagen coating, was hypothesised to 
enhance surface roughness (Brodie et al., 2005, Zan et al., 2016).  
Coating with fibronectin was also assessed in terms of its ability to enhance 
cellular attachment and growth. One study compared the chondrocyte growth 
ability between fibronectin coated polymer scaffolds and uncoated scaffolds. 
The findings revealed that fibronectin coatings encourage cell ingrowth within 
the porous scaffolds (Bhati et al., 2001). Another correlated study examined 
PCL scaffold surface modification by plasma, fibronectin and plasma and 
fibronectin together. This study assessed the topographical effect, the cell 
attachment, the cell proliferation and the secretion of differentiation markers. 
The findings suggested that all the surface modification techniques had 
better results than those of the uncoated scaffolds. Though plasma treated 
surfaces exhibited more encouraging results than the fibronectin coated 
groups in term of cell attachment and cell proliferation. However, fibronectin 
is necessary for osteodifferentiation (Yildirim et al., 2010).  
According to the literature, most of the performed studies on glass 
bioceramic scaffolds are correlated to the silicate based bioglass with no 
consideration of the cell density optimisation. This chapter is aimed at 
discussing the production of porous zinc and strontium containing 
phosphate-based glass scaffolds by sintering a technique and to surface 
modify these scaffolds by proteins that are known to enhance cell attachment 
and improve seeding efficiency. 
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The results of this study may be valuable in terms of producing scaffolds with 
novel compositions that could be of clinical significance. 
6.2 Material and methods  
6.2.1 Phosphate glass scaffold preparation 
Two different compositions of phosphate glass scaffolds were developed. 
Glass scaffolds were manufactured by using the following precursors: 
phosphorus pentoxide (P2O5 98%, VWR, Lutterworth, UK), sodium 
dihydrogen phosphate (NaH2PO4, 99%, VWR, Lutterworth, UK), titanium 
dioxide (TiO2, 99%, VWR, Lutterworth, UK), calcium carbonate (CaCO3, 
98.5%, VWR, Lutterworth, UK), strontium carbonate (SrCO3, 99.9% Sigma-
Aldrich, Dorset, UK) and zinc oxide (ZnO, 99.95%, Sigma-Aldrich, Dorset, 
UK). The two glass formulas were zinc phosphate scaffolds (50 P2O5 - 
10Na2O - 5TiO2 – 30CaO –5ZnO) and strontium phosphate scaffolds (50 
P2O5 - 10Na2O - 5TiO2 – 17.5CaO –17.5SrO). An electronic balance 
(Sartorius) was used for weighing precursor powders (Table 6.1). The 
precursors powder was mixed for 1 minute by using Stomacher 400 blender 
apparatus. This was followed by melting the glass powder in a 200ml volume 
Pt/10%Rh crucible type 71040 (Johnson Matthey, Royston, UK) at a 
temperature of 1350oC for four hours using a furnace (Carbolite). The melted 
glass was quenched directly onto cold stainless surface and left overnight to 
cool down gradually to room temperature. Following this, the cold quenched 
glass was ground into small particles using MM 301 Mixer Mill (Retsch 
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GmbH, Hope, UK) grinder. Glass particles were sieved to select only glass 
particles with size ranging between 400µm-600µm. 
 
Table ‎6-1 phosphate glass scaffold composition 
Glass composition P2O5 NaH2PO4 TiO2 CaCO3 SrCO3 ZnO 
ZnO5 P50Na10Ti5Ca30Zn5 56.8 24 4 30 0 4 
SrO17.5 P50Na10Ti5Ca17.5Sr17.5 56.8 24 4 17.5 25.8 0 
 
A graphite mold with a 5mm diameter rod cavity was loaded with the selected 
glass particles. Glass sintering was carried out by introducing the glass 
particle-loaded mold into a furnace for 180 minutes. To identify the optimal 
sintering temperature, three different temperatures were applied for each 
glass composition according to the glass transition temperature. For ZnO 5 
glass scaffolds, the temperatures were: 470oC, 475oC and 480oC. whereas 
for SrO17.5 they were 480oC,485oC and 490oC. After the sintering 
procedure, glass scaffolds were allowed to cool down overnight ending in the 
manufacturing of 5 mm diameter by 5cm long sintered rod (figure 6.1). The 
sintered glass rods were cut down to different sizes cylindrical scaffolds 
using diamond discs burs using a slow speed hand piece (Dremel, USA) to 
allow testing of both their mechanical and structural properties (figure 6.1 e). 
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Figure ‎6-1 Glass scaffold manufacturing steps. a. quenched glass, b. glass powder, c. glass 
powder loaded into the graphite mold, d. sintered glass rod and e. cylindrical glass scaffold 
 
6.2.2 Glass scaffolds production optimisation  
Six different produced glass scaffolds (according to their composition and 
their sintering temperatures) were structurally and mechanically tested to 
determine the optimum sintering temperature for scaffold production of each 
composition. 
6.2.2.1 Scaffold porosity estimation  
The assessment of the micro-architecture, structure and porosity of the 
scaffolds was performed using Bruker Skyscan micro CT instrument 
(Belgium). Six different glass scaffolds were scanned at normal voxel sizes of 
4 µm at 70 kV and 100 mA x-ray sources. A thickness of 4 mm of each 
sample was scanned resulting in multiple image slices.  Porosity percentages 
calculation for each sample was performed using image analysis software 
(CTvox). The calculation of porosity was performed for all the CT scanned 
b c 
d e 
a 
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samples. Moreover, subjective pore size determination was executed on 
some scaffold slices by using the same software. Other software (NRecon 
software) was used also to construct a 3D image of each scaffold out of the 
whole x-ray image slices (figure 6.2). 
 
Figure ‎6-2 3-D image of phosphate -based porous scaffold 
6.2.2.2 Diametral compressive strength  
Diametral compressive strength was carried out by using a Shimadzu AGS-X 
(Shimadzu co, Japan) as an alternative method to the conventional 
compression strength method as glass scaffolds are brittle materials. In this 
method, ten samples of each prepared glass scaffolds of the dimension 5mm 
x 10mm were tested at room temperature using an Shmiadzu hydraulic 
material tester. The speed of testing of the instrument (the hydraulic moving 
part) was 0.5 mm/min following the previous studies of (Pilliar et al., 2001). 
All the samples were fixed on special stainless-steel holder positioned 
horizontally in a position that permits the application of a compressive force 
on their diameter and not on their long axis (figure 6. 3). Initially, a 
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compressive force of 5 N was applied until it touched the scaffold passively, 
then the sample was load until obtaining a fracture. Loading data of the 
sample fracture were collected using Trapezium x software. The fracture was 
identified in the software by the appearance of sharp peak considered for 
tensile stress calculation. Due to the brittleness and porous nature of the 
scaffolds, it is worth mentioning that this test was challenging to perform and 
hence bias should be avoided when obtaining the force readings. For this 
reason, only near –vertical fractures were accepted as results in accordance 
to the criteria that is previously described (Pilliar et al., 2001). Then, the 
diametral compressive strength were calculated via the software utilising the 
equation 1:   
                          σx‎=‎2P‎/‎DT‎………………. equation 1 
Where x is the compressive strength, P is the load, D is the diameter of 
glass scaffolds and T is the height of scaffold. 
                                               
Figure ‎6-3 Diagram showing the orientation of phosphate glass scaffolds during diametral 
compressive strength (Drawn by Sketch Up Software) 
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6.2.3 Cellular studies 
6.2.3.1 Cells preparation 
Human mesenchymal stem cells (hMSCs) were prepared following the 
procedure explained in (4.2.6.1). 
The culture media used for all cellular studies was DMEM (Thermo Fisher 
Scientific, USA) supplemented by 50 ml of (FBS) fetal bovine serum 
(Invitrogen) and 5 ml of penicillin and streptomycin (Sigma Aldrich, Dorset, 
UK) in 500ml of DMEM.  
6.2.3.2 Scaffold Coating  
Based on the previous results of sintering temperature optimisation, both zinc 
(ZnO5) glass scaffolds that were made by sintering temperature 475C and 
strontium (SrO17.5) glass scaffolds that were manufactured by sintering 
temperature 485C were used for the further cell studies. 
Initially these scaffolds were coated by two different proteins known to 
promote cells attachment to the scaffolds. Coating was either by fibronectin 
or collagen type 1 as follows: 
1-Scaffold coating by fibronectin: Coating with fibronectin was carried out 
after immersing the scaffolds in (20 µg/ml) fibronectin solution for 1.5 hour 
under 37C following the procedure that explained previously (Bhati et al., 
2001). The intended fibronectin concentration (20µg/ml) was determined by 
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diluting 100 µl of 1000µg.ml-1 fibronectin (Gibco Thermo Fischer, USA) in 4.9 
ml of PBS (Lonza, USA) following the equation   M1 X V1= M2 X V2 where: 
M1: the main concentration of fibronectin in µg.ml-1. 
V1: the volume of the stock fibronectin in ml. 
M2: the intended dilution of fibronectin in µg.ml-1. 
V2: the final volume of the diluted solution in ml. 
2-Scaffold coating by collagen 1:  Coating with collagen 1 was carried out by 
immersing the scaffold in (1 mg.ml-1) collagen solution for 1 hour under 37C 
following the procedure explained previously (Linsley et al., 2013). The 
intended collagen 1 concentration (1 mg.ml-1) was made via the dilution of 
acetic acid 0.2% solution.  A volume of 500 µl of rat tail collagen type 1 stock 
solution of 2mg/ml (Firstlink.UK) was diluted with the same volume of 0.2% 
acetic acid following the equation M1 X V1= M2 X V2 where: 
M1: the main concentration of collagen 1 µg.ml-1. 
V1: the volume of the stock collagen 1 in ml. 
M2: the intended dilution of collagen 1 in µg.ml-1. 
V2: the final volume of the diluted solution in ml. 
6.2.3.3 Cells seeding techniques 
Scaffold seeding was performed at six different conditions to optimise the cell 
culturing procedure ensuring the most efficient cell attachment to the 
scaffolds. 
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The various seeding conditions (techniques) varied according to the scaffold 
coating (uncoated scaffolds, fibronectin coated scaffold and collagen type 1 
coated scaffold) in different 48-well plates types (normal well plate and low 
attachment well plate) culminating in six groups of seeding that are 
graphically explained in (figure 6.4). 
 
         
 
  
 
Figure ‎6-4 Diagram explaining the six different seeding techniques. The upper pink row denotes 
the low attachment well plates (a. uncoated scaffold, b. fibronectin coated scaffold and c 
collagen 1 coated scaffold). Whereas the lower row is normal well plates (d. free coated 
scaffold, e. fibronectin coated scaffold and f collagen 1 coated scaffold). 
The intended seeding density (25000 cells / scaffold) was prepared in 30 µl 
of culture media. Seeding was performed by pipetting out the culture media 
around all the sides of the scaffold (5 mm x 6mm) sides to ensure an even 
distribution of hMSCs through the scaffold microstructure. Then, the hMSCs 
cultured scaffolds were left for 30 minutes in the incubator to provide enough 
time for cells to attach to the scaffold structure before adding 1 ml of culture 
media -MEM (Thermo Fisher, UK) for further investigation. 
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6.2.3.4 Cells attachment assessment study 
Zinc (ZnO5) containing phosphate-based scaffolds prepared at 475 C were 
used for seeding optimisation. The aim of this study was to find the best way 
to permit the cell attachment. The study entailed seeding hMSCs onto zinc 
based phosphate glasses scaffolds at six different conditions as explained 
previously. 
A triplicate of each of prepared ZnO5 (free coated, fibronectin coated, 
collagen 1 coated) scaffolds were seeded twice in 1ml -MEM; first in normal 
48- well plates (Corning, USA) and in low attachment 48 -well plates 
(Corning, USA). The hMSCs seeding density was 25000 cells/scaffold. Cell 
attachments assessment was performed twice at (1-hour and 2 hours) after 
seeding. 
After one hour, scaffolds were transferred from their initial seeding plate to 
another new well plate filled with 1ml of -MEM. Culture media was then 
aspirated from the first seeding well plate which was then washed with PBS 
(Lonza, USA). Then around 500 µl of trypsin was added to each well plate for 
3 minutes under 37C to aid in cells detachment. The trypsin was deactivated 
through adding 500µl of -MEM culture media. Then the resultant 1 ml of 
(trypsin+ -MEM + suspended detached cells) was centrifuged in 1ml plastic 
tubes under speed of 1000 rpm for 5 minutes. 
Following centrifuging, the supernatant culture media was aspirated and 
hMSCs cells pellets were suspended in 1 ml of culture media. 10 µl of the 
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suspended cells solution were mixed with 10µl of trypan blue stain (Sigma 
Aldrich, Dorset, UK). The mixtures were introduced into the hemocytometer 
and direct cell quantification was performed according to the Strober 
procedure (Strober, 2001). At the second hour, the same procedure was 
followed, and the detached cell number was quantified again. 
6.2.3.5 Cells metabolism assay 
Cells metabolic activity of hMSCs was assessed following their seeding on a 
triplicate of ZnO5 scaffolds at a density of 20000 cells/ scaffold using the six 
different seeding conditions explained previously. Metabolic activity 
assessment was performed using alamar blue assay (Bio-Rad, UK). One 
milliliter of -MEM culture media was added to the seeded scaffolds for one 
hour. After one hour, the scaffolds were transferred to other new plate to 
avoid any bias in reading the detached cells within the same well plate. 
Fluorescence reading for fully reduced alamar blue was performed initially 
following the previous procedure in (3.2.6.3). Fluorescence reduction 
percentage to the full reduced was quantified at 3 different time points (1, 4 
and 7 days) following the same procedure explained in (3.2.6.3) 
6.2.3.6 Metabolic activity assay (CCK assay) 
Metabolic activity of hMSCs was also assessed on a triplicate of SrO17.5 
glass scaffolds sintered at 485 C. Cells were initially seeded at a density of 
20000 cells/ scaffold following the six seeding conditions procedure. One 
milliliter of -MEM culture media was added to the seeded scaffolds for one 
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hour. After one hour, the scaffolds were transferred to other new plate to 
avoid any bias in reading the detached cells within the same well plate. 
Absorbance readings were measured at 3 different time points (1, 4 and 7 
days) and cell number was quantified indirectly following the procedure 
described in (4.2.6.2). 
6.2.3.7 Confocal Imaging 
Human Mesenchymal stem cells (hMSCs) were seeded at a density of 20000 
cells/ strontium glass scaffolds. Seeding procedure was performed in six 
conditions as explained previously and laser confocal images were taken at 3 
different time points (1, 4 and 7 days) following the techniques explained 
previously in (4.2.6.6). 
6.2.4 Statistical Analysis 
All the data were statistically analysed via one-way ANOVA or Kruskal Wallis 
according to their data normality. Statistics were performed to test the null 
hypothesis regarding both scaffolds manufacturing and scaffolds seeding 
technique.Concerning scaffold manufacturing, the null hypothesis stated that 
there is no structural and mechanical difference between various sintering 
temperatures that are used in zinc and strontium scaffolds construction. 
Whereas for the scaffold seeding technique, the null hypothesis was that 
there is no statistical variation in seeding efficiency, cellular metabolic activity 
and cellularproliferation between the different cells seeding techniques. All 
the statistical analyses considered p<0.05 to be the significance degree of 
estimation. 
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6.3 Results  
6.3.1 Porosity  
Figure 6.5 and 6.6 show the relation between percentage of scaffolds 
porosity and the sintering temperature of strontium (SrO17.5) phosphate-
based scaffolds. The highest porosity figure was found in scaffolds sintered 
at 480°C which was about 47.5±3.6% which was statistically higher than the 
other sintering temperatures at 40.6 % and 35.5 % for both 485 °C and 
490°C sintering temperatures respectively. 
 
Figure ‎6-5 Porosity percentage of SrO17.5 scaffolds sintered in different temperatures showing 
that porosity is indirectly related with the sintering temperature 
  
Figure ‎6-6 CT-cross sections of strontium scaffolds made at different temperatures. a 480°C, b. 
485°C and c.490°C displaying the decrease in porosity as sintering temperature rose 
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The relation between sintering temperature and the porosity of zinc (ZnO5) 
produced scaffolds is explained in both figures 6.7 and 6.8. The porosity 
seemed to be inversely correlated with the sintering temperature as it 
decreased when a high sintering temperature was used for scaffold 
manufacturing. The highest porosity (58±1.3 %) was found with scaffolds 
sintered at temperature of 470°C followed by (47.5±2.7%) and (40±3.7%) for 
both 475°C and 480°C sintering temperatures respectively.  
 
Figure ‎6-7 Porosity percentage of ZnO5 scaffolds sintered in different temperatures showing 
that porosity is indirectly related with the sintering temperature 
                                                         
Figure ‎6-8 CT-cross sections of zinc scaffolds made at different temperatures. a 470°C, b. 475°C 
and c.480°C displaying the decrease in porosity as sintering temperature rose 
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6.3.2  Diametral compressive strength 
Figures 6.9 and 6.10 present the mechanical property measurement 
(diametral compressive strength) of the different zinc and strontium scaffolds 
sintered at different temperatures. Generally, the diametral compressive 
strength increased with increasing sintering temperature. 
Regarding strontium based scaffolds (figure 6.9), the results revealed that 
the diametral compressive strength of the 490°C sintered scaffolds was 
around 4.2±0.42 MPa which was statistically different (P<0.05) from the other 
two sintered groups. 
 
Figure ‎6-9 Diametral compressive strength for different manufactured strontium glasses 
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Similarly, zinc scaffolds diametral compression strength (figure 6.10) 
improved as sintering temperature rose from 470°C to 480°C with a sign of 
statistical difference (P<0.05). It was 0.36±0.08 MPa for the 470°C group in 
comparison to 0.6 ± 0.17 MPa and 1.3 ± 0.2 MPa for both the 475°C and the 
480°C sintered group respectively. 
 
Figure ‎6-10 Diametral compressive strength for different manufactured zinc glasses 
6.3.3 Cell Detachment 
Figure 6.11 shows the percentage of detached cells in relation to the initial 
cell seeding density. Overall, the percentage of the detached cells is higher 
in the uncoated scaffolds and the majority of cell detachment occurred at 
one-hour post seeding. At the first hour, the data of uncoated scaffolds 
groups revealed that about 36±2.6% and 31±4.3 % of the primarily seeded 
cells were detached in both the normal and the low attachment coated plates 
respectively with clear statistical significance in comparison with other groups 
(P<0.05). Regarding the data of the second hour, the uncoated scaffolds 
exhibited the highest percentage of detached cells which was about 25±1.8% 
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and this was significantly more than the other groups which displayed cell 
detachment of around 15%. Another significant point was found suggesting 
there is no clear effect of the seeding plate on the cells detachment of the 
same coating material.  
 
Figure ‎6-11 The percentage of detached cells from Zn O5 scaffolds(1 and 2 hours post seeding) 
displaying the most percentage of cells detachment was found in the non-coated scaffold 
groups 
Figure 6.12 displays the images of detached cells on well plates of the six 
different seeding conditions. The images confirmed the findings of figure 6.11 
in which there was more scaffold non-attached cells in the free coating glass 
scaffolds (figure 6.12 a). Though, both collagen and fibronectin coated 
scaffolds images suggested that these proteins showed low numbers of 
detached cells.  
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Figure ‎6-12 Microscope images of the seeding well plates one-hour post seeding. A. normal 
plate/ uncoated scaffold, b. normal plate/ fibronectin coated scaffold, c. normal plate/ collagen 
coated, d. low attachment plate/ uncoated scaffold, e. low attachment plate/ fibronectin coated 
scaffold and f. low attachment plate/ collagen coated 
6.3.4 Cell metabolic activity  
Figure 6.13 presents the percentage of alamar blue fluorescence reduction 
(as a percentage of fully reduced alamar blue) of the hMSCs seeded on zinc 
phosphate glass scaffold using six different seeding conditions at three time-
points. The change in fluorescence was considered as an indication of 
cellular metabolic activity where the low reduction refers to the low metabolic 
activity. Generally, the lowest reduction was found in the normal uncoated 
scaffold groups. On day 1, the highest reduction was found in the collagen 
coated scaffold that was seeded on the low attachment well plates. The 
amount of reduction was about 13.5%±0.6 which was clearly significant 
 
b 
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compared to the other groups (P<0.05). The pattern of data on day 4 and day 
7 was similar in which the collagen coated scaffolds exhibited the highest 
metabolic activity, this was followed by the fibronectin coated samples. 
Though, there was no statistical variation between the collagen and the 
fibronectin coated groups (P>0.05). The uncoated scaffolds seeded on 
normal well plates displayed the lowest metabolic activity on these two days 
with a reduction of 9±1% and 18±1.5 % on day 4 and 7 respectively. Similar 
to the detachment study results, there was no clear variation in metabolic 
activity between the same material coated scaffolds seeded using a different 
well plate. 
 
 
Figure ‎6-13 Alamar blue fluorescence reduction of the six seeding groups at three-time points 
(day 1,4,7) displaying that free coating scaffolds groups had the lowest metabolic activity 
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6.3.5 Metabolic assay (CCK Assay) 
Human mesenchymal stem cell proliferation using different conditions at 
three-time points is presented in figure 6.14. On day 1, the lowest cellular 
proliferative activity was found in the free coated scaffolds at around 
9700±600 cells, this was clearly significant from other groups that showed a 
better proliferative ability at around 15000-19000 cells. On day 4, all groups 
showed similar data in which cell numbers were doubled in comparison with 
the first day. On day 7, there was an increase in the cell number for all the 
samples. Though, the ultimate cellular growth was more prominent in the low 
attachment well plate seeded groups which was around 65000 ±2600 cells 
for the collagen coated scaffolds. The lowest significant proliferation (P<0.05) 
was noticed in the free coated scaffolds at around 34500±3900 cells.  
 
Figure ‎6-14 Cells number proliferation on different seeding groups at three-time points (day 
1,4,7) displaying that free coating scaffolds groups had the lowest proliferative ability 
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6.3.6 Confocal imaging 
Figure 6.15 presents the laser confocal imaging of hMSCs seeded on the 
strontium glass scaffolds one-week post seeding. The images exhibit 
samples of the different seeding techniques. Generally, cells seemed to have 
the ability to attach, adhere and proliferate on scaffolds irrespective of their 
seeding condition. Some images show the ability of cells to extend around 
the glass particles and follow the scaffold microstructure (figure 6.15 b and f).  
 
    
    
Figure ‎6-15 Confocal images of hMSCs seeded on strontium glass scaffolds by different 
seeding conditions. a. normal plate/ uncoated scaffold, b. normal plate/ fibronectin coated 
scaffold, c. normal plate/ collagen coated scaffold, d. low attachment plate/uncoated scaffold, e. 
low attachment plate/ fibronectin coated scaffold and f. low attachment plate/ collagen coated 
scaffold 
a 
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6.4 Discussion  
The main purpose of this chapter was to develop zinc and strontium (ZnO5, 
SrO17.5) phosphate glass 3D scaffolds based on the findings of the previous 
chapters. Glass scaffolds were made from phosphate glass powder using 
sintering technique with no other additives or porosifiers. The main reason for 
choosing this method rather than other techniques such as sol gel technique 
or the foam replica technique (Jones et al., 2006, Boccaccini et al., 2007) 
was to eliminate the effect of the other added ingredients such as polymer 
and alkoxide that is needed in other techniques. Glass powder size was 
chosen between (400µm-600 µm) to obtain the intended porosity percentage 
and the‎ porous‎ size‎ following‎Kozeny’s‎ equation‎which‎ related‎ the‎ powder‎
size to the porosity and the porous size (Skorokhod et al., 1988). The 
equation 2 correlating these variables is: 
            𝐷𝑝𝑜 =
2
3
𝑥
𝜃
1−𝜃
𝑥 𝐷𝑝𝑎 …………………….‎Equation‎2‎‎ 
Where Dpo is the intended pores size, Dpa is‎ the‎ particle‎ size‎ and‎ θ‎ is‎ the‎
porosity. Consequently, via applying 60% as the intended porosity 
percentage and 500 µm as the final intended pores size, the result of particle 
size is around 500 µm.  
The sintering procedure was performed taking into account the differential 
thermal analysis stated in the previous chapters. The sintering temperature 
was designed to be the temperature in the window of glass transition 
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temperature which is the initial temperature when glass starts to soften and 
changes from solid status to rubbery status. The range of this temperature 
was about (465°C-480°C) and (475°C-495°C) for both ZnO5 and SrO17.5 
glasses respectively. Three different temperatures were considered to 
optimise the scaffold sintering technique. The produced scaffolds 
manufactured via different sintering temperatures were studied structurally 
and mechanically to find out the optimal temperature for the scaffold 
manufacturing process. 
Regarding the porosity results performed via CT image calculation similar to 
a previous study (Alonso-Sierra et al., 2017), it was revealed that for both 
zinc and strontium scaffolds the porosity percentage tend to decrease as the 
sintering temperature increased. It changed for the strontium scaffolds from 
47 % at 480°C to around 35.5 % for 490°C and from 58% at 480°C to 40% at 
490°C for the zinc scaffolds. The objective pore size quantification followed 
the same concept of the porosity percentage in which it was around 250-400 
µm for the low sintering temperature group. It decreased gradually with 
increasing the temperature to be around 200- 350µm for the middle sintering 
parameters and ended at around <150µm for the high temperature- sintered 
scaffolds.  The explanation of this indirect relation between the sintering 
temperature and the porosity could be related to that rising temperature may 
influence the glass network and hence might cause a break up in many 
intermolecular bonds. This may decrease the glass viscosity on its way to 
changing to liquid. Consequently, the glass status might be changed as the 
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viscosity may obliterate many pores and spaces among the glass structure 
via the softened material causing a porosity reduction (Ebbing and Gammon, 
2016). According to these results, the glass produced at the highest 
temperatures (480C for Zn and 490C for Sr) yielded a low percentage of 
porosity and for this reason these temperatures were excluded as their 
scaffolds may not have the proper structural requirements that permit cellular 
growth (Jones et al., 2010). On the other hand, the glasses developed at 
other temperatures produced an acceptable porosity. Although this porosity 
is not so excessive, it was within the limit (porosity>40%) that was suggested 
in previous studies to promote osteogenic growth (Yuan et al., 2001, 
Sepulveda et al., 2002, El‐Ghannam, 2004). 
The scaffold mechanical property was assessed using the diametral 
compressive strength measurement technique. This technique is mostly 
suitable for brittle materials and materials with irregular surface preventing 
them from optimum loading and positioning by the conventional methods of 
mechanical characterisation such as compressive and tensile strength 
testing (Sakaguchi and Powers, 2012).  Scaffolds were designed as cylinders 
with 1:2 diameter height proportion (5 mm in diameter and 10 mm in height 
or thickness). This was done following the specimen preparation criteria for 
mechanical tests that was stated previously (Hing et al., 1998). These 
scaffolds were placed in adjustable two connected metal rods - holder with 
controlling screws to adjust the distance between the holder components and 
preventing the scaffolds from moving during the test. Due to the lack of 
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studies performed on phosphate glass scaffolds, the machine crosshead was 
set to 0.5 mm.min-1 following the procedure suggested for other types of 
bioceramic material (Pilliar et al., 2001). Both the strontium and the zinc 
scaffolds findings suggested that using high sintering temperatures may 
enhance the mechanical properties of the scaffold material. This was 
compatible with previous findings of which different sintering temperature 
were used in scaffold manufacturing (Jones et al., 2010). These findings may 
be explained as being due to an increase in the temperature may lead 
increased flow and thus and increase in the glass contact points attachment. 
This might result in improving the mechanical structure of the material. As a 
result of this study, it seemed that using low sintering temperature produced 
glass scaffolds with poor mechanical characteristics that cannot withstand 
the external loads and also may not support the cellular complex for enough 
time for bone formation.  
Depending on the results of the porosity and the diametral tensile strength, 
the sintering temperatures of 485 °C and 475°C were optimised for both the 
strontium and the zinc scaffolds production respectively. The scaffolds 
manufactured at these temperatures were intended to be used in in vitro 
analysis. Though, one of the obstacles in static scaffolds cellular studies is 
the poor cellular seeding as there is a high chance for cells to detach and 
flow away from the scaffold framework due to the action of culture media flow 
(Shimizu et al., 2006). This poor level of seeding can lead to biased findings 
and poor results. Consequently, proteins such as fibronectin and collagen 
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type 1 were used to enhance the cell adhesion taking into account previous 
findings (Hynes, 1992). Also, the low attachment well plates were used as 
seeding platforms because they have been used previously to ensure 
efficient stem cells seeding on microcarriers (Nie et al., 2009) .  
The detachment study was carried out by seeding the same cells number 
through different seeding techniques by coating the scaffolds with different 
materials and using different seeding plates (normal and low attachment 48-
well plates) ending in six different seeding groups. The findings of this study 
suggested that fibronectin and collagen type 1 coated scaffolds play a major 
controlling factor in seeding optimisation rather than the type of the seeding 
well plate. This can be interpreted by hypothesising that although the low 
attachment well plate can prevent the cell immobalisation on the plate 
surface, it is not necessary that the suspended cells will attach to the scaffold 
with the possibility of these cells to remain suspended within the culture 
media. For this reason, the detached cell number between different well plate 
types in the same scaffold group were slightly similar. However, the statistical 
variance was clearly present between different scaffolds (whether they were 
free scaffolds or fibronectin and collagen coated). The findings revealed that 
the coated scaffolds promoted better cell adhesion and the most positive 
results were found in the fibronectin coated groups that were non-
significantly better than the collagen coated groups. These findings were very 
compatible with a previous study that examined the intervertebral disc cells 
attachment to different types of coating proteins. The results showed that 
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fibronectin notably promoted cell adhesion more than the other coating 
proteins including collagen (Attia et al., 2011). 
The metabolic study using alamar blue was performed to estimate the effect 
of seeding technique; specifically, the coating, on the physiological metabolic 
activity of cells. This study was performed on three different days and the 
general conclusion from the results suggested that there was no clear effect 
of using different kinds of well plates (normal and low attachment). Though, 
alamar blue results explained that the scaffold coated with collagen resulted 
in the most prominent metabolic activity among the fibronectin coated and 
the free coated scaffolds. These results are very compatible with previous 
results that examined the effect of coating flask plates with different proteins 
including collagen and fibronectin and showed a higher alamar blue activity 
with collagen coated plates than that in fibronectin coated samples (Linsley 
et al., 2013).  
Indirect cellular numbers via the CCK assay revealed that the high rate of 
proliferation was found with the collagen coated scaffold followed by the 
fibronectin coated, both of these samples were significantly different from the 
uncoated scaffolds at all time points (P<0.05). Cells were initially seeded at 
20000 cells/ scaffold. Though, the cell proliferation data on the first-time point 
was less than the initial cellular seeding density. This may relate to the 
seeding procedure being performed according to the detachment study in 
which scaffolds were transferred into new plates after one hour to eliminate 
measurement of any metabolic activity due to the detached cells and 
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ensured that all the results are yielded from the cells seeded on the scaffolds 
only. Another interesting finding is that both the metabolic and the 
proliferative studies suggested that there is no clear effect of using different 
types of well plates in seeding as there is no significant difference in the 
cellular associated data (P>0.05). The only factor affecting the results is the 
variation in the scaffold coating.  
The confocal images confirmed the alamar blue and the CCK assays in 
which cells seemed to have a denser organisation and multilayer proliferation 
in collagen and fibronectin coated scaffolds in comparison with the uncoated 
scaffolds. These results were similar to the cell proliferation studies 
performed previously on fibronectin and collagen coated titanium and flask 
plate surfaces in which cell number growth was more enhanced in the 
presence of these protein coatings than the free uncoated samples (Van Den 
Dolder et al., 2003, Tsai et al., 2010).   
In conclusion, the results revealed that the glass based scaffolds were 
successfully produced by a sintering technique. Using different temperatures 
in the sintering procedure affected the mechanical properties of the produced 
scaffold. Sintering at high temperature may cause a decrease in porosity 
while sintering at low temperature may affect the glass strength negatively. 
Hence, using midpoint temperatures as 485 °C and 475°C for the strontium 
and the zinc glass scaffolds respectively was recommended because the 
scaffolds manufactured at these temperatures were within acceptable 
parameters for both structural and mechanical properties. For seeding 
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techniques, it is suggested to coat the scaffolds with either collagen or 
fibronectin, however, collagen coated scaffolds displayed slightly better 
results. Based on the findings of this chapter, null hypothesis was rejected in 
regard to the different sintering temperatures in which application of various 
temperatures in producing scaffolds may yield different mechanical and 
morphological variations between scaffolds. The null hypothesis was also 
rejected regarding seeding techniques where there was significant difference 
between cell attachment on collagen and fibronectin scaffolds compared to 
non- coated scaffolds. 
Other studies are needed to improve the mechanical properties of the 
scaffold by modifying the glass structure or the surface functionalisation to 
produce biocomposite with enhanced properties. Moreover, it is required to 
test these scaffolds in a more clinically relevant way to assess the cellular 
effects of these scaffolds within a dynamic environment. 
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Chapter 7 Determination the Effect of Cultivating Stem Cells 
on Scaffolds Under Dynamic and Static Conditions on 
Osteodifferentiation 
7.1 Introduction 
One of the main aspirations of bone tissue engineering is to produce a 
suitable biocompatible biomaterial that is cultivated with bone cells providing 
a suitable scaffold for them to expand over an extended period of time prior 
to implanting such scaffold inside the body (Chen and Hu, 2006). Bioreactors 
are systems used to fulfill the aim of translating cells and tissue based 
constructs into large-scale biological products that can be cultured for longer 
times under a controlled environment (Zhao et al., 2016). Birla (2014) stated 
that each bioreactor could have the following design requirements: bioreactor 
stimulus, culture variables (pH, oxygen and temperature), sensors for culture 
variable and stimulus (Birla, 2014). Although there are different types of 
bioreactors used successfully for bone tissue engineering such as spinner 
flasks, rotating wall and perfusion bioreactors, the latter type is the more 
preferred than the others due to its simplicity and better culture perfusion 
ability (Yeatts and Fisher, 2011).  
Many studies were carried out to investigate the effect of cultivating stem 
cells in perfusion bioreactors. One study seeded the bone marrow stem cells 
on scaffolds that was made from silicate and tricalcium phosphate (TCP). 
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These scaffolds were then cultured in a perfusion bioreactor (dynamic 
conditions) and static conditions separately. The findings showed that the 
osteodifferentiation ability of stem cells was induced more under dynamic 
conditions (Bjerre et al., 2008). Similar results were found in another study 
which aimed to prepare polymer scaffolds to repair small bone tissue defects. 
These polymer scaffolds were cultivated within mesenchymal stem cells and 
cultured in both dynamic and static conditions. The osteogenic lineage was 
found clearly in samples cultured under dynamic conditions (Kleinhans et al., 
2015). More recent research aimed to develop an automated type of 
perfusion bioreactor to control the different culture variables. Two groups of 
tricalcium phosphate scaffolds were cultured in this bioreactor for 20 days; 
one group was seeded within bone marrow stem cells whereas the other 
kept without cells. The results revealed that bone was formed in the cell 
seeded scaffolds in compare with the free cell scaffolds where no bone 
formation was noticed  (Ding et al., 2016b). 
Although there are different kinds of biomaterials used for bone repair in the 
craniofacial region using metal, ceramics or polymers, there are still 
drawbacks of using them individually. These drawbacks encouraged 
researchers to develop new types of biomaterials called biocomposites that 
are composed of a combination of more than of one of the these materials 
(Sharif et al., 2016a). These biocomposites are designed to overcome the 
drawbacks of using bioceramics or polymer individually as they aim to 
combine the flexibility presenting in polymer with the hardness  and 
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bioactivity of bioceramics resulting in a new material that has better 
properties than any of the two basic materials separately (Qidwai et al., 
2014). Will et al (2012) mentioned that there is an advantage of combining 
polymers with glass ceramics in biocomposite production as the polymer 
provides the construct with flexibility, plasticity and formability whereas the 
glass would add stiffness and mechanical strength to the composite (Will et 
al., 2012). 
There are many studies intended to fabricate different types of biocomposites 
for bone tissue engineering via including different components such as 
bioactive glasses, polycaprolactone polymer (PCL) and carbon nanotubes 
(CNT). One study compared the pins made of the PCL polymer with 
phosphate glass to the stainless-steel pins. These pins were implanted within 
in vivo environment (in rabbits) and the results showed that these hybrid pins 
were well tolerated with a minimal inflammatory reaction (Lowry et al., 1997). 
Other related attempts were performed to investigate the mechanical and the 
structural properties of the phosphate glass fibers with PCL polymer 
complex. These glass fibers-PCL composite were manufactured via either in 
situ polymerization or compression molding techniques and their results were 
promising (Ahmed et al., 2008, Khan et al., 2010). 
Other studies modified the PCL polymers to be used for bone tissue repair. 
Two academic papers examined a potential modification of the PCL-CNT 
biocomposite by using different concentrations of CNTs to reach acceptable 
mechanical and biological properties. The results showed that adding CNTs 
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to the PCL can promote better mechanical properties however this might 
affect the cellular response negatively (Mattioli-Belmonte et al., 2012, Pan et 
al., 2012). A different study related to neural tissue engineering was used 
CNT coated phosphate glass fibers as a candidate material that support 
neural growth. The findings revealed a great potential for this material to 
enhance neural growth due to the electrical properties of the CNTs and the 
morphological features of these glass fibers (Ahn et al., 2015). Despite the 
huge efforts spent on various bioactive glass biocomposites in the field of 
bone tissue engineering, there is little published on the phosphate glass 
biocomposites with most of the work performed previously was on the use of 
glass fibers or glass powder as a filler material. 
This chapter focuses mainly on manufacturing a biocomposite scaffold that is 
made mainly from zinc (ZnO5) and strontium (SrO17.5) phosphate glasses 
as core materials. These scaffolds were surface functionalised via CNT-PCL 
coating layer to enhance the glass characteristics of the scaffolds. The 
prepared scaffolds were seeded and tested within both dynamic and static 
conditions to assess the impact of culture media flow on cell activity. 
This may provide us with a better understanding of cells response to 
scaffolds materials as well as to different types of stimulus which can be of 
clinically relevant value for craniofacial bone defect applications. 
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7.2 Materials and Methods  
7.2.1 Sample preparation  
7.2.1.1 Phosphate glass scaffold preparation 
Two different compositions of phosphate glass scaffolds were developed 
based on the previous findings. The compositions were zinc (ZnO5) 
containing phosphate glass scaffolds sintered at 475 C and strontium 
(SrO17.5) phosphate glass scaffolds sintered at 485 C. Both scaffolds were 
developed following the procedure mentioned in (6.2.1). Glass scaffolds were 
prepared in two different sizes cuboidal shapes (5mmx5mm and 
5mmx10mm). 
The surfaces of some of the prepared glass scaffolds were modified by CNT-
PCL coating. Initially CNT–PCL solution was prepared by dissolving the PCL 
polymer (Sigma Aldrich, Dorset, UK) in chloroform solvent (> 99%, Sigma 
Aldrich, Dorset, UK) at a percentage of 2 wt/v %. Then, carboxylated CNT 
(manually prepared as described primarily in 5.2.2) was dispersed in the PCL 
solution at the percentage of 25µg/ml. The final produced CNT-PCL solution 
was stored in a glass container for coating scaffolds.   
The procedure of coating glass scaffolds (5mmX5mm) was preceded by 
scaffold cleaning with acetone. Coating was carried out by immersing the 
scaffolds in 10 ml of CNT-PCL polymer solution within a bath sonication for 
15 minutes to ensure that glass scaffolds were coated with CNTs. Glass 
scaffolds were then removed from the immersion glass containers and left to 
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dry in the desiccator over 12 hours. Coated scaffolds were stored for further 
studies.  
7.2.1.2 Bio Oss (control) scaffold preparation  
Bio-Oss® blocks (1cm width X 1cm height X 2cm length) (Geistlich, 
Switzerland) were used to prepare the control groups. The block heights 
were cut firstly into two halves using a diamond bur mounted on a slow 
speed engine (Dremel, USA) to obtain two half-blocks of (0.5cm X 0.5cm X 
2cm). The half block was then cut into various (5mm x 5mm) cylindrical 
shape BioOss scaffolds using a trephine bur. These cylindrical scaffolds 
were stored for further biological and non-biological tests. Other Bio Oss 
scaffolds of the dimension of 5mm x 10mm were prepared for mechanical 
testing studies.  
At the end of this stage, five groups of samples (figure 7.1) were ready for 
further analyses which are: 
1- Uncoated zinc(ZnO5) glass scaffolds named as (ZnO)  
2- CNT coated zinc (ZnO5) glass scaffolds named as (ZnO-CNT) 
3- Uncoated strontium (SrO17.5) glass scaffolds named as (SrO) 
4- CNT coated glass scaffolds named as (SrO-CNT) 
5- Bio Oss scaffolds named as (Bio Oss) 
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Figure ‎7-1 Scaffolds samples: a. Bio Oss, b. ZnO, c. ZnO-CNT, d. SrO and e. SrO-CNT 
7.2.2 Samples characterisation 
7.2.2.1 Scaffold porosity estimation 
One sample from each of the five-prepared group was scanned via a micro 
computed topography (CT) scan (Skyscan Bruker, Belgium). Porosity 
estimation and pore size quantification was performed for all the sample as 
described previously in (6.2.2.1). 
7.2.2.2 Diametral compressive strength  
Ten samples of (5mm x 10mm) from each of the formulated samples were 
mechanically tested using diametral tensile strength via Shimadzu AGS-X 
(Shimadzu co, Japan) as explained previously in (6.2.2.2). 
7.2.2.3 Scaffold degradation  
A degradation study was performed by using a triplicate of 5 mm x 5mm 
scaffolds from each of the five prepared groups at three-time point (1 month, 
2 months and 3 months) within both static and dynamic conditions. Initially 
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the scaffolds were weighed and stored in plastic vials (Sterilin tube) and then 
immersed in 25 ml of phosphate buffered saline (PBS)(Lonza.UK). 
For the static conditions, triplicate of each scaffold was incubated at 37°C for 
the whole study period. Whereas, in parallel other triplicates were used within 
dynamic studies in which scaffolds were shaken continuously at 70 rpm for 
three months using Mini Orbital shaker SO5 (Stuart Scientific, Staffordshire, 
UK).  
At each time point, scaffolds were removed from their container and left to 
dry for 6 hours at 50 °C. After dryness, scaffolds were weighed and then 
introduced again to new sterilin tubes within a fresh 25 ml of PBS.  
7.2.3 Perfusion Bioreactor System  
A multi-channel perfusion bioreactor was designed, engineered and 
constructed to study the seeded cells-scaffold complex within dynamic 
conditions aiming to mimic the fluid flow environment of the human body 
more closely than a static system.  
The perfusion bioreactor was made of plastic resin cylinders (chambers) (2.5 
cm x 5cm) which were sterilisable in autoclave and permitting for its contents 
to be visualised as they are partially transparent.  These bioreactor cylinders 
have two holes, the bottom hole and the top hole within the screw cap. The 
top screw cap is provided with O ring to secure the bioreactor cap tightly. 
Each chamber was loaded with three vertically lined up three (6.5 mm 
diameter 0.4µm pore size) polyester trans-wells inserts (Corning, USA). Each 
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trans-well in the chamber was loaded with same type of scaffold. Culture 
medium passed through the chamber at the rate of 1.25 ml/ min from its 
lower inlet hole, passed through the scaffolds and exited at the tops screw 
hole. Scaffolds in the trans-wells were surrounded with sterilised glass beads 
(Polyscience Inc., USA) to increase the culture flow through the scaffolds. 
The complete flow system was composed of five chambers, held in metal 
racks, resembling the five different scaffold groups. Culture media flow 
passed in and out the system through a group of autoclavable accessories: 
1- Heat‎resistant‎PharMed‎BPT‎tubing‎(1/4″‎outer‎and‎1/8″‎inner‎diameter)‎
(Sigma Aldrich, UK). 
2- Connectors 
3- Two glass multi-channels flow distributor (Ebers, Spain). 
4- PharMed‎ BPT‎ tubes‎ (1/8″‎ outer‎ and‎ 3/16″‎ inner‎ diameter)‎ (Sigma‎
Aldrich, UK). 
Osteogenic medium; the culture media, was prepared as the previous work 
(de Girolamo et al., 2007) by‎using‎a‎low‎glucose‎Dulbecco’s‎modified‎eagle‎
medium (DMEM), supplemented with fetal bovine serum, 
penicillin/streptomycin 1%, dexamethasone‎ (0.1‎ μM),‎ ascorbic‎ acid‎ 2-
phosphate (0.2 mM), and glycerol 2-phosphate (10 mM; the last three 
reagents were procured from Sigma–Aldrich, UK). This medium was pumped 
from a 500-ml common reservoir through the system via a peristaltic pump 
(Watson Marlow, UK). The pressure force of the peristaltic pump drove the 
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culture media from the common reservoir to the main feeding tube (PharMed 
BPT‎tubing‎1/4″‎outer‎and‎1/8″‎inner‎diameter)‎that‎was‎connected‎to‎the‎first‎
multi-channels flow distributor which was connected to the bioreactor 
chamber‎ via‎ sterilisable‎ tubes‎ (PharMed‎ BPT‎ tubes‎ 1/8″‎ outer‎ and‎ 3/16″‎
inner diameter). The main function of the glass distributor is to dispense the 
osteogenic media through and out the bioreactors chambers evenly.  Then, 
the medium was pushed out by the peristaltic pressure action. After exiting 
from the outlet, the culture media passed through the second multi-channels 
distributor to be delivered back to the common reservoir (Figure 7.2) 
 
Figure ‎7-2 Schematic diagram explaining the different parts of the perfusion bioreactor 
(common reservoir, peristallic pump and the bioreactor chambers) and the culture media flow 
direction that is notated by the arrows. This diagram was drawn by using Sketchup software 
 
The common reservoir was secured tightly with three holes Duran Cap (Eber, 
Spain), one hole for the medium outlet, one for the medium inlet and the last 
one for the gas and the oxygen perfusion through the system via 0.2 um 
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filter. The culture media was changed on a weekly basis. The whole system 
was incubated for 28 days at 37°C/ 5% CO2 as shown in (Figure 7.3). 
 
Figure ‎7-3 perfusion bioreactor 
7.2.4 Cell culture studies 
7.2.4.1 Cells preparation 
Human mesenchymal stem cells (hMSCs) were prepared following the 
procedure explained in (4.2.6.1).  
7.2.4.2 Cell Seeding 
Triplicate of each of the five prepared scaffolds (5 mm x 5 mm) groups were 
seeded within hMSCs in two separated 24-well plates (Corning, USA). 
Primarily, the prepared scaffolds were sterilised via immersion in ethanol for 
1 minute then under UV light for 20 minutes. 
The sterilised uncoated glass scaffolds and Bio Oss scaffolds were coated 
with 1 mg.ml-1 of collagen to improve the cell attachment following the 
procedure previously stated in (6.2.3.2).   
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Human mesenchymal stem cells were seeded at different seeding densities 
depending on the study; 25000 cells/scaffold for the DNA study and 100000 
cells/scaffolds for the mineralisation study. The seeded cells were prepared 
in 30 µl of culture media that was pipetted out around all the scaffold sides to 
ensure even distribution of the hMSCs through the scaffold microstructure. 
Then, the hMSCs cultured scaffolds were left for half an hour in the incubator 
to provide enough time for the cells to attach to the scaffold structure prior to 
adding 1 ml of osteogenic media for one day. On the next day, the cells of 
one of the plates were transferred into 6.5 mm trans-well and then to the 
bioreactor chambers to be assessed within dynamic conditions for 28 days, 
whereas the seeded scaffolds in the other plate were incubated at 37°C/ 5% 
CO2 to be assessed within static conditions, also for 28 days. The osteogenic 
medium for the static group was changed every three days. 
7.2.4.3 DNA Assessment 
DNA quantification assay of the hMSCs was carried out within static 
conditions to primarily assess the cellular proliferative response to the 
scaffolds materials. This study was performed at two time-points (day 7 and 
day 14) by using triplicate of seeded scaffolds at an initial density of 25000 
cells‎/‎scaffold.‎The‎culture‎media‎used‎in‎this‎study‎was‎α-MEM.  
At each time point, DNA purification was carried out by using QIAamp® DNA 
Mini kit (Qiagen). The first step of the purification was to detach the cells by 
immersing the cylindrical scaffolds in 750 µl of trypsin for 5 minutes at 37oC. 
Then, the trypsin was deactivated by adding 750µl of culture media. This 
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solution was then centrifuged and then DNA was purified from the 
centrifuged samples following the steps described previously in (5.2.7.3). The 
next step was the DNA quantification performed using Quant-iT™‎
PicoGreen™‎dsDNA‎Assay Kit (Fischer) following the kit steps as explained 
in (5.2.7.3). 
7.2.4.4 Mineralisation (Ca) Assay  
Calcium assay was carried out within both static and dynamic environments. 
The hMScs were seeded at a density of 100000 cells/discs for 28 days. On 
day 28, two scaffolds of each group were removed from their container (well-
plate or trans-well), washed twice with phosphate buffered saline PBS 
(Lonza, USA) and then agitated by a shaker for 40 minutes adding 1 ml of 
HCL to it to aid in the cell lysis. After the lysis step, triplicates of 5 ul of each 
of the scaffolds lysis liquid was transferred to 96 well-plate and about 200 ul 
of the prepared Ca working agent was added to each triplicate. Calcium 
concentration measurement were then determined following the steps 
described previously in (4.2.6.4). 
 Another two cell-free samples of each of the compositions were analysed 
individually to deduce the calcium concentration released from the scaffolds 
individually and to offset this number from that measured on the samples 
with cells. 
7.2.4.5 Scanning Electron Microscope (SEM) Images  
SEM images were taken to each sample on day 28. All scaffolds were 
removed from culture media then washed with PBS (Lonza, USA). The cells 
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were then fixed, and the scaffolds were coated prior to finally imaging them 
following the steps prescribed previously in (4.2.6.6). 
7.2.5 Statistical Analysis 
All the data apart from the degradation rate were statistically analysed using 
one-way ANOVA and Kruskal Wallis according to the data normality. 
Statistical analysis was performed to test the null hypothesis regarding both 
the scaffolds manufacturing and the cell osteodifferentiation response within 
different culture conditions; static and dynamic. 
Concerning the scaffold manufacturing, the null hypothesis stated that there 
is no structural and mechanical difference between the various produced 
prepared scaffolds; the coated and the uncoated ones, and the Bio-Oss 
scaffolds.  
Whereas for the cellular studies, the null hypothesis stated that there is no 
statistical difference of the osteodifferentiation ability of cells cultured on 
scaffolds within both static and dynamic conditions. 
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7.3 Results 
7.3.1 Scaffold porosity  
Figure 7.4 displays the scaffold porosity percentage of the different prepared 
scaffolds groups. Data showed that the Bio-Oss scaffold is the most porous 
84.6 ± 3.1%. Concerning the remaining groups, the recorded porosity was 
ranging between 42.8 to 51 % with no statistical difference between them. 
The only statistical difference was found between the higher porosity Bio-Oss 
and the other lower porosity scaffolds (P<0.05).  
Figure 7.5 presents the CT scan images of each of the scaffold groups and 
clearly confirming the statistical significance between the Bio-Oss and the 
other scaffold groups. 
 
 
Figure ‎7-4 porosity percentage of different scaffolds displaying that BioOss is the highest 
porous material. 
0
10
20
30
40
50
60
70
80
90
100
ZnO ZnO-CNT SrO SrO-CNT Bio Oss
P
o
ro
s
it
y
 p
e
rc
e
n
ta
g
e
 (
%
) 
Scaffold   
* 
299 
 
         
        
 
Figure ‎7-5 CT-cross sections of different scaffolds a. ZnO, b. ZnO-CNT, c. SrO, d. SrO-CNT and 
e. BioOss 
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7.3.2 Diametral compressive strength  
Diametral compressive strength data of the five tested scaffold groups are 
displayed in figure 7.6. The findings revealed that the CNT coated SrO 
scaffolds had the highest diametral compressive strength at 1.6 ± 0.15 MPa 
followed by the free coating SrO; both were statistically significant from the 
other groups (P<0.05). The Bio-Oss scaffolds were in the third place at about 
0.6 ± 0.06 MPa. The coated ZnO and the uncoated ZnO scaffolds were in the 
fourth and the last place respectively at around 0.3 MPa. Although coating 
scaffolds with PCL-CNT coating seemed to enhance the scaffold strength, 
this increase did not seem to be statistically significant (p>0.05). 
 
Figure ‎7-6 Diametral compressive strength for all the tested scaffolds, showing that strontium 
coated scaffolds had the highest strength among the other prepared scaffolds. 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
ZnO ZnO-CNT SrO SrO-CNT bio oss
D
ia
m
e
tr
a
l 
c
o
m
p
re
s
s
iv
e
 s
tr
e
n
g
th
 (
 M
P
a
) 
scaffold composition  
* 
* 
301 
 
7.3.3  Degradation study (mass loss) 
Percentage Mass loss of the scaffolds within dynamic conditions is presented in 
(Figure 7.7). Generally, the uncoated zinc scaffolds (ZnO) showed the highest rate 
of mass loss during the whole study period. In the first month, the mass loss of ZnO 
represented around 8.8±1.8% of the original scaffold weight which was around 
double the mass loss percentage of the other scaffolds. This pattern continued in 
the second month where all the scaffold lost around the same lost mass percentage 
as the first month. In the third month, ZnO scaffolds lost about 22 ± 2.6% of their 
original weight followed by the strontium scaffold (SrO) which lost around half that of 
the ZnO; 13±1.5%. The other groups displayed similar mass degradation 
percentage; 8-11%.  
 
Figure ‎7-7 Percentage of mass loss under dynamic condition showing that ZnO uncoated 
scaffolds had the highest degradation percentage in relating to the other groups 
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Degradation within static conditions had a similar trend to that of the dynamic 
conditions (Figure 7.8). The zinc uncoated sample exhibited the highest mass loss 
rate in comparison with the other groups in which they lost about 4±0.6% of their 
initial mass after 1 month. This increased continuously to reach 11±0.6% at the end 
of the study. The SrO uncoated scaffolds were in the second place regarding the 
percentage of their weight loss and was slightly less than that of the ZnO at around 
7.2 ±1.4% on the last day. This was followed by the Bio-Oss scaffolds whose loss in 
percentage mass was around half that of the ZnO over the whole study period. The 
CNT coated scaffolds were in the last place in which they lost percentage mass of 
around 1.2% per month. 
 
Figure ‎7-8 Percentage of mass loss under static condition showing that ZnO non-coated 
scaffolds had the highest degradation percentage in relating to the other groups 
Other interesting findings is that all scaffolds lost double the mass within 
dynamic conditions in compare to the static conditions during the whole 
experiment. 
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7.3.4 DNA assessment 
DNA concentration quantification results are shown in (Figure 7.9). The 
general trend obtained from the DNA study explained that all groups did not 
have statistical variation among them regarding their cellular DNA content. 
On day 7, both the CNT coated glass scaffolds showed the highest mean of 
DNA concentration which was around 70000 pg/ml, this was followed by the 
Bio-Oss and the uncoated scaffolds. A similar trend was found on day 14 
where the trend was the CNT coated scaffolds> the Bio Oss> the uncoated 
scaffolds. On day 14, high DNA contents were detected in the CNT coated 
scaffolds (around 240000 pg/ml) this followed by the Bio-Oss (around 
198000 pg/ml) and finally the coated scaffolds (around 150000 pg/ml). 
 
Figure ‎7-9 DNA concentration measured by pg/ml for the tested scaffolds (CNT-coated glass 
scaffolds, uncoated glass scaffolds and Bio Oss) after one week and two-week periods. 
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7.3.5 Mineralisation assay (Ca assay) 
Figure 7.10 displays the Ca assay results for the scaffolds cultured within 
both static and dynamic conditions on day 28. The general summary of the 
results revealed that the cells seeded within the dynamic conditions 
(bioreactor) had higher concentration of calcium in comparison to the cells 
within the static conditions.  
Regarding the dynamic conditions group, the cells seeded on the Bio-Oss 
scaffolds showed the highest Ca concentration which was about 29.7 ±3.1 µg 
followed by the CNT coated zinc and strontium scaffolds at around 24.7-26.3 
µg and finally the uncoated scaffolds exhibited the lowest amounts of calcium 
at around 18 µg.  
The calcium pattern within the static conditions followed the same features 
similar to the dynamic conditions. The highest calcium concentration was 
detected in the Bio-Oss groups (19.7 ± 1.8 µg) which was higher than the 
CNT coated scaffolds at around (16 µg). The uncoated scaffolds revealed the 
lowest calcium concentration at around (11.7-12.6 µg). 
 
Figure ‎7-10 Ca concentration under static and dynamic conditions revealing that more calcium 
was released under dynamic conditions 
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7.3.6 SEM imaging 
Figure 7.11 presents the hMSCs seeded on different scaffolds and cultured 
within both static and dynamic conditions on day 28. The images were taken 
at different magnifications. Generally, it appeared that the cells cultured 
within dynamic conditions exhibited higher levels of proliferation. Figure (Ai) 
displays the hMSCs and BioOss scaffold complex.   
Figure (Bi) shows the cells seeded on the uncoated strontium glass scaffolds 
cultured under static conditions. The cells were attached to the glass surface 
by their appendages following the irregularity on the scaffold surface 
platform. Similarly, the cells looked to be attached to other samples of 
uncoated glass scaffolds cultured under static conditions (figure Bii), but with 
lower cell densities than that of dynamic cultured scaffolds. It is worth 
mentioning that the glass degradation was clearly noted through the 
presence of cracks and indentations on the glass surface.  
The cells cultivated on the PCL-CNT coated strontium glass scaffolds within 
both static and dynamic conditions (figures Ci and Cii respectively) showed a 
similar trend in their results to that of the BioOSS and uncoated samples 
where cells within the dynamic culture had higher density than the static 
cultured cells. Furthermore, it can be noticed that the presence of the coating 
polymer layer with CNT on scaffolds confirmed the retention of this layer 
even within the dynamic flow of the culture media. 
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Figure ‎7-11 SEM showing cells cultured under static and dynamic conditions. (Ai) BioOss 
scaffolds under static conditions, (Aii) BioOss scaffolds under dynamic conditions, (Bi) 
uncoated strontium glass scaffolds under static conditions, (Bii) uncoated strontium glass 
scaffolds under dynamic conditions, (Ci) PCL-CNT coated strontium glass scaffolds under 
static conditions, (Cii) PCL-CNT strontium coated glass scaffolds under dynamic condition 
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7.4 Discussion 
The main aim of this chapter was to produce glass scaffolds in light of the 
results of the previous chapters and study them within dynamic conditions to 
mimic more closely, the normal physiological condition in the human body. 
Although the zinc (ZnO5) and the strontium (SrO17.5) glass scaffolds were 
prepared successfully by sintering technique in the previous chapter, the 
produced scaffolds did not possess acceptable mechanical properties. 
Therefore,‎ the‎ preliminary‎ effort‎ was‎ to‎ promote‎ scaffolds’‎ strength‎ by‎
coating them with PCL-CNT layer. PCL (polycaprolactone) polymer was 
chosen because it can be considered as a good candidate for such 
application due to both its low degradation rate and potential for long-term 
implant applications (Ma, 2004). Carbon nanotubes were added also to the 
polymer coating layer because of their potential to improve the strength of 
scaffolds used for bone repair applications (Cheng et al., 2013). The Bio-Oss 
scaffolds were used as control groups due to its clinical applicability and 
biocompatibility  as well as their high success rates (Mordenfeld et al., 2016). 
The first step following sample manufacturing coating procedure was to 
assess the morphological and the mechanical characteristics of both the 
PCL-CNT coated scaffolds and the uncoated scaffolds.  
Regarding their porosity, the findings showed that the Bio-Oss samples were 
superior in their porosity and pores sizes in compare with the other glass 
scaffold samples. Although coating scaffolds with CNT-PCL decreased the 
porosity of scaffolds, this decline in porosity did not affect the overall porosity 
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significantly which remained within the acceptable values required for bone 
repair applications.  
The diametral compressive strength was used to examine all the scaffolds as 
it is the most suitable test for such brittle materials (Sakaguchi and Powers, 
2012). The highest tensile strength was uniformly directed through the 
central portion of the diametrical plane of the specimens. This yielded in 
breaking the sample into two similar pieces. The main significant results were 
related to the coated samples of which their mechanical properties were 
slightly enhanced for the strontium (1.67 MPa) and for the zinc (0.36 MPa) in 
compare to the uncoated samples (1.38 MPa for the strontium and about 
0.29 for the zinc). This enhancement in the mechanical properties could be 
correlated to the coating layer of both the PCL and the CNT. The PCL was 
suggested to promote scaffolds and materials mechanically reducing their 
brittleness due to its binding effect (Zhang et al., 2014). Whereas adding the 
CNT incrementally was proven previously to promote the mechanical 
properties of scaffolds (Gonçalves et al., 2016).  The strontium coated 
scaffolds displayed promising results concerning the scaffold strength as it 
was slightly higher than the Bio-Oss group (0.7 MPa) and comparably better 
than the zinc scaffolds. There is a lack of information in the literature about 
the diametral compression strength of cancellous (trabecular) bone and 
hence the only information used as a reference was related to the 
compressive strength of cancellous bone which stated that the cancellous 
bone compressive strength is between 2-20MPa (Jones et al., 2010, Zheng 
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et al., 2014). Although the diametral compression strength is not comparable 
to the compression strength due to the difference in the geometry, the 
compressive strength was used as a reference to provide an idea about the 
mechanical property of the scaffold.  The degradation results revealed that 
there was a gradual mass loss during time for all the samples within both the 
static and the dynamic conditions. Within both conditions, the pattern of mass 
release was as follows: (ZnO > SrO > BioOss > ZnO-CNT and SrO-CNT). 
This could be interpreted by relating this to the difference between the ionic 
bonds strength of each group. In the glass network, the zinc and the 
strontium combine usually with the oxygen via ionic bonds. However, the 
variation in these ionic bonds strength can be linked to the strength of the 
whole glass system. The dissociation energy of the Zn-O bond is (284 Kj. 
mol-1) which is weaker than that of the Sr-O bond (454 Kj.mol-1). Hence, the 
glass group containing zinc seemed to be more susceptible to hydrolysis 
because of its weak bond strength. These results were compatible with the 
findings in the previous chapters which can also be emphasised by the 
differential thermal analysis where Tg of the glass was 452 °C and 475 °C for 
both the zinc and the strontium respectively. Though, coating glass discs with 
CNT-PCL layer changed the whole concept in which the glass degradation 
was governed by the coating layer and not by the glass composition. This 
could be due to the effect of the PCL layer which protected the scaffold 
degradation as the PCL polymers are hydrophobic polymers as well as 
having high molecular weights (Sung et al., 2004). These results were 
parallel‎ to‎ other‎ study‎ findings‎ that‎ found‎ that‎ the‎ pure‎ PCL‎ construct’s‎
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degradation was much lower than the PCL/ phosphate glass complex, and 
correlated this increase of degradation rate to the incorporation of the glass 
within the polymer (Kim et al., 2005b). This could be explained also due to 
the lower degradation rate of the PCL in compare to the phosphate glass 
(Onal et al., 2008). The results of the mass loss of the CNT-coated scaffolds 
were insignificantly different to that of the Bio-Oss.  
The mass loss study was performed using both static and dynamic 
conditions to assess the effects of the dynamic fluid flow on the scaffold 
degradation. The dynamic motion was applied at orbital movements of 70 
rpm following a previous study (Hedberg et al., 2005). The scaffolds mass 
degradation within the dynamic conditions was much higher than that of the 
static conditions. This clear variation in mass degradation findings was 
compatible with previous studies that suggested that the degradation was 
higher in scaffolds within mechanical and dynamic conditions (Yang et al., 
2008b, Kang et al., 2009). 
Following the scaffolds characterisation, an initial cell proliferation study was 
performed to determine the scaffold ability to affect stem cells and as well as 
assessing the effects of scaffold materials and microstructure on the cellular 
proliferative activity. The DNA concentration was used as an indirect way for 
cell proliferation assessment. The results after one and two weeks revealed 
that the highest DNA concentration was detected in the PCL-CNT coated 
samples being double that of the uncoated scaffolds. This could be due to 
the roughness resulting from the PCL -CNT coating layer that might improve 
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the cell attachment ability. This was in harmony with the previous results that 
correlate the surface roughness to the enhanced osteogenicity and the 
cellular proliferation (Boyan et al., 2017). These results supported the 
previous‎chapters’‎findings‎of‎the‎scaffold‎cytocompatibility. 
The next step was to design the bioreactor aiming to assess the cytological 
osteodifferentiation response of the hMSCs cultivated on the prepared 
scaffolds for extended time duration as well as comparing these results to 
those within the static conditions. 
Regarding the culture study within the dynamic conditions, a multichannel 
perfusion bioreactor was designed and installed to gain an advantage of 
allowing the oxygen and the nutrients to exchange, supplying cells in the 
deeper parts of the scaffolds and ensuring a more effective medium 
perfusion into the scaffold using spinner flasks and rotating wall bioreactors 
(Yeatts and Fisher, 2011). Furthermore, previous comparative study of 
different bioreactors designed for bone tissue engineering applications 
showed that the type of bioreactor did not have a clear effect on the 
osteodifferentiation of the stem cells but has an impact on the cell 
proliferation in which the perfusion bioreactors displayed a better cell growth 
than the other two types (Zhang et al., 2010). Moreover, there is a possibility 
for cells or scaffolds collisions because of the mechanical forces associated 
with the spinner and the rotating wall bioreactors. 
To optimise the culture media flow rate through the bioreactor, calibration 
was performed prior to the experiment within the same working conditions 
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(the culture media fluid, the type of tubes, the type of the pump head, the 
pressure in the reactor). The flow rate was fixed on the rate of 1.25 ml/ 
minutes in line with the recommendation of previous studies (Bancroft et al., 
2002, Zhao et al., 2016). 
Scaffold seeding procedures were performed by using a high concentrated 
culture media to minimise the possibility of cells to escape away from the 
scaffolds. Furthermore, the uncoated glass scaffolds and the Bio-Oss 
scaffolds were coated by collagen type 1 prior to seeding to enhance their 
initial cellular attachment (Linsley et al., 2013).  
Following the seeding procedure, scaffolds were transferred into trans-wells. 
These scaffolds were packed with sterilised glass beads to form a direct 
perfusion bioreactor by ensuring the tight sealing of the scaffold to the trans-
well wall. The direct perfusion bioreactors displayed preferable results 
regarding the cellular viability and the cytogenic marker expression in 
comparison with the indirect types. This may be related to the  enhanced 
shear strength inside the scaffold complex associated with the direct type 
(Rauh et al., 2011). The whole system parameters were controlled by using 
the incubator at 37°C/ 5 % CO2.  
 The mineralisation study results of the different scaffold groups after 4 
weeks within both the dynamic and the static conditions revealed that the 
highest mineralisation activity was seen in the Bio-Oss scaffolds followed by 
the CNT coated glass scaffolds (ZnO-CNT and SrO-CNT) and finally the 
coating free glass scaffolds (ZnO and SrO). The high calcium concentration 
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in the Bio-Oss samples could be related to the positive effect of the Bio-Oss 
in enhancing the expression of calcium related bone morphogenic proteins 
such as osteocalcin and Receptor‎Activator‎ of‎Nuclear‎ Factor‎ κ‎B (RANK) 
(Tapety et al., 2004, Chaves et al., 2012). The CNT-coated scaffolds 
displayed promising results of Ca concentration in comparison to the Bio-Oss 
which was higher by 20% than the uncoated samples. This could be due to 
the high cell proliferation that is correlated with the roughness of the coating 
layer. This increase in cell number may subsequently lead to the increase of 
the released calcium. Also it could be related to the effect of the CNT which 
may enhance the calcium ion concentration that was found previously 
(Newman et al., 2015).  
Other interesting findings that should be mentioned is that the calcium ions 
concentration within the dynamic conditions was much higher than that within 
the static conditions. These findings were previously stated in other studies 
where the mineralisation was enhanced, and the proteins were more highly 
expressed by mechanically stimulated cells via perfusion bioreactors and not 
with the normal static normal conditions (Bancroft et al., 2002, Porter et al., 
2007, Jagodzinski et al., 2008, Kleinhans et al., 2015).  
The SEM images confirmed most of the cellular study results where the cells 
displayed more proliferative activity within dynamic conditions in comparison 
to the static conditions. This was significant as it showed the ability of the 
cells to align in multi overlapped layers in some parts of the scaffold and the 
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ability to produce a larger cellular layer extending and covering the scaffold 
pores. 
In conclusion, the CNT coated scaffolds were developed successfully and 
assessed by the cellular studies within both static and dynamic conditions. 
The findings revealed that the CNT coated scaffolds can show promising 
results to be used as biomaterial for bone tissue repair when the CNT 
contents in the coating does not exceed 25ug/ml. The CNT-PCL coating 
layer improved the scaffold mechanical properties. Moreover, seeding the 
mesenchymal stem cells in the scaffolds within dynamic conditions can 
promote mineralisation and osteodifferentiation in comparison to the static 
conditions.‎The‎cellular‎studies’‎ results‎of‎ the‎CNT‎coated‎scaffolds‎did‎not‎
reveal a significant difference from the Bio-Oss scaffolds. The strontium 
glass scaffolds are more favourable to be used as scaffolds because they 
showed better mechanical properties than that of the zinc contained scaffolds 
enabling them to support the intended bone growth process. According to 
these results the null hypothesis was rejected in some points related to the 
scaffold and the Bio-Oss porosity whereas it was accepted concerning the 
mechanical and the biological properties of the phosphate-based scaffolds 
constructs. Furthermore, the null hypothesis was rejected also concerning 
the difference between the culture media conditions in which there was more 
osteodifferentiation related response in the cells cultivated within dynamic 
conditions than that in the static conditions.  
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Further studies are required to be performed to manufacture strontium 
containing phosphate-based glasses with better mechanical characteristics 
accompanied with further experiments within dynamic conditions and for a 
longer time. In vivo studies on animals may be needed in the future to study 
the effect of strontium glass scaffolds‎implantation‎on‎animals’‎bone‎growth.‎‎‎ 
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Chapter 8 Conclusions and Future Work Suggestions 
8.1  Conclusion 
The work carried out in this thesis aimed to use phosphate-based glasses as 
a biomaterial for craniofacial bone defects repair applications. The work was 
performed on a hierarchical basis starting from the basic studies performed 
on glass discs and reaching the manufacturing of phosphate glass scaffolds 
that were seeded and cultured within dynamic conditions by using custom 
made multi-channel perfusion bioreactors.  
Overall, there are six studies performed aiming to produce phosphate-based 
glass scaffolds for craniofacial bone tissue repair applications. The first and 
second studies examined four different compositions of both strontium and 
zinc phosphate glass discs respectively to obtain a primary idea about the 
physical, chemical and biological properties of the different glass 
formulations and to analyse the cellular response of these compositions. The 
following step (the third study) of this thesis aimed to use the best two 
compositions of the strontium and the zinc based glass compositions from 
the preliminary glass discs studies (the first and the second steps) to develop 
the glass in a more clinically useful form; glass beads. 
 The next phase (the fourth study) was designed to topographically modify 
the smooth glass discs surfaces by using the polycaprolactone (PCL)- CNT 
coating‎ layer.‎ This‎ experiment‎ intended‎ to‎ add‎ roughness‎ to‎ glass‎ discs’‎
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surfaces and examine both the cellular attachment and the metabolic 
properties. Following this, another study (the fifth study) was performed to 
produce porous scaffolds depending on the glass compositions obtained 
from the glass beads study. This study used sintered glass powders of 
specific size for scaffold manufacturing. This study concluded the optimal 
scaffold sintering temperatures as well as confirmed the effect of various 
temperature values on both the mechanical and the morphological 
properties. 
The final study (the sixth study) was to collect and use all the findings of the 
previous studies to manufacture phosphate glass scaffolds. In other words, it 
used the best compositions of strontium and zinc glasses obtained from the 
third study (the glass beads study) and combined them with the PCL – CNT 
coating layer taking into account the results of the fourth study. The sintering 
temperature data of the fifth study was adopted to produce these scaffolds. 
The outcome was producing sintered strontium and zinc glass scaffolds that 
were coated with PCL-CNT coating layer. Those prepared scaffolds were 
further analysed mechanically, morphologically and biologically. The next 
phase of this study was to design and manufacture a custom-made perfusion 
bioreactor to be used as a source of mechanical stimulus (dynamic 
conditions) to mimic the normal physiological in vivo conditions. This 
experiment compared the cellular osteodifferentiation activity within both 
dynamic and static conditions.  
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The first and second studies were preliminary studies to test both strontium 
and zinc containing glasses respectively in which different compositions of 
glass discs were prepared depending on previous studies. Regarding the 
strontium phosphate glass discs study (the first experiment), four different 
compositions of glass discs were prepared in which strontium oxides 
replaced calcium oxides within the glass network at different proportions 
(SrO0%, SrO1%, SrO17.5%, SrO35%). These formulations were prepared 
depending on previous studies that investigated specific formulations 
(Gentleman et al., 2010). The physical, chemical and biological aspects of all 
the prepared glass discs were assessed to find out the general effect of ion 
substitution on glass properties. The most significant results showed that an 
incorporation of strontium oxides ions in favour of calcium oxides ions in 
glass formulation might upregulate both glass degradation and ion release.  
These results were confirmed by the differential thermal analysis which 
emphasised that adding strontium to the glass structure in favour of calcium 
may have a negative effect on the glass network integrity. The cellular 
related outcomes showed that adding strontium to the glass network might 
enhance both the metabolic and the proliferative cellular responses. Though, 
the most significant effect was found in SrO 17.5 (50 P2O5 - 10Na2O - 5TiO2 
– 17.5CaO –17.5SrO) and ZnO 35 (50 P2O5 - 10Na2O - 5TiO2 – 0 CaO –35 
SrO). Both formulations were considered for further assessment. 
Regarding the second study which was focused on zinc phosphate glasses, 
four different compositions of glass discs were prepared in which zinc oxides 
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substitute calcium oxides within the glass network at different proportions 
(ZnO0%, ZnO5%, ZnO10%, ZnO10%). These formulations were prepared 
depending on previous studies that investigated specific formulations (Salih 
et al., 2007). Different glass disc formulations were assessed physically, 
chemically and biologically. The findings showed that adding zinc to the glass 
formulation instead of calcium may have a negative effect on some of the 
physical properties. This was confirmed also in differential thermal analysis 
studies. Furthermore, the incorporation of zinc oxide may enhance glass 
degradation in aqueous media which will consequently lead to enhanced 
levels of different ions release into the immersing liquid. One of these ions is 
the zinc which was found to have unfavourable cellular responses outcomes 
in case of presenting in a high concentration. These outcomes were clearly 
identified in the high zinc content formulations ZnO15 (50 P2O5 - 10Na2O - 
5TiO2 - 20CaO -15ZnO) and were compatible with previous related results 
(Abou Neel et al., 2008c). This study recommended that ZnO5 and ZnO10 
showed acceptable results that are needed to be assessed further. 
The third study intended to produce phosphate glasses in forms that are 
more clinically relevant as a step forward towards scaffold manufacturing. 
Hence, phosphate glass was produced in the form of glass beads rather than 
glass discs. Glass bead formulations were produced in four different 
compositions based on the first and the second studies which were SrO 
17.5%, SrO 35%, ZnO5% and ZnO10%. The main aim of this study was to 
examine the cellular response to spherical formed glasses and to determine 
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the most suitable strontium and zinc phosphate glass composition that might 
be used in bone tissue engineering applications. Therefore, degradation and 
ion release studies were performed initially followed by biological related 
assays. The studies confirmed the previous findings of the first and the 
second studies that clarified the link between the incorporation of metal ions 
in the glass and the mass degradation and the ion release rates. The results 
also highlighted that the zinc-based glass beads had a higher degradation 
rate than the strontium glass beads. The metabolism and the 
osteodifferentiation related studies suggested that the glass beads with less 
degradation resulted in better cellular results. The outcome of the glass bead 
study offered more information about the most suitable strontium and zinc 
containing phosphate-based glasses that were considered for the 
succeeding studies. These formulations were (50 P2O5 - 10Na2O - 5TiO2 – 
17.5CaO –17.5SrO) and (50 P2O5 - 10Na2O - 5TiO2 – 30CaO –5ZnO). 
The fourth study was implemented to determine and examine the biological 
effects of coating glass discs with specific coating materials 
(polycaprolactone (PCL)+ carbon nanotube (CNT)) that are known to 
enhance bone growth (Boyan et al., 2017). The aim of this coating procedure 
was to modify the smooth surface of glass discs that may help in cell 
attachment promotion. Initially, the strontium (SrO17.5) and the zinc (ZnO5) 
glass discs were prepared prior to coating them with PCL and CNT layer. 
Then the coated glass discs were assessed in terms of roughness and 
contact angle studies before being analysed for their cellular impacts. The 
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roughness and the contact angle studies revealed that both the roughness 
and the hydrophilicity were increased with coating. The cellular results 
showed that coating provoked cell attachment and did not exhibit any signs 
of cytotoxicity. The findings were promising concerning the cellular response 
to the coating layer and displayed a positive role of both PCL and CNT in 
enhancing the cellular attachment and proliferation. 
The fifth study intended to manufacture zinc (ZnO5) and strontium (SrO17.5) 
glass scaffolds using the glass formulations determined in the glass bead 
study (the third study). Glass scaffolds were manufactured by sintering 
technique. To optimise sintering procedure, three different glass 
temperatures were used for both strontium and zinc glass compositions. The 
applied different sintering temperatures were assigned based on the glass 
transition temperature that was determined in the first and the second 
studies. To find the optimum sintering temperature for strontium and zinc 
individually, mechanical and morphological assessments for all the produced 
scaffolds were performed. The results suggested that increasing the sintering 
temperature is directly correlated with enhancing the scaffold strength and 
was indirectly correlated with the scaffold porosity; the main morphological 
scaffold properties. These results were compatible with previously 
determined findings (Jones et al., 2010). 
Following the sintering temperature optimisation, cell seeding optimisation 
was performed. This was done because the scaffolds are porous constructs 
and there is a possibility for cells to flow away from the scaffold due to the 
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culture media flow. For this reason, different techniques were used for 
seeding optimisation by seeding in different types of well plates and coating 
the produced sintered scaffolds with different proteins such as fibronectin 
and collagen which are known for their ability to enhance cell attachment and 
cell metabolism  (Linsley et al., 2013). The outcome of the seeding 
optimisation showed that both the cell attachment and the metabolic activity 
was enhanced by coating with collagen and fibronectin. These results 
support the potential of coating scaffolds specifically with collagen. 
The last study (the sixth study) was intended to produce individual 
strontium and zinc containing phosphate glass scaffolds using all the findings 
of the previous experiments. The optimal percentages of both strontium and 
zinc were 17.5 mol% and 5 mol% respectively. These percentages provided 
the most acceptable cellular responses. The scaffolds were produced by 
using specific sintering temperatures which were 475°C and 485°C for the 
zinc and the strontium glasses respectively based on the sintering 
optimisation study (the fifth study). The produced scaffolds were further 
coated following the results of the coating study (fourth study). Initially, 
studies were performed to assess the effect of coating on the mechanical 
and the morphological properties of the scaffold. These studies aimed to 
determine if the mechanical strength of scaffolds was promoted and whether 
the scaffold porosity was significantly affected by the coating procedures. 
The findings related to the mechanical strength revealed that strength was 
enhanced after coating. Though, this rise in scaffold strength was not 
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significantly different from the uncoated scaffolds. This increase was 
probably correlated to both PCL polymer and CNT components of the 
coating layer. However, the zinc phosphate scaffolds attained lower strength 
compared to the strontium based scaffolds. The morphological related 
findings revealed that coating scaffolds with PCL-CNT layer did not have a 
clear impact on the glass scaffold porosity. Hence, PCL-CNT coated 
scaffolds were used for further cellular studies. The first study was performed 
within static conditions of which the cellular proliferation ability was analysed 
by the quantification of DNA concentration of the cultivated hMSCs on 
different scaffolds including the PCL-CNT coated scaffolds with the Bio-Oss 
scaffolds used as a control group. The results showed that all the samples 
revealed acceptable results compared to the BioOss samples. Further 
studies were performed on the same scaffolds by measuring the calcium 
concentration aiming to obtain an indication of the osteodifferentiation ability 
after cultivating the seeded scaffolds within both static and dynamic 
conditions. A perfusion bioreactor was custom made for this study and the 
calcium concentration was quantified after 4 weeks. The outcomes of this 
study suggested that cultivating cells in scaffolds within dynamic environment 
has a positive role on the osteogenic lineage stem cells differentiation. 
To conclude, the main aim of this whole study was fulfilled by producing 
different types of porous phosphate-based glass scaffolds and assessing 
these scaffolds within conditions mimicking the human body more closely. 
These scaffolds were containing either zinc or strontium in specific 
325 
 
concentrations. The determined zinc and strontium concentrations were 
found by performing many basic studies on different zinc and strontium oxide 
concentrations. The results revealed the success in manufacturing the 
scaffolds in the intended chemical composition and showed a good biological 
potential for application in the craniofacial bone repair. Strontium based 
scaffolds are more favourable in scaffold production because of their better 
mechanical properties than the zinc based constructs. Strontium containing 
glass mechanical properties were slightly better than that of the Bio-Oss. 
This may be of great clinical value and a great potential to be used for 
craniofacial region bone defects repair as their mechanical properties are 
suitable for the non-loading cancellous bone characterisations. 
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8.2 Future work 
Major areas should be assessed in future studies as following:  
1-Performing further biological related studies of strontium and zinc 
containing phosphate glass scaffolds especially those related to 
quantification of the osteodifferentiation enzymes and markers. 
2-Determination of the effect of long period (2 or 3 months) scaffold 
incubation within dynamic conditions via using a perfusion bioreactor or other 
types of bioreactors such as spinner flask or rotating wall bioreactor.  
3-In vivo application of the produced phosphate glass scaffolds. This could 
be performed by implanting the produced scaffolds specifically to the 
strontium phosphate glass scaffolds in animals such as rabbits or rats. 
Performing multiple small size defects in the animal jaw bone can be done 
prior to implanting the glass scaffolds with the other materials such as 
BioOss. This can also be used as a comparative study to measure the bone 
healing ability by using different biomaterials or without using any material.  
4-Development of novel bone biocomposites containing zinc or strontium 
glasses by using different scaffold manufacturing techniques such as the 
foam replica technique, the thermally phase separation (TIPS) technique or 
the solvent casting technique. These composites may have better 
mechanical properties than that of the scaffolds manufactured via the 
sintering technique used here. 
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